2021 |
Bonevski B, Manning V, Wynne O, Gartner C, Borland R, Baker AL, et al., 'QuitNic: A Pilot Randomized Controlled Trial Comparing Nicotine Vaping Products With Nicotine Replacement Therapy for Smoking Cessation Following Residential Detoxification.', Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 23 462-470 (2021)
|
|
|
2021 |
Rahman T, Eftekhari P, Bovill M, Baker A, Gould G, 'Socioecological mapping of barriers and enablers to smoking cessation in Indigenous Australian women during pregnancy and postpartum: A systematic review.', Nicotine Tob Res, (2021)
|
|
|
2021 |
Kelly PJ, Ingram I, Deane FP, Baker AL, McKay JR, Robinson LD, et al., 'Predictors of consent and engagement to participate in telephone delivered continuing care following specialist residential alcohol and other drug treatment', Addictive Behaviors, 117 (2021)
© 2021 Introduction and aims: Although continuing care programs have been shown to improve alcohol and other drug (AOD) treatment outcomes, uptake of continuing care has been low.... [more]
© 2021 Introduction and aims: Although continuing care programs have been shown to improve alcohol and other drug (AOD) treatment outcomes, uptake of continuing care has been low. The current study aimed to determine predictors of participants¿ who both re-confirmed consent to engage in telephone-based continuing care and commenced continuing care once they left residential AOD treatment. These participants had initially consented to partake in continuing care during the course of their residential stay. Methods: Participants were 391 individuals (232 males, 59% and 158 females, 40%) accessing therapeutic communities for AOD treatment provided by The Australian Salvation Army and We Help Ourselves (WHOS). Measures at baseline, collected during residential treatment, included demographics, primary substance of concern, abstinence goal, refusal self-efficacy, cravings for substances, mental health diagnoses, psychological distress, quality of life and feelings of loneliness. All measures were used as predictor variables to determine characteristics of participants who re-confirmed consent to engage in continuing care and commenced continuing care following residential AOD treatment. Results: Completing residential treatment, being unmarried, and higher levels of loneliness predicted re-confirmation of consent to participate in continuing care following discharge from residential treatment. Participants who were Aboriginal and/or Torres Strait Islander were less likely to provide re-confirmation of consent. Participants were more likely to commence continuing care if they completed residential treatment, were older, and had longer years of substance use. Conclusions: Tailoring continuing care programs to reach a broader array of individuals such as Indigenous populations and persons who exit treatment services early is needed to ensure these programs can reach all individuals who might need them.
|
|
|
2020 |
Kelly P, Deane F, Baker A, Byrne G, Degan T, Osborne B, et al., 'Study protocol the Continuing Care Project: a randomised controlled trial of a continuing care telephone intervention following residential substance dependence treatment (vol 20, 107, 2020)', BMC PUBLIC HEALTH, 20 (2020)
|
|
|
2020 |
Jackson MA, Brown AL, Baker AL, Dunlop AJ, Dunford A, Gould GS, 'Intensive behavioural and pharmacological treatment for tobacco dependence in pregnant women with complex psychosocial challenges: A case report', International Journal of Environmental Research and Public Health, 17 1-8 (2020)
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Up to 95% of women who use other substances also smoke tobacco during pregnancy. Challenging psychosocial circumstances a... [more]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Up to 95% of women who use other substances also smoke tobacco during pregnancy. Challenging psychosocial circumstances and other barriers that contribute to high levels of tobacco dependence result in few quitting successfully. This case report describes the treatment of a highly tobacco dependent 34-year-old pregnant woman with a history of recent substance use, mental illness and trauma, enrolled in the Incentives to Quit Tobacco in Pregnancy program. Heavy smoking, both during the day and overnight, was reported. An extensive history of quit attempts, as well as a strong desire to cease tobacco use during pregnancy, was also noted. Treatment utilising extensive behavioural supports, including financial incentives for carbon monoxide verified abstinence and telephone-based counselling, in combination with nicotine replacement therapy (NRT), was offered to assist cessation. Excellent uptake and adherence to all aspects of treatment saw tobacco cessation achieved and maintained for 24 weeks while on the program. NRT used at doses well above those recommended for pregnancy was required to alleviate strong withdrawal symptoms and maintain abstinence. Daily monitoring of carbon monoxide, financial incentives for continued abstinence and regular phone support were critical to maintaining motivation and preventing relapse to smoking. Post-program relapse to smoking did occur, as is common, and highlights the need for longer-term intensive support for pregnant women with complex behavioural and social problems. Given the prevalence of tobacco smoking in such populations, long-term harm reduction treatment models using extensive behavioural support in combination with NRT should be considered for inclusion in current smoking cessation guidelines.
|
|
|
2020 |
McKetin R, Boden JM, Foulds JA, Najman JM, Ali R, Degenhardt L, et al., 'The contribution of methamphetamine use to crime: Evidence from Australian longitudinal data', Drug and Alcohol Dependence, 216 1-6 (2020) [C1]
|
|
|
2020 |
Denham AMJ, Baker AL, Spratt NJ, Wynne O, Hunt SA, Bonevski B, Kumar R, 'YouTube as a resource for evaluating the unmet needs of caregivers of stroke survivors', Health Informatics Journal, 26 1599-1616 (2020) [C1]
© The Author(s) 2019. Content produced by caregivers of stroke survivors on the online video-sharing platform YouTube may be a good source of knowledge regarding caregivers¿ unmet... [more]
© The Author(s) 2019. Content produced by caregivers of stroke survivors on the online video-sharing platform YouTube may be a good source of knowledge regarding caregivers¿ unmet needs. We aimed to examine the content, quantity and quality of YouTube videos that target and discuss the needs and concerns of caregivers of stroke survivors. YouTube was systematically searched using six search strings, and the first 20 videos retrieved from each search were screened against the inclusion criteria. A pre-determined coding schedule was used to report the rate of unmet needs in each video. Twenty-six videos were included in the analysis. In total, 291 unmet needs were reported by caregivers of stroke survivors, an average of 11.2 unmet needs per video. The most common unmet needs domain was ¿Impact of Caregiving on Daily Activities¿ (44%). Most videos were developed in the United States (61.5%) and featured spouses of stroke survivors (65.47%). Content produced by caregivers of stroke survivors on YouTube may be used as a tool for caregivers to provide and receive support through online communication. YouTube videos offer insight into the unmet needs of caregivers of stroke survivors and may be used as an additional resource for stroke services to support caregivers.
|
|
|
2020 |
Giles A, Nasstasia Y, Baker A, Kelly B, Dascombe B, Halpin S, et al., 'Exercise as Treatment for Youth With Major Depression: The Healthy Body Healthy Mind Feasibility Study', Journal of psychiatric practice, 26 444-460 (2020) [C1]
The goals of this study were to determine the feasibility of engaging youth with major depressive disorder (MDD) in a multimodal exercise intervention (Healthy Body Healthy Mind) ... [more]
The goals of this study were to determine the feasibility of engaging youth with major depressive disorder (MDD) in a multimodal exercise intervention (Healthy Body Healthy Mind) plus usual care and to evaluate the magnitude of its effects on psychological, physical fitness, and biomarker outcomes to inform a future randomized controlled trial. Youth (15 to 25¿y of age) with MDD diagnosed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) were eligible to participate. Feasibility measures included recruitment, retention, and program adherence rates. The exercise program consisted of a single session of motivational interviewing to enhance exercise adherence, then 1-hour, small-group supervised exercise sessions 3 times per week for 12 weeks. Assessments were administered at baseline and at 12 weeks. Depression symptoms were assessed using the Beck Depression Inventory (BDI-II). Physical fitness and blood biomarkers were also measured. Three males and 10 females with MDD, who were 18 to 24 years of age, participated. Retention at 12 weeks was 86%, and attendance at exercise sessions averaged 62%±28%. After 12 weeks, 69% of participants experienced a remission of MDD based on the SCID. Mean BDI-II scores decreased from 31.9±9.1 to 13.1±10.1 [Cohen d effect size (ES)=1.96]. Improvements were observed in upper (ES=0.64) and lower (ES=0.32) body muscular endurance. Exercise session attendance was moderately correlated with changes in BDI-II scores (Pearson r=0.49). It appears feasible to attract and engage some youth with MDD in an exercise intervention. The positive impact on depression symptoms justifies further studies employing exercise interventions as an adjunct to routine care for young people with MDD.
|
|
|
2020 |
Raftery D, Kelly PJ, Deane FP, Baker AL, Ingram I, Goh MCW, et al., 'Insight in substance use disorder: A systematic review of the literature', Addictive Behaviors, 111 (2020)
© 2020 Elsevier Ltd Insight refers to a person's understanding of themselves and the world around them. Recent literature has explored people's insight into their substa... [more]
© 2020 Elsevier Ltd Insight refers to a person's understanding of themselves and the world around them. Recent literature has explored people's insight into their substance use disorder (SUD) and how this is linked to treatment adherence, abstinence rates, and comorbid mental health symptoms. The aim of this systematic review was to synthesise and critically examine the existing literature on insight in SUD. Five academic databases (Medline, PsychINFO, SCOPUS, CINAHL, Web of Science) were searched for key terms related to insight and substance use. Included studies were on humans aged 18 years or over with SUD that examined the relationship between substance use and insight using a quantifiable measure of insight. Of 10,067 identified papers, 20 met the inclusion criteria, employing 13 different measures of insight. The most commonly used measure was the Hanil Alcohol Insight Scale (HAIS) which was the only measure designed for a substance use population and was specific to alcohol use. Based on a pooled sample from five studies (n = 585), 57% of participants had poor insight, 36% had fair insight, and 7% had good insight on the HAIS. Better insight was generally related to negative consequences from substance use, better treatment adherence and maintaining abstinence. Insight appears to be an important factor to consider within SUD. Exploring the most appropriate way to measure insight and assess its role in SUD has implications for intervention design, and engaging and maintaining people with SUD in treatment.
|
|
|
2020 |
Manning V, Kelly PJ, Baker AL, 'The role of peer support and mutual aid in reducing harm from alcohol, drugs and tobacco in 2020', ADDICTIVE BEHAVIORS, 109 (2020)
|
|
|
2020 |
McKETIN R, Quinn B, Higgs P, Berk M, Dean OM, Turner A, et al., 'Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial.', Drug Alcohol Rev, (2020)
|
|
|
2020 |
Walton CJ, Bendit N, Baker AL, Carter GL, Lewin TJ, 'A randomised trial of dialectical behaviour therapy and the conversational model for the treatment of borderline personality disorder with recent suicidal and/or non-suicidal self-injury: An effectiveness study in an Australian public mental health service', Australian and New Zealand Journal of Psychiatry, 54 1020-1034 (2020) [C1]
|
|
|
2020 |
Denham AMJ, Wynne O, Baker AL, Spratt NJ, Turner A, Magin P, et al., 'An online cross-sectional survey of the health risk behaviours among informal caregivers', Health Promotion Journal of Australia, 31 423-435 (2020) [C1]
|
|
|
2020 |
Bailey KA, Baker AL, McElduff P, Kay-Lambkin F, Kavanagh DJ, 'Do outcomes of cognitive-behaviour therapy for co-occurring alcohol misuse and depression differ for participants with symptoms of posttraumatic stress?', Journal of Mental Health, (2020)
|
|
|
2020 |
Kelly PJ, Baker AL, Fagan NL, Turner A, Deane F, McKetin R, et al., 'Better Health Choices: Feasability and preliminary effectiveness of a peer delivered healthy lifestyle intervention in a community mental health setting', Addictive Behaviors, 103 (2020) [C1]
|
|
|
2020 |
Gray RM, Kelly PJ, Beck AK, Baker AL, Deane FP, Neale J, et al., 'A qualitative exploration of SMART Recovery meetings in Australia and the role of a digital platform to support routine outcome monitoring', ADDICTIVE BEHAVIORS, 101 (2020) [C1]
|
|
|
2020 |
Davis EL, Kelly PJ, Deane FP, Baker AL, Buckingham M, Degan T, Adams S, 'The relationship between patient-centered care and outcomes in specialist drug and alcohol treatment: A systematic literature review', Substance Abuse, 41 216-231 (2020) [C1]
© 2019, © 2019 Taylor & Francis Group, LLC. Background: Patient-centered care is strongly advocated as a key for improving the quality of healthcare. Research examining the ... [more]
© 2019, © 2019 Taylor & Francis Group, LLC. Background: Patient-centered care is strongly advocated as a key for improving the quality of healthcare. Research examining the impact of patient-centered care in healthcare has concluded that there are demonstrable albeit inconsistent relationships between patient experience, quality of care, and healthcare outcomes. Knowledge of the impact of patient-centered care in the treatment of substance use disorder is limited. The aim of this review was to assess relationships between indicators of patient-centered care (satisfaction and patient-reported experience measures) and patient outcomes (substance use, psychological wellbeing, and service use) among people attending treatment for substance use disorder. Methods: A systematic electronic literature search of a range of databases was conducted with variations of the search terms ¿patient-centered care¿, ¿substance use disorders¿, and residential or community specialist ¿treatment¿. The populations, interventions and outcomes were summarized and described according to the PRISMA statement. Results: A total of 25 articles were identified, of which only five included a patient-centered indicator other than satisfaction. Indicators of patient-centered care showed a generally positive association with improved outcomes, particularly between satisfaction with treatment and substance use. Nonetheless, mixed and contradictory results were not uncommon, more so for psychological wellbeing outcomes. Conclusions: There were demonstrable relationships between patient-centered indicators and outcomes for people receiving treatment for substance use disorder. However, conclusions are limited due to underrepresentation of patient-reported experience measures. Further research in the area is needed involving comparisons of patient centered indicators with outcomes and use of patient-reported experience measures together with satisfaction. Registration number: CRD42018092829.
|
|
|
2020 |
Ingram I, Kelly PJ, Deane FP, Baker AL, Goh MCW, Raftery DK, Dingle GA, 'Loneliness among people with substance use problems: A narrative systematic review', Drug and Alcohol Review, 39 447-483 (2020) [C1]
© 2020 Australasian Professional Society on Alcohol and other Drugs Issues: Despite the serious implications of loneliness on health and wellbeing, little is understood about this... [more]
© 2020 Australasian Professional Society on Alcohol and other Drugs Issues: Despite the serious implications of loneliness on health and wellbeing, little is understood about this experience across people with substance use problems. This systematic review aimed to examine: (i) correlates and predictors of loneliness; (ii) theories underpinning loneliness; (iii) methods employed to measure loneliness; and (iv) loneliness interventions for people with substance use problems. Approach: Empirical sources were identified from key databases for all publications preceding February 2019. Overall, 41 studies met the eligibility criteria and were included in the review. Key Findings: Findings from this review suggest that loneliness is related to poor physical and mental health, substance use, the quality of relationships, stigma and perception of ill treatment by others. Although cognitive theories have proposed cognitive patterns underlying the onset and maintenance of loneliness, they had not been investigated in relation to measurement or intervention efforts. Just one loneliness measure (UCLA Loneliness Scale) is valid for use with this population. Finally, only a single loneliness intervention had been trialled and was not found to be efficacious in reducing loneliness for people with substance use problems. Implications: Understanding possible links between loneliness and substance use and how to alleviate loneliness is important for this population in terms of their wellbeing and recovery. Conclusion: Loneliness is prevalent and experienced as problematic among people with substance use problems. Future research should focus on employing longitudinal designs, using validated, multidimensional measures of loneliness and on developing and trialling loneliness interventions that meet the specific needs of people with substance use problems.
|
|
|
2020 |
Denham AMJ, Wynne O, Baker AL, Spratt NJ, Turner A, Magin P, et al., 'An online survey of informal caregivers' unmet needs and associated factors', PLOS ONE, 15 (2020) [C1]
|
|
|
2020 |
Kelly P, Deane F, Byrne G, Degan T, Osborne B, Townsend C, et al., 'Study protocol the Continuing Care Project: A randomised controlled trial of a continuing care telephone intervention following residential substance dependence treatment', BMC Public Health, 20 (2020)
© 2020 The Author(s). Background: A priority area in the field of substance dependence treatment is reducing the rates of relapse. Previous research has demonstrated that telephon... [more]
© 2020 The Author(s). Background: A priority area in the field of substance dependence treatment is reducing the rates of relapse. Previous research has demonstrated that telephone delivered continuing care interventions are both clinically and cost effective when delivered as a component of outpatient treatment. This protocol describes a NSW Health funded study that assesses the effectiveness of delivering a telephone delivered continuing care intervention for people leaving residential substance treatment in Australia. Methods/design: All participants will be attending residential alcohol and other drug treatment provided by The Salvation Army or We Help Ourselves. The study will be conducted as a randomised controlled trial, where participants will be randomised to one of three treatment arms. The treatment arms will be: (i) 12-session continuing care telephone intervention; (ii) 4-session continuing care telephone intervention, or (iii) continuing care plan only. Baseline assessment batteries and development of the participants' continuing care plan will be completed prior to participants being randomised to a treatment condition. Research staff blind to the treatment condition will complete follow-up assessments with participants at 3-months and 6-months after they have been discharged from their residential service. Discussion: This study will provide comprehensive data on the effect of delivering the continuing care intervention for people exiting residential alcohol and other drug treatment. If shown to be effective, this intervention can be disseminated to improve the rates of relapse among people leaving residential alcohol and other drug treatment. Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12618001231235. Registered on 23rd July 2018. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=375621&isReview=true
|
|
|
2020 |
Beck AK, Baker AL, Carter G, Wratten C, Bauer J, Wolfenden L, et al., 'Assessing adherence, competence and differentiation in a stepped-wedge randomised clinical trial of a complex behaviour change intervention', Nutrients, 12 1-18 (2020) [C1]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Background: A key challenge in behavioural medicine is developing interventions that can be delivered adequately (i.e., w... [more]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Background: A key challenge in behavioural medicine is developing interventions that can be delivered adequately (i.e., with fidelity) within real-world consultations. Accordingly, clinical trials should (but tend not to) report what is actually delivered (adherence), how well (competence) and the distinction between intervention and comparator conditions (differentiation). Purpose: To address this important clinical and research priority, we apply best practice guidelines to evaluate fidelity within a real-world, stepped-wedge evaluation of ¿EAT: Eating As Treatment¿, a new dietitian delivered health behaviour change intervention designed to reduce malnutrition in head and neck cancer (HNC) patients undergoing radiotherapy. Methods: Dietitians (n = 18) from five Australian hospitals delivered a period of routine care and following a randomly determined order each site received training and began delivering the EAT Intervention. A 20% random stratified sample of audio-recorded consultations (control n = 196; intervention n = 194) was coded by trained, independent, raters using a study specific checklist and the Behaviour Change Counselling Inventory. Intervention adherence and competence were examined relative to apriori benchmarks. Differentiation was examined by comparing control and intervention sessions (adherence, competence, non-specific factors, and dose), via multiple linear regression, logistic regression, or mixed-models. Results: Achievement of adherence benchmarks varied. The majority of sessions attained competence. Post-training consultations were clearly distinct from routine care regarding motivational and behavioural, but not generic, skills. Conclusions: Although what level of fidelity is ¿good enough¿ remains an important research question, findings support the real-world feasibility of integrating EAT into dietetic consultations with HNC patients and provide a foundation for interpreting treatment effects.
|
|
|
2020 |
Perreault D, Baker A, Cohen L, Blanchard C, 'The influence of social climate on transformational leadership potential in young adults', Canadian Journal of Behavioural Science, 52 188-197 (2020)
© 2020 American Psychological Association. Drawing on self-determination theory, two experimental studies were designed to test the influence of social climate on leadership self-... [more]
© 2020 American Psychological Association. Drawing on self-determination theory, two experimental studies were designed to test the influence of social climate on leadership self-efficacy and transformational leadership behaviours in independent samples of university students. Across both studies, participants were randomly assigned to one of three conditions: basic needs-supportive (BNS), behaviourally controlling (BC), or psychologically controlling (PC). Participants' interim leadership self-efficacy, transformational leadership potential, group satisfaction, and group performance were subsequently evaluated. Study 1 (n = 199) and Study 2 (n = 176) found that the BNS climate predicted a significant effect on transformational leadership potential, but contrary to our hypotheses, did not have an effect on leadership self-efficacy. Furthermore, all three social climates did not reveal a significant effect on group satisfaction or performance. Overall, the findings emphasise the beneficial role of a BNS climate on leadership development in young adults.
|
|
|
2020 |
Raftery D, Kelly PJ, Deane FP, Baker AL, Dingle G, Hunt D, 'With a little help from my friends: cognitive-behavioral skill utilization, social networks, and psychological distress in SMART Recovery group attendees', Journal of Substance Use, 25 56-61 (2020) [C1]
© 2019, © 2019 Taylor & Francis Group, LLC. Objective: SMART Recovery provides cognitive behavior therapy based mutual support groups for addictions. The aim of the present ... [more]
© 2019, © 2019 Taylor & Francis Group, LLC. Objective: SMART Recovery provides cognitive behavior therapy based mutual support groups for addictions. The aim of the present study was to explore the impact of cognitive behavior skill use and the influence of a person¿s social network on psychological distress.Method: Paper based surveys were mailed out to 121 SMART Recovery groups across Australia. A sample of 75 SMART Recovery group members participated. Measures of social network size and composition, psychological distress and cognitive behavior skill use were collected.Results: There are high rates of self-reported mental illness within SMART Recovery respondents. Use of behavioral skills and social network influence was significantly associated with level of psychological distress.Discussion: The current results indicate that engaging in behavioral activation and having a social network of non-drinking or non-using people is associated with lower levels of psychological distress. Given the high rates of self-reported comorbid mental illness in this population, it is important research continues to explore the role of specific cognitive behavioral¿therapy components and social networks on recovery within mutual support groups.
|
|
|
2020 |
Denham AMJ, Wynne O, Baker AL, Spratt NJ, Loh M, Turner A, et al., 'The long-term unmet needs of informal carers of stroke survivors at home: a systematic review of qualitative and quantitative studies', DISABILITY AND REHABILITATION, (2020)
|
|
|
2020 |
Denham AM, Wynne O, Baker AL, Spratt NJ, Bonevski B, 'The unmet needs of carers of stroke survivors: An evaluation of Google search results.', Health informatics journal, 26 934-944 (2020) [C1]
|
|
|
2020 |
Forbes E, Baker AL, Britton B, Clover K, Skelton E, Oultram S, et al., 'Non-pharmacological approaches to procedural anxiety reduction for patients undergoing radiotherapy for cancer: systematic review protocol.', BMJ Open, 10 e035155 (2020)
|
|
|
2020 |
Ingram I, Kelly PJ, Deane FP, Baker AL, Dingle GA, 'Perceptions of loneliness among people accessing treatment for substance use disorders', Drug and Alcohol Review, 39 484-494 (2020) [C1]
© 2020 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: Guided by cognitive theory of loneliness, this study sought to explore the experience of... [more]
© 2020 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: Guided by cognitive theory of loneliness, this study sought to explore the experience of loneliness among people accessing treatment for substance use disorders. Specifically, contributors to, consequences and alleviators of loneliness were explored. Design and Methods: Individual semi-structured interviews were conducted with 20 participants. Interviews were conducted onsite at two residential treatment facilities in New South Wales, Australia. Interviews were audio recorded and transcribed and an iterative categorisation approach was used to guide data analysis and reporting. Results: Four key themes emerged as contributors to and consequences of loneliness: cognitions (mistrust, perceived support from others, low self-worth and fear of negative evaluation), quality and authenticity of relationships, unhelpful interpersonal behaviours and the role of substance use. Participants indicated that overcoming the cognitive and behavioural perpetuators helped to alleviate loneliness and also described the utility of support groups, pursuit of authentic relationships and activities that provide a sense of purpose as helpful. Discussion and Conclusions: Cognitions related to mistrust, lack of perceived support, low self-worth, fear of negative evaluation and identification and pursuit of meaningful relationships supportive of recovery should be key treatment targets for this population.
|
|
|
2020 |
Ingram I, Kelly PJ, Haslam C, O'Neil OJ, Deane FP, Baker AL, Dingle GA, 'Reducing loneliness among people with substance use disorders: Feasibility of Groups for Belonging ', Drug and Alcohol Review, 39 495-504 (2020) [C1]
© 2020 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: Although loneliness is common among people with substance use disorders, few interventio... [more]
© 2020 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: Although loneliness is common among people with substance use disorders, few interventions to reduce loneliness have been developed for this population. This study aimed to determine the feasibility of delivering a six-session group-based intervention, ¿Groups for Belonging¿, that builds social group connectedness. Design and Methods: Participants were 41 individuals accessing residential substance use treatment services. The primary aims of the present study were to determine indicators of feasibility of Groups for Belonging; namely, demand (recruitment, attendance and retention) for and acceptability (program adherence and participant satisfaction) of the Groups for Belonging program in residential substance use treatment settings. Results: Over half of the people attending the services were interested in participating in Groups for Belonging. Of 41 participants who commenced the program, 20 participants completed the program per protocol. In terms of acceptability, the average number of sessions attended was 3.7 (SD = 1.76, range 1¿6). Program adherence was 99.3% and overall satisfaction with the program was high, with 95% of participants reporting they enjoyed Groups for Belonging. Discussion and Conclusions: The Groups for Belonging program may be feasible for delivery in residential substance use treatment services. Findings from this study suggest that an adequately powered replication study is warranted.
|
|
|
2020 |
Kelly PJ, Beck AK, Baker AL, Deane FP, Hides L, Manning V, et al., 'Feasibility of a mobile health app for routine outcome monitoring and feedback in mutual support groups coordinated by SMART recovery Australia: Protocol for a pilot study', JMIR Research Protocols, 9 (2020)
© Peter J Kelly, Alison K Beck, Amanda L Baker, Frank P Deane, Leanne Hides, Victoria Manning, Anthony Shakeshaft, Briony Larance, Joanne Neale, John Kelly, Christopher Oldmeadow,... [more]
© Peter J Kelly, Alison K Beck, Amanda L Baker, Frank P Deane, Leanne Hides, Victoria Manning, Anthony Shakeshaft, Briony Larance, Joanne Neale, John Kelly, Christopher Oldmeadow, Andrew Searles, Carla Treloar, Rebecca M Gray, Angela Argent, Ryan McGlaughlin. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 09.07.2020. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included. Background: Despite the importance and popularity of mutual support groups, there have been no systematic attempts to implement and evaluate routine outcome monitoring (ROM) in these settings. Unlike other mutual support groups for addiction, trained facilitators lead all Self-Management and Recovery Training (SMART Recovery) groups, thereby providing an opportunity to implement ROM as a routine component of SMART Recovery groups. Objective: This study protocol aims to describe a stage 1 pilot study designed to explore the feasibility and acceptability of a novel, purpose-built mobile health (mHealth) ROM and feedback app (Smart Track) in SMART Recovery groups coordinated by SMART Recovery Australia (SRAU) The secondary objectives are to describe Smart Track usage patterns, explore psychometric properties of the ROM items (ie, internal reliability and convergent and divergent validity), and provide preliminary evidence for participant reported outcomes (such as alcohol and other drug use, self-reported recovery, and mental health). Methods: Participants (n=100) from the SMART Recovery groups across New South Wales, Australia, will be recruited to a nonrandomized, prospective, single-arm trial of the Smart Track app. There are 4 modes of data collection: (1) ROM data collected from group participants via the Smart Track app, (2) data analytics summarizing user interactions with Smart Track, (3) quantitative interview and survey data of group participants (baseline, 2-week follow-up, and 2-month follow-up), and (4) qualitative interviews with group participants (n=20) and facilitators (n=10). Feasibility and acceptability (primary objectives) will be analyzed using descriptive statistics, a cost analysis, and a qualitative evaluation. Results: At the time of submission, 13 sites (25 groups per week) had agreed to be involved. Funding was awarded on August 14, 2017, and ethics approval was granted on April 26, 2018 (HREC/18/WGONG/34; 2018/099). Enrollment is due to commence in July 2019. Data collection is due to be finalized in October 2019. Conclusions: To the best of our knowledge, this study is the first to use ROM and tailored feedback within a mutual support group setting for addictive behaviors. Our study design will provide an opportunity to identify the acceptability of a novel mHealth ROM and feedback app within this setting and provide detailed information on what factors promote or hinder ROM usage within this context. This project aims to offer a new tool, should Smart Track prove feasible and acceptable, that service providers, policy makers, and researchers could use in the future to understand the impact of SMART Recovery groups.
|
|
|
2020 |
Hides L, Baker A, Norberg M, Copeland J, Quinn C, Walter Z, et al., 'A web-based program for cannabis use and psychotic experiences in young people (keep it real): Protocol for a randomized controlled trial', JMIR Research Protocols, 9 (2020)
© Leanne Hides, Amanda Baker, Melissa Norberg, Jan Copeland, Catherine Quinn, Zoe Walter, Janni Leung, Stoyan R Stoyanov, David Kavanagh. Originally published in JMIR Research Pro... [more]
© Leanne Hides, Amanda Baker, Melissa Norberg, Jan Copeland, Catherine Quinn, Zoe Walter, Janni Leung, Stoyan R Stoyanov, David Kavanagh. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 29.07.2020. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included. Background: Young Australians (16-25 years) have the highest rates of past-month cannabis use in the world. Cannabis use increases the risk of alcohol and other drug disorders and depressive disorders, and has a robust dose-response association with psychotic experiences (PEs) and disorders. PEs are subthreshold positive psychotic symptoms, including delusions and hallucinations, which increase the risk of substance use, depressive or anxiety disorders, and psychotic disorders. Access to effective web-based early interventions targeting both cannabis use and PEs could reduce such risk in young people. Objective: The objective of this study is to determine the efficacy and cost-effectiveness of the Keep it Real web-based program compared to an information-only control website among young cannabis users (16-25 years) with PEs. Methods: Participants are recruited online, and consenting individuals meeting inclusion criteria (aged 16-25 years, who have used cannabis in the past month and experienced PEs in the past 3 months) are automatically randomized to either the Keep it Real web-based program (n=249) or an information-only control website (n=249). Both websites are self-guided (fully automated). The baseline and follow-up assessments at 3, 6, 9, and 12 months are self-completed online. Primary outcome measures are weekly cannabis use, PEs, and the relative cost-effectiveness for quality-adjusted life years. Secondary outcomes include other substance use and related problems, PE-related distress, cannabis intoxication experiences, severity of cannabis dependence, depression/anxiety symptoms, suicidality, and mental well-being and functioning. Results: Recruitment commenced in February 2019, and the results are expected to be submitted for publication in mid-2021. Conclusions: This study protocol describes a large randomized controlled trial of a new web-based program for young cannabis users experiencing PEs. If effective, the accessibility and scalability of Keep it Real could help reduce growing public health concerns about the significant social, economic, and health impacts of cannabis use.
|
|
|
2020 |
Stuart AM, Baker AL, Denham AMJ, Lee NK, Hall A, Oldmeadow C, et al., 'Psychological treatment for methamphetamine use and associated psychiatric symptom outcomes: A systematic review', Journal of Substance Abuse Treatment, 109 61-79 (2020) [C1]
© 2019 The Authors Background: Regular methamphetamine use is associated with increased rates of psychiatric symptoms. Although there has been a substantial body of research repor... [more]
© 2019 The Authors Background: Regular methamphetamine use is associated with increased rates of psychiatric symptoms. Although there has been a substantial body of research reporting on the effectiveness of psychological treatments for reducing methamphetamine use, there is a paucity of research examining the effects of these treatments on co-occurring psychiatric symptoms. We addressed this gap by undertaking a systematic review of the evidence of the effectiveness of psychological treatments for methamphetamine use on psychiatric symptom outcomes in randomized controlled trials. Methods: A narrative synthesis of studies was conducted following the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement to inform methodology. Eight electronic peer-reviewed databases were searched. Ten eligible studies were assessed. Results: Most studies found an overall reduction in levels of methamphetamine use and psychiatric symptoms among samples as a whole. Although brief interventions were effective, there is evidence that more intensive interventions have greater impact on methamphetamine use and/or psychiatric symptomatology. Intervention attendance was variable. Conclusions: The evidence suggests that a variety of psychological treatments are effective in reducing levels of methamphetamine use and improving psychiatric symptoms. Future research should consider how psychological treatments could maximize outcomes in the co-occurring domains of methamphetamine use and psychiatric symptoms, with increasing treatment attendance as a focus. PROSPERO registration number: CRD42016043657.
|
|
|
2019 |
Castle D, Baker AL, Bonevski B, 'Editorial: Smoking and Schizophrenia', FRONTIERS IN PSYCHIATRY, 10 (2019)
|
|
|
2019 |
Stain HJ, Baker AL, Jackson C, Lenroot R, Paulik G, Attia J, et al., 'Study protocol: a randomised controlled trial of a telephone delivered social wellbeing and engaged living (SWEL) psychological intervention for disengaged youth', BMC PSYCHIATRY, 19 (2019)
|
|
|
2019 |
McCrabb S, Baker AL, Attia J, Skelton E, Twyman L, Palazzi K, et al., 'Internet-based programs incorporating behavior change techniques are associated with increased smoking cessation in the general population: A systematic review and meta-analysis', Annals of Behavioral Medicine, 53 180-195 (2019) [C1]
© Society of Behavioral Medicine 2018. All rights reserved. Background and aims This study aims to (i) examine the effectiveness of internet-based smoking cessation programs; (ii)... [more]
© Society of Behavioral Medicine 2018. All rights reserved. Background and aims This study aims to (i) examine the effectiveness of internet-based smoking cessation programs; (ii) describe the number and type of behavior change techniques (BCTs) employed; and (iii) explore whether BCTs included in internet-based smoking cessation programs are related to program effectiveness. Methods MEDLINE, CINAHL, EMBASE, PsycINFO, and CENTRAL databases were searched. Randomized controlled trials were included if they described the study of a smoking cessation program delivered via the internet; included current adult tobacco smokers from the general population; and were written in English. Random effects meta-analyses and meta-regressions were used to examine program effectiveness (pooled odds ratios, by outcome measure, i.e., 7 day point prevalence abstinence [PPA], 30 day PPA, other abstinence measure) in short- and long-term outcomes, and examine the associations between BCT number and type (individual BCTs and BCT domain) and program effectiveness. Results Results from 45 studies were included (n = 65,736). Intervention effectiveness was found in the short term for all outcome measures (OR = 1.29, 95% CI 1.12, 1.50, p = .001), for "prolonged abstinence" (OR = 1.43, 95% CI 1.09, 1.87, p = .009), and "30 day PPA" (OR = 1.75, 95% CI 1.13, 2.72, p = .013). Internet-based programs were effective in the long term for all outcome measures (OR = 1.19, 95% CI = 1.06, 1.35, p = .004) and for "prolonged abstinence" (OR = 1.40, 95% CI 1.19, 1.63, p < .001). On average, interventions used more BCTs than comparison groups (6.6 vs. 3.1, p = .0002). The impact of specific individual BCTs and BCT domains on effectiveness was examined and is reported. Conclusions Internet-based smoking cessation interventions increased the odds of cessation by 29 per cent in the short term and by 19 per cent in the long term. Internet-based smoking cessation intervention development should incorporate BCTs to increase effectiveness. Registration CRD42015014676.
|
|
|
2019 |
Raftery D, Kelly PJ, Deane FP, Mcketin R, Baker AL, Turner A, Dean OM, 'Measuring cognitive insight in people with problematic substance use: An exploration of the factor validity of the Beck Cognitive Insight Scale', Drug and Alcohol Review, 38 622-629 (2019) [C1]
© 2019 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: Insight is a multi-dimensional construct that predicts treatment outcomes of people with... [more]
© 2019 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: Insight is a multi-dimensional construct that predicts treatment outcomes of people with mental illness. Research into insight in substance dependent populations is limited and measures of cognitive insight have not been validated for this population. Design and Methods: A cross sectional survey was conducted with residents of nine residential substance dependence treatment facilities in Australia. Cognitive insight was assessed using the Beck Cognitive Insight Scale (BCIS). Psychological distress was assessed using the Kessler 6 (K6). Results: Participants (N = 312) were primarily male (68.6%), with an average age of 37.51 years (SD = 9.85). Methamphetamine (45.2%) and alcohol (35.9%) were the primary substances of use. A confirmatory factor analysis confirmed the two-factor model of the BCIS (CMIN/DF = 2.91, CFI = 0.84). Removing two items from the Self-Reflection subscale improved model fit (CMIN/DF = 2.71, CFI = 0.84, ¿ 2[22, n = 312] = 76.43, P ' 0.02). Internal consistency analyses indicated acceptable internal reliability (Self-Reflection a = 0.73, Self-Certainty a = 0.72, composite a = 0.75). Self-Certainty scores were significantly higher for participants with a self-reported psychotic disorder (M = 14.95 vs. M = 13.04, P = 0.007). Self-Reflection scores were higher for people experiencing psychological distress (M = 17.57 vs. M = 15.95, P = 0.001). Discussion and Conclusions: We found that a 12-item version of the BCIS had good psychometric properties in this substance-using population. Further research is needed to explore whether insight can predict treatment outcomes for substance use.
|
|
|
2019 |
Jackson MA, Baker AL, McCarter KL, Brown AL, Gould GS, Dunlop AJ, 'Interventions for pregnant women who use tobacco and other substances: a systematic review protocol', BMJ OPEN, 9 (2019)
|
|
|
2019 |
Murray R, Baker A, Halpin S, Britton B, McCarter K, Palazzi K, Beck AK, 'Therapeutic Alliance Between Dietitians and Patients With Head and Neck Cancer: The Effect of Training in a Health Behavior Change Intervention', ANNALS OF BEHAVIORAL MEDICINE, 53 756-768 (2019) [C1]
|
|
|
2019 |
Louie E, Giannopoulos V, Baillie A, Uribe G, Byrne S, Deady M, et al., 'Translating Evidence-Based Practice for Managing Comorbid Substance Use and Mental Illness Using a Multimodal Training Package', Journal of Dual Diagnosis, 14 111-119 (2019) [C1]
|
|
|
2019 |
Lubman DI, Grigg J, Manning V, Hall K, Volpe I, Dias S, et al., 'A structured telephone-delivered intervention to reduce problem alcohol use (Ready2Change): study protocol for a parallel group randomised controlled trial', TRIALS, 20 (2019)
|
|
|
2019 |
McKetin R, Dean OM, Turner A, Kelly PJ, Quinn B, Lubman DI, et al., 'A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence', TRIALS, 20 (2019)
|
|
|
2019 |
Baker AL, Borland R, Bonevski B, Segan C, Turner A, Brophy L, et al., '"Quitlink"-A Randomized Controlled Trial of Peer Worker Facilitated Quitline Support for Smokers Receiving Mental Health Services: Study Protocol', FRONTIERS IN PSYCHIATRY, 10 (2019)
|
|
|
2019 |
Graham HL, Copello A, Griffith E, Clarke L, Walsh K, Baker AL, Birchwood M, 'Mental Health Hospital Admissions: a Teachable Moment and Window of Opportunity To Promote Change in Drug and Alcohol Misuse', International Journal of Mental Health and Addiction, 17 22-40 (2019) [C1]
© 2018, The Author(s). Hospital admissions provide a ¿teachable moment¿. Many patients admitted to mental health hospitals have co-existing substance misuse. As acute symptoms dec... [more]
© 2018, The Author(s). Hospital admissions provide a ¿teachable moment¿. Many patients admitted to mental health hospitals have co-existing substance misuse. As acute symptoms decline, a window of increased insight into factors that contributed to becoming unwell and admission may present. This study used this ¿teachable¿ opportunity to assess the acceptability of delivering a brief integrated motivational intervention (BIMI) to inpatients and the feasibility of delivery by inpatient staff. Qualitative interviews were completed with 21 inpatients experiencing co-occurring schizophrenia-related or bipolar disorder diagnoses and substance misuse who received the BIMI. Twelve staff members completed either individual interviews or a focus group. Four themes were identified from the qualitative interviews with participants; these were openness/readiness to talk about substance use, feeling valued, understanding substance use and helpful skills and processes; each with a number of subthemes. Participants appeared to find the intervention useful; although, felt they did not always have the ¿headspace¿. One theme emerged from the staff data, the acceptability of the approach for inpatient ward staff, which had four subthemes; training in the intervention; delivering the intervention; joint working; and feasibility. Staff considered the targeted style of the BIMI useful. Delivery considerations included ¿timing¿ and competing ward duties. Hospital admission presents a natural window of opportunity for staff to start conversations with inpatients about substance misuse.
|
|
|
2019 |
Nasstasia Y, Baker AL, Lewin TJ, Halpin SA, Hides L, Kelly BJ, Callister R, 'Differential treatment effects of an integrated motivational interviewing and exercise intervention on depressive symptom profiles and associated factors: A randomised controlled cross-over trial among youth with major depression', Journal of Affective Disorders, 259 413-423 (2019) [C1]
© 2019 Background: Exercise is increasingly recognised as an efficacious intervention for major depressive disorder (MDD) but to our knowledge differential treatment effects on de... [more]
© 2019 Background: Exercise is increasingly recognised as an efficacious intervention for major depressive disorder (MDD) but to our knowledge differential treatment effects on depressive symptom profiles (cognitive, somatic and affective) and associated changes in psychological, physiological and behavioural factors have not been examined among youth with MDD. Methods: Sixty-eight participants (mean age 20.8) meeting DSM-IV diagnostic criteria for MDD were randomised to an Immediate intervention or Control/delayed condition (n = 34 per group). The integrated intervention comprised an initial session of motivational interviewing (MI) followed by a 12-week, multi-modal exercise program. Changes in depressive symptom profiles were assessed with the Beck Depression Inventory-II (BDI-II) total score and factorial symptom subscales. Results: There were significant differential improvements in BDI-II total scores post-treatment among intervention participants, which were also observed across the cognitive and affective subscales. Individual BDI-II items from the cognitive subscale showing significant differential improvement related to negative self-concept, while those from the affective subscale related to interest/activation; the energy item within the somatic subscale also revealed significant differential improvement. Significant differential improvements were also observed in exercise participation, negative automatic thoughts, behavioural activation and bench press repetitions among intervention participants, which correlated significantly with depression improvements. Limitations: The exercise intervention was delivered in a supervised, group format and potential social meditators of change cannot be excluded. Conclusions: Exercise differentially effects depressive symptom profiles with similar antidepressant effects as would be expected from psychological therapies improving negative cognition and emotional health.
|
|
|
2019 |
Denham AMJ, Wynne O, Baker AL, Spratt NJ, Turner A, Magin P, et al., '"This is our life now. Our new normal": A qualitative study of the unmet needs of carers of stroke survivors', PLOS ONE, 14 (2019) [C1]
|
|
|
2019 |
Clark V, Conrad AM, Lewin TJ, Baker AL, Halpin SA, Sly KA, Todd J, 'Addiction Vulnerability: Exploring Relationships Among Cigarette Smoking, Substance Misuse, and Early Psychosis', Journal of Dual Diagnosis, 14 78-88 (2019) [C1]
|
|
|
2019 |
Britton B, Baker AL, Wolfenden L, Wratten C, Bauer J, Beck AK, et al., 'A Randomised Controlled Trial of a Health Behaviour Change Intervention Provided by Dietitians to Improve Nutrition in Patients With Head and Neck Cancer Undergoing Radiotherapy (TROG 12.03) Reply', INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 103 1283-1284 (2019)
|
|
|
2019 |
Guillaumier A, McCrabb S, Spratt NJ, Pollack M, Baker AL, Magin P, et al., 'An online intervention for improving stroke survivors' health-related quality of life: study protocol for a randomised controlled trial', TRIALS, 20 (2019)
|
|
|
2019 |
Blanchard C, Baker A, Perreault D, Mask L, Tremblay M, 'The importance of keeping employees satisfied Three prevailing factors for health organization leaders', JOURNAL OF HEALTH ORGANIZATION AND MANAGEMENT, 34 23-39 (2019)
|
|
|
2019 |
Baker A, Elnakouri A, Blanchard C, 'The Protective Role of Autonomous Motivation Against the Effects of the "Muscular Ideal" on Men's Self-Objectification, Appearance Schema Activation, and Cognitive Performance', MEDIA PSYCHOLOGY, 22 473-500 (2019)
|
|
|
2019 |
Denham AMJ, Guillaumier A, McCrabb S, Turner A, Baker AL, Spratt NJ, et al., 'Development of an online secondary prevention programme for stroke survivors: Prevent 2nd Stroke', BMJ Innovations, 5 35-42 (2019) [C1]
© 2019 Author(s). Background Stroke events often result in long-term negative health outcomes. People who experience a first stroke event are 30%-40% more likely to experience a s... [more]
© 2019 Author(s). Background Stroke events often result in long-term negative health outcomes. People who experience a first stroke event are 30%-40% more likely to experience a second stroke event within 5 years. An online secondary prevention programme for stroke survivors may help stroke survivors improve their health risk behaviours and lower their risk of a second stroke. Objectives This paper describes the development and early iteration testing of the usability and acceptability of an online secondary prevention programme for stroke survivors (Prevent 2nd Stroke, P2S). P2S aims to address six modifiable health risk behaviours of stroke: blood pressure, physical activity, nutrition, depression and anxiety, smoking, and alcohol consumption. Methods P2S was developed as an eight-module online secondary prevention programme for stroke survivors. Modelled on the DoTTI (Design and development, Testing early iterations, Testing for effectiveness, Integration and implementation) framework for the development of online programmes, the following stages were followed during programme development: (1) content development and design; and (2) testing early iteration. The programme was pilot-tested with 15 stroke survivors who assessed P2S on usability and acceptability. Results In stage 1, experts provided input for the content development of P2S. In stage 2, 15 stroke survivors were recruited for usability testing of P2S. They reported high ratings of usability and acceptability of P2S. P2S was generally regarded as easy to use' and relevant to stroke survivors'. Participants also largely agreed that it was appropriate to offer lifestyle advice to stroke survivors through the internet. Conclusions The study found that an online secondary prevention programme was acceptable and easily usable by stroke survivors. The next step is to conduct a randomised controlled trial to assess the effectiveness of the programme regarding behaviour change and determine the cost-effectiveness of the intervention.
|
|
|
2019 |
Beck AK, Forbes E, Baker AL, Britton B, Oldmeadow C, Carter G, 'Adapted motivational interviewing for brief healthcare consultations: protocol for a systematic review and meta-analysis of treatment fidelity in real-world evaluations of behaviour change counselling', BMJ OPEN, 9 (2019)
|
|
|
2019 |
Hides L, Quinn C, Stoyanov S, Kavanagh D, Baker A, 'Psychological interventions for co-occurring depression and substance use disorders', Cochrane Database of Systematic Reviews, 2019 (2019) [C1]
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Background: Comorbid depression and substance use disorders are common and have poorer outc... [more]
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Background: Comorbid depression and substance use disorders are common and have poorer outcomes than either disorder alone. While effective psychological treatments for depression or substance use disorders are available, relatively few randomised controlled trials (RCTs) have examined the efficacy of these treatments in people with these comorbid disorders. Objectives: To assess the efficacy of psychological interventions delivered alone or in combination with pharmacotherapy for people diagnosed with comorbid depression and substance use disorders. Search methods: We searched the following databases up to February 2019: Cochrane Central Register of Controlled Trials, PubMed, Embase, CINAHL, Google Scholar and clinical trials registers. All systematic reviews identified, were handsearched for relevant articles. Selection criteria: The review includes data from RCTs of psychological treatments for people diagnosed with comorbid depression and substance use disorders, using structured clinical interviews. Studies were included if some of the sample were experiencing another mental health disorder (e.g. anxiety); however, studies which required a third disorder as part of their inclusion criteria were not included. Studies were included if psychological interventions (with or without pharmacotherapy) were compared with no treatment, delayed treatment, treatment as usual or other psychological treatments. Data collection and analysis: We used standard methodological procedures expected by Cochrane. Main results: Seven RCTs of psychological treatments with a total of 608 participants met inclusion criteria. All studies were published in the USA and predominately consisted of Caucasian samples. All studies compared different types of psychological treatments. Two studies compared Integrated Cognitive Behavioural Therapy (ICBT) with Twelve Step Facilitation (TSF), another two studies compared Interpersonal Psychotherapy for Depression (IPT-D) with other treatment (Brief Supportive Therapy (BST) or Psychoeducation). The other three studies compared different types or combinations of psychological treatments. No studies compared psychological interventions with no treatment or treatment as usual control conditions. The studies included a diverse range of participants (e.g. veterans, prisoners, community adults and adolescents). All studies were at high risk of performance bias, other main sources were selection, outcome detection and attrition bias. Due to heterogeneity between studies only two meta-analyses were conducted. The first meta-analysis focused on two studies (296 participants) comparing ICBT to TSF. Very low-quality evidence revealed that while the TSF group had lower depression scores than the ICBT group at post-treatment (mean difference (MD) 4.05, 95% confidence interval (CI) 1.43 to 6.66; 212 participants), there was no difference between groups in depression symptoms (MD 1.53, 95% CI -1.73 to 4.79; 181 participants) at six- to 12-month follow-up. At post-treatment there was no difference between groups in proportion of days abstinent (MD -2.84, 95% CI -8.04 to 2.35; 220 participants), however, the ICBT group had a greater proportion of days abstinent than the TSF group at the six- to 12-month follow-up (MD 10.76, 95% CI 3.10 to 18.42; 189 participants). There were no differences between the groups in treatment attendance (MD -1.27, 95% CI -6.10 to 3.56; 270 participants) or treatment retention (RR 0.95, 95% CI 0.72 to 1.25; 296 participants). The second meta-analysis was conducted with two studies (64 participants) comparing IPT-D with other treatment (Brief Supportive Psychotherapy/Psychoeducation). Very low-quality evidence indicated IPT-D resulted in significantly lower depressive symptoms at post-treatment (MD -0.54, 95% CI -1.04 to -0.04; 64 participants), but this effect was not maintained at three-month follow-up (MD 3.80...
|
|
|
2019 |
Twyman L, Cowles C, Walsberger SC, Baker AL, Bonevski B, ' They're going to smoke anyway : A qualitative study of community mental health staff and consumer perspectives on the role of social and living environments in tobacco use and cessation', Frontiers in Psychiatry, 10 1-11 (2019) [C1]
|
|
|
2019 |
Nasstasia Y, Baker AL, Lewin TJ, Halpin SA, Hides L, Kelly BJ, Callister R, 'Engaging youth with major depression in an exercise intervention with motivational interviewing', Mental Health and Physical Activity, 17 (2019) [C1]
|
|
|
2019 |
McCrabb S, Baker AL, Attia J, Balogh ZJ, Lott N, Palazzi K, et al., 'Comorbid tobacco and other substance use and symptoms of anxiety and depression among hospitalised orthopaedic trauma patients', BMC PSYCHIATRY, 19 (2019) [C1]
|
|
|
2019 |
Sweeney R, Moodie M, Baker AL, Borland R, Castle D, Segan C, et al., 'Protocol for an Economic Evaluation of the Quitlink Randomized Controlled Trial for Accessible Smoking Cessation Support for People With Severe Mental Illness', FRONTIERS IN PSYCHIATRY, 10 (2019)
|
|
|
2019 |
Kable A, Baker A, Pond D, Southgate E, Turner A, Levi C, 'Health professionals perspectives on the discharge process and continuity of care for stroke survivors discharged home in regional Australia: A qualitative, descriptive study', Nursing and Health Sciences, 21 253-261 (2019) [C1]
© 2018 John Wiley & Sons Australia, Ltd Many stroke patients are discharged home due to advances in treatment approaches and reduced residual disability. The aim of this stu... [more]
© 2018 John Wiley & Sons Australia, Ltd Many stroke patients are discharged home due to advances in treatment approaches and reduced residual disability. The aim of this study was to understand health professionals¿ perspectives on the discharge process and continuity of care during the transition between hospital and home for stroke survivors. In this qualitative, descriptive study, we used focus groups with 25 health professionals involved in discharge processes for transition from hospital to home in 2014, in a regional area of Australia. Discontinuity in the discharge process was affected by pressure to discharge patients, discharge medications and associated risks, inadequate or late discharge summaries, and challenges involving carers. Discontinuity in post-discharge services and follow up was affected by availability of post-discharge services, number of services arranged at the time of discharge, general practitioner follow up after discharge, delays and waiting lists, carer problems, and long-term follow up. There were complex organizational barriers to the continuity of care for stroke survivors discharged home. It is important to address these deficits so that stroke survivors and their carers can make the transition home with minimal risk and adequate support following a stroke.
|
|
|
2019 |
Kelly PJ, Baker AL, Townsend CJ, Deane FP, Callister R, Collins CE, et al., 'Healthy Recovery: A Pilot Study of a Smoking and Other Health Behavior Change Intervention for People Attending Residential Alcohol and Other Substance Dependence Treatment', JOURNAL OF DUAL DIAGNOSIS, 15 207-216 (2019) [C1]
|
|
|
2019 |
Jackson MA, Brown AL, Baker AL, Gould GS, Dunlop AJ, 'The Incentives to Quit tobacco in Pregnancy (IQuiP) protocol: Piloting a financial incentive-based smoking treatment for women attending substance use in pregnancy antenatal services', BMJ Open, 9 (2019)
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. Introduction While tobacco smoking pr... [more]
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. Introduction While tobacco smoking prevalence is falling in many western societies, it remains elevated among high-priority cohorts. Rates up to 95% have been reported in women whose pregnancy is complicated by other substance use. In this group, the potential for poor pregnancy outcomes and adverse physical and neurobiological fetal development are elevated by tobacco smoking. Unfortunately, few targeted and effective tobacco dependence treatments exist to assist cessation in this population. The study will trial an evidence-based, multicomponent tobacco smoking treatment tailored to pregnant women who use other substances. The intervention comprises financial incentives for biochemically verified abstinence, psychotherapy delivered by drug and alcohol counsellors, and nicotine replacement therapy. It will be piloted at three government-based, primary healthcare facilities in New South Wales (NSW) and Victoria, Australia. The study will assess the feasibility and acceptability of the treatment when integrated into routine antenatal care offered by substance use in pregnancy antenatal services. Methods and analysis The study will use a single-arm design with pre-post comparisons. One hundred clients will be recruited from antenatal clinics with a substance use in pregnancy service. Women must be <33 weeks' gestation, =16 years old and a current tobacco smoker. The primary outcomes are feasibility, assessed by recruitment and retention and the acceptability of addressing smoking among this population. Secondary outcomes include changes in smoking behaviours, the comparison of adverse maternal outcomes and neonatal characteristics to those of a historical control group, and a cost-consequence analysis of the intervention implementation. Ethics and dissemination Protocol approval was granted by Hunter New England Human Research Ethics Committee (Reference 17/04/12/4.05), with additional ethical approval sought from the Aboriginal Health and Medical Research Council of NSW (Reference 1249/17). Findings will be disseminated via academic conferences, peer-reviewed publications and social media. Trial registration number Australia New Zealand Clinical Trial Registry (Ref: ACTRN12618000576224).
|
|
|
2018 |
Battersby M, Kidd MR, Licinio J, Aylward P, Baker A, Ratcliffe J, et al., 'Improving cardiovascular health and quality of life in people with severe mental illness: study protocol for a randomised controlled trial', TRIALS, 19 (2018)
|
|
|
2018 |
McCarter KL, Baker A, Britton B, Halpin S, Beck A, Carter G, et al., 'Head and neck cancer patient experience of a new dietitian-delivered health behaviour intervention: "You know you have to eat to survive ', SUPPORTIVE CARE IN CANCER, 26 2167-2175 (2018) [C1]
|
|
|
2018 |
McCarter KL, Baker A, Britton B, Beck A, Carter G, Bauer J, et al., 'Effectiveness of clinical practice change strategies in improving dietitian care for head and neck cancer patients according to evidence based clinical guidelines: A stepped wedge randomised controlled trial.', Translational Behavioral Medicine, 8 166-174 (2018) [C1]
|
|
|
2018 |
Ingram I, Kelly PJ, Deane FP, Baker AL, Raftery DK, 'Loneliness in Treatment-Seeking Substance-Dependent Populations: Validation of the Social and Emotional Loneliness Scale for Adults-Short Version', JOURNAL OF DUAL DIAGNOSIS, 14 211-219 (2018)
|
|
|
2018 |
Kelly PJ, Townsend CJ, Osborne BA, Baker AL, Deane FP, Keane C, et al., 'Predicting Intention to Use Nicotine Replacement Therapy in People Attending Residential Treatment for Substance Dependence.', Journal of dual diagnosis, 14 120-129 (2018) [C1]
|
|
|
2018 |
Thornton L, Kay-Lambkin F, Tebbutt B, Hanstock TL, Baker AL, 'A mobile phone Based healthy lifestyle monitoring tool for people with mental health problems (MyHealthPA): Development and pilot testing', Journal of Medical Internet Research, 20 (2018) [C1]
|
|
|
2018 |
McKetin R, Kothe A, Baker AL, Lee NK, Ross J, Lubman DI, 'Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study', Drug and Alcohol Review, 37 70-78 (2018) [C1]
© 2017 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: We previously found that residential rehabilitation increased continuous abstinence from... [more]
© 2017 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: We previously found that residential rehabilitation increased continuous abstinence from methamphetamine use 1 year after treatment. We examine what client and treatment characteristics predict this outcome. Design and Methods: Participants (n = 176) were dependent on methamphetamine and entering residential rehabilitation for methamphetamine use. Simultaneous logistic regression was used to identify independent predictors of continuous abstinence from methamphetamine use at 1 year follow-up. Measures included demographics, drug use, psychiatric comorbidity (Diagnostic and Statistical Manual of Mental Disorders, major depression, social phobia, panic disorder, schizophrenia, mania and conduct disorder), symptoms of psychosis and hostility, readiness to change, motivations for treatment and treatment characteristics (duration, rapport, group and individual counselling). Results: Participants stayed in treatment for a median of 8 weeks; 23% remained abstinent at 1 year. The only independent predictors of abstinence were more weeks in treatment [adjusted odds ratio (AOR) 1.2, P < 0.001], better rapport with treatment providers (AOR 2.4, P = 0.049) and receipt of individual counselling (AOR 3.7, P = 0.013), whereas injecting methamphetamine predicted not achieving abstinence (AOR = 0.25, P = 0.002). Individual counselling and good rapport increased abstinence to 45%; for injectors, longer stays in treatment (13+ weeks) were additionally needed to produce similar abstinence rates (43%). Discussions and Conclusions: Abstinence from methamphetamine use following residential rehabilitation could be significantly increased by providing individual counselling, maintaining good rapport with clients and ensuring longer stays for people who inject the drug. [McKetin R, Kothe A, Baker AL, Lee NK, Ross J, Lubman DI. Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study. Drug Alcohol Rev 2018;37:70¿78].
|
|
|
2018 |
Kelly PJ, Kyngdon F, Ingram I, Deane FP, Baker AL, Osborne BA, 'The Client Satisfaction Questionnaire-8: Psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment', Drug and Alcohol Review, 37 79-86 (2018) [C1]
© 2017 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: The Client Satisfaction Questionnaire (CSQ-8) is one of a limited number of standardised... [more]
© 2017 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: The Client Satisfaction Questionnaire (CSQ-8) is one of a limited number of standardised satisfaction measures that have been used widely across mental health services. This study examined the CSQ-8 as a measure of general satisfaction within residential substance abuse treatment. It compared the CSQ-8 with another established measure of client satisfaction that was developed for substance abuse treatment settings (Treatment Perceptions Questionnaire, TPQ). It also sought to examine the relationship between the CSQ-8 and commonly used process measures. Design and Methods: Cross-sectional data was collected from across 14 Australian residential medium-to-long term alcohol and other drug treatment facilities (N = 1378). Demographic, substance abuse and mental health characteristics were collected, as well as process measures of craving, general functioning, self-perceptions, recovery and symptom distress. Results: A confirmatory factory analysis established that the CSQ-8 retains a single factor. The scale was strongly correlated with the TPQ, suggesting high concurrent validity. However, while the TPQ was normally distributed, the CSQ-8 was highly negatively skewed. Significant associations were found between the CSQ-8 and cross-sectional process measures. Discussion and Conclusions: Results suggest that that CSQ-8 is an appropriate measure to be used in residential substance abuse treatment settings. However, because of the high levels of negative skew, it is likely that the TPQ is more accurate in capturing clients' dissatisfaction than the CSQ-8. Future research should include longitudinal studies of satisfaction in order to examine how changes in satisfaction may be related to client characteristics, outcome measures, dropout or re-engagement in treatment. [Kelly PJ, Kyngdon F, Ingram I, Deane FP, Baker AL, Osborne BA. The Client Satisfaction Questionnaire-8: Psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment. Drug Alcohol Rev 2018;37:79¿86].
|
|
|
2018 |
Kelly PJ, Robinson LD, Baker AL, Deane FP, Osborne B, Hudson S, Hides L, 'Quality of life of individuals seeking treatment at specialist non-government alcohol and other drug treatment services: A latent class analysis', Journal of Substance Abuse Treatment, 94 47-54 (2018) [C1]
© 2018 Elsevier Inc. Quality of Life (QOL) is increasingly being recognised as an important indicator of recovery from substance use treatment. The current study aimed to determin... [more]
© 2018 Elsevier Inc. Quality of Life (QOL) is increasingly being recognised as an important indicator of recovery from substance use treatment. The current study aimed to determine if there are distinct subclasses of QOL among a broad range of people attending specialist non-government alcohol and other drug treatment services, and how QOL might be associated with substance use, mental health, treatment and demographic characteristics of these individuals. The sample included 9958 individuals attending specialist non-government treatment for alcohol or other substance use in New South Wales, Australia. Cross sectional data on quality of life, drug use, treatment variables, psychological distress and substance dependence severity was collected. Latent class analysis was conducted to identify quality of life classes within the sample. Regression analyses were then performed to identify which individual, treatment and health outcomes were associated with these classes. Three distinct quality of life classes were identified, and termed low (n = 3048), moderate (n = 4211) and high quality of life (n = 2699). Classes differed across individual characteristics, substance use and psychological distress. As hypothesised, greater substance use and higher distress was evident in the lowest quality of life class. Quality of life is an important measure of an individuals¿ level of functioning during recovery from substance use. The identification of subgroups of individuals with substance use disorders based on their quality of life classes may help guide interventions to improve their overall global functioning and treatment outcomes.
|
|
|
2018 |
McKetin R, Lubman DI, Baker A, Dawe S, Ross J, Mattick RP, Degenhardt L, 'The relationship between methamphetamine use and heterosexual behaviour: evidence from a prospective longitudinal study', Addiction, 113 1276-1285 (2018) [C1]
© 2018 Society for the Study of Addiction Aims: To estimate the extent to which specific sexual behaviours (being sexually active, having multiple sex partners, casual sex, condom... [more]
© 2018 Society for the Study of Addiction Aims: To estimate the extent to which specific sexual behaviours (being sexually active, having multiple sex partners, casual sex, condomless casual sex, anal sex and condomless anal sex) change during periods of methamphetamine use. Design: Within-person estimates for the relationship between methamphetamine use and sexual behaviour were derived from longitudinal panel data from the Methamphetamine Treatment Evaluation Study (MATES) cohort (2006¿10). Setting: Sydney and Brisbane, Australia. Participants: Participants (n¿=¿319) were recruited through treatment and other health services, self-identified as heterosexual, were aged 17¿51¿years, 74% were male and all were dependent on methamphetamine on study entry. Measurements: Days of methamphetamine use in the past month and sexual behaviour in the past month were both assessed using the Opiate Treatment Index. Findings: When using methamphetamine, participants had double the odds of being sexually active compared with when they were not using, after adjustment for demographics and other substance use [adjusted odds ratio (aOR)¿=¿1.9, P¿=¿0.010]. When participants were sexually active, they were more likely to have multiple sex partners (aOR¿=¿3.3, P¿=¿0.001), casual sex partners (aOR¿=¿3.9, P¿<¿0.001) and condomless casual sex (aOR¿=¿2.6, P¿=¿0.012) when using methamphetamine than when they were not using. During months when participants had a casual sex partner, there was no significant reduction in their likelihood of condom use when they were using methamphetamine. There was no significant change in the likelihood of having anal sex or condomless anal sex during months of methamphetamine use. Conclusions: Methamphetamine use is associated with an increase in being sexually active, having multiple sex partners and casual sex partners and having condomless sex with casual partners, but it is not associated with a change in condom use per se.
|
|
|
2018 |
Nasstasia Y, Baker AL, Halpin SA, Hides L, Lewin TJ, Kelly BJ, Callister R, 'Evaluating the efficacy of an integrated motivational interviewing and multi-modal exercise intervention for youth with major depression: Healthy Body, Healthy Mind randomised controlled trial protocol', CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 9 13-22 (2018)
|
|
|
2018 |
Robinson M, Wilkinson RB, Fletcher R, Bruno R, Baker AL, Maher L, et al., 'Alcohol Text Messages: A Developmental Study', International Journal of Mental Health and Addiction, 16 1125-1139 (2018) [C1]
|
|
|
2018 |
McKetin R, Degenhardt L, Shanahan M, Baker AL, Lee NK, Lubman DI, 'Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact', Drug and Alcohol Review, 37 196-204 (2018) [C1]
© 2017 Australasian Professional Society on Alcohol and other Drugs Aim and background. We estimated health service utilisation attributable to methamphetamine use, its national i... [more]
© 2017 Australasian Professional Society on Alcohol and other Drugs Aim and background. We estimated health service utilisation attributable to methamphetamine use, its national impact and examined other predictors of health service utilisation among dependent methamphetamine users. Method. Past year rates of health service utilisation (number of attendances for general hospitals, psychiatric hospitals, emergency departments, general practitioners, psychiatrists, counsellors or psychologists, and dentists) were estimated for three levels of methamphetamine use (no use, < weekly, = weekly) using panel data from a longitudinal cohort of 484 dependent methamphetamine users from Sydney and Brisbane, Australia. Marginal rates for methamphetamine use were multiplied by 2013 prevalence estimates from the National Drug Strategy Household Survey. Covariates included other substance use, demographics, mental disorders and drug treatment. Findings. Health service use was high. More frequent methamphetamine use was associated with more frequent presentations to emergency departments (incidence rate ratios 1.3¿2.1) and psychiatric hospitals (incidence rate ratios 5.3¿8.3) and fewer presentations to general practitioners, dentists and counsellors. We estimate methamphetamine use accounted for between 28¿400 and 80¿900 additional psychiatric hospital admissions and 29¿700 and 151¿800 additional emergency department presentations in 2013. More frequent presentations to these services were also associated with alcohol and opioid use, comorbid mental health disorders, unemployment, unstable housing, attending drug treatment, low income and lower education. Conclusions. Frequent methamphetamine use has a significant impact on emergency medical and psychiatric services. Better provision of non-acute health care services to address the multiple health and social needs of dependent methamphetamine users may reduce the burden on these acute care services. [McKetin R, Degenhardt L, Shanahan M, Baker AL, Lee NK, Lubman DI. Health service utilisation attributable to methamphetamine use in Australia: patterns, predictors and national impact. Drug Alcohol Rev 2017;00:000¿000].
|
|
|
2018 |
Baker AL, Turner A, Beck A, Berry K, Haddock G, Kelly PJ, Bucci S, 'Telephone-delivered psychosocial interventions targeting key health priorities in adults with a psychotic disorder: Systematic review', Psychological Medicine, 48 2637-2657 (2018) [C1]
© 2018 Cambridge University Press. Background The mental and physical health of individuals with a psychotic illness are typically poor. Access to psychosocial interventions is im... [more]
© 2018 Cambridge University Press. Background The mental and physical health of individuals with a psychotic illness are typically poor. Access to psychosocial interventions is important but currently limited. Telephone-delivered interventions may assist. In the current systematic review, we aim to summarise and critically analyse evidence for telephone-delivered psychosocial interventions targeting key health priorities in adults with a psychotic disorder, including (i) relapse, (ii) adherence to psychiatric medication and/or (iii) modifiable cardiovascular disease risk behaviours.Methods Ten peer-reviewed and four grey literature databases were searched for English-language studies examining psychosocial telephone-delivered interventions targeting relapse, medication adherence and/or health behaviours in adults with a psychotic disorder. Study heterogeneity precluded meta-analyses.Results Twenty trials [13 randomised controlled trials (RCTs)] were included, involving 2473 participants (relapse prevention = 867; medication adherence = 1273; and health behaviour = 333). Five of eight RCTs targeting relapse prevention and one of three targeting medication adherence reported at least 50% of outcomes in favour of the telephone-delivered intervention. The two health-behaviour RCTs found comparable levels of improvement across treatment conditions.Conclusions Although most interventions combined telephone and face-to-face delivery, there was evidence to support the benefit of entirely telephone-delivered interventions. Telephone interventions represent a potentially feasible and effective option for improving key health priorities among people with psychotic disorders. Further methodologically rigorous evaluations are warranted.
|
|
|
2018 |
Beck AK, Baker A, Jones S, Lobban F, Kay-Lambkin F, Attia J, Banfield M, 'Exploring the feasibility and acceptability of a recovery-focused group therapy intervention for adults with bipolar disorder: trial protocol', BMJ OPEN, 8 (2018)
|
|
|
2018 |
Denham AMJ, Baker AL, Spratt N, Guillaumier A, Wynne O, Turner A, et al., 'The unmet needs of informal carers of stroke survivors: a protocol for a systematic review of quantitative and qualitative studies', BMJ OPEN, 8 (2018)
|
|
|
2018 |
Kable AK, Pond C, 'Evaluation of discharge documentation after hospitalization for stroke patients discharged home in Australia: A cross-sectional, pilot study', Nursing and Health Sciences, 20 24-30 (2018) [C1]
|
|
|
2018 |
Ezard N, Dunlop A, Hall M, Ali R, McKetin R, Bruno R, et al., 'LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence', BMJ OPEN, 8 (2018)
|
|
|
2018 |
Wynne O, Guillaumier A, Twyman L, McCrabb S, Denham AMJ, Paul C, et al., 'Signs, fines and compliance officers: A systematic review of strategies for enforcing smoke-free policy', International Journal of Environmental Research and Public Health, 15 (2018) [C1]
|
|
|
2018 |
McCarter K, Baker A, Britton B, Wolfenden L, Wratten C, bauer J, et al., 'Smoking, drinking, and depression: comorbidity in head and neck cancer patients undergoing radiotherapy', Cancer Medicine, 7 2382-2390 (2018) [C1]
|
|
|
2018 |
Stain H, Halpin S, Baker A, Startup M, Carr V, Schall U, et al., 'The impact of rurality and substance use on young people at ultra-high risk for psychosis', Early Intervention in Psychiatry, 12 1173-1180 (2018) [C1]
|
|
|
2018 |
McKetin R, Voce A, Burns R, Ali R, Lubman DI, Baker AL, Castle DJ, 'Latent Psychotic Symptom Profiles Amongst People Who Use Methamphetamine: What Do They Tell Us About Existing Diagnostic Categories?', FRONTIERS IN PSYCHIATRY, 9 (2018) [C1]
|
|
|
2018 |
Baker AL, Robson D, Lawn S, Steinberg ML, Bucci S, McNeill A, et al., 'Reducing Smoking Among People With Schizophrenia: Perspectives on Priorities for Advancing Research', FRONTIERS IN PSYCHIATRY, 9 (2018) [C1]
|
|
|
2018 |
Guillaumier A, Manning V, Wynne O, Gartner C, Borland R, Baker AL, et al., 'Electronic nicotine devices to aid smoking cessation by alcohol- and drug-dependent clients: protocol for a pilot randomised controlled trial', TRIALS, 19 (2018)
|
|
|
2018 |
Baker AL, Richmond R, Kay-Lambkin FJ, Filia SL, Castle D, Williams JM, et al., 'Randomised controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders: Outcomes to 36 months', Australian and New Zealand Journal of Psychiatry, 52 239-252 (2018) [C1]
© 2017, © The Royal Australian and New Zealand College of Psychiatrists 2017. Objective: People living with psychotic disorders (schizophrenia spectrum and bipolar disorders) have... [more]
© 2017, © The Royal Australian and New Zealand College of Psychiatrists 2017. Objective: People living with psychotic disorders (schizophrenia spectrum and bipolar disorders) have high rates of cardiovascular disease risk behaviours, including smoking, physical inactivity and poor diet. We report cardiovascular disease risk, smoking cessation and other risk behaviour outcomes over 36 months following recruitment into a two-arm randomised controlled trial among smokers with psychotic disorders. Methods: Participants (N = 235) drawn from three sites were randomised to receive nicotine replacement therapy plus (1) a Healthy Lifestyles intervention delivered over approximately 9 months or (2) a largely telephone-delivered intervention (designed to control for nicotine replacement therapy provision, session frequency and other monitoring). The primary outcome variables were 10-year cardiovascular disease risk and smoking status, while the secondary outcomes included weekly physical activity, unhealthy eating, waist circumference, psychiatric symptomatology, depression and global functioning. Results: Significant reductions in cardiovascular disease risk and smoking were detected across the 36-month follow-up period in both intervention conditions, with no significant differences between conditions. One-quarter (25.5%) of participants reported reducing cigarettes per day by 50% or more at multiple post-treatment assessments; however, few (8.9%) managed to sustain this across the majority of time points. Changes in other health behaviours or lifestyle factors were modest; however, significant improvements in depression and global functioning were detected over time in both conditions. Participants experiencing worse ¿social discomfort¿ at baseline (e.g. anxiety, mania, poor self-esteem and social disability) had on average significantly worse global functioning, lower scores on the 12-Item Short Form Health Survey physical scale and significantly greater waist circumference. Conclusion: Although the telephone-delivered intervention was designed as a comparison condition, it achieved excellent retention and comparable outcomes. Telephone-delivered smoking cessation support may potentially help to reduce smoking rates among people with psychotic disorders. Discomfort in social situations may also be a useful target for future health interventions, addressing confidence and social skills, and promoting social networks that reduce inactivity.
|
|
|
2018 |
Hobden B, Bryant J, Carey M, Baker AL, Farrell M, Oldmeadow C, et al., 'Finding the optimal treatment model: A systematic review of treatment for co-occurring alcohol misuse and depression', Australian and New Zealand Journal of Psychiatry, 52 737-750 (2018) [C1]
© The Royal Australian and New Zealand College of Psychiatrists 2018. Objectives: Alcohol misuse and depression are commonly co-occurring conditions. To date, no review has examin... [more]
© The Royal Australian and New Zealand College of Psychiatrists 2018. Objectives: Alcohol misuse and depression are commonly co-occurring conditions. To date, no review has examined the most efficacious treatment model for psychosocial treatment of co-occurring alcohol misuse and depression. This systematic review determined the: (i) methodological quality of publications examining psychosocial treatment of co-occurring alcohol misuse and depression using a sequential, parallel or integrated treatment model; and (ii) effectiveness of each dual treatment model compared to single treatment for those with co-occurring alcohol misuse and depression. Methods: PubMed, Medline and PsycInfo databases were searched for studies which were included if they involved treatment for alcohol misuse and depression and could be classified into one of the three treatment models. Included studies were assessed using the Cochrane¿s Effective Practice and Organisation of Care risk of bias criteria. Relevant study characteristics and outcomes were extracted and are presented in a narrative review format. Results: Seven studies met inclusion criteria. None were categorised as low risk on the risk of bias criteria. No studies examined a sequential model of treatment, three examined a parallel model and four examined an integrated model of dual-focussed treatment. The studies examining the parallel model and two out of four studies examining the effectiveness of an integrated model demonstrated greater improvement for alcohol or depression outcomes compared to control conditions. Conclusion: Evidence for the psychosocial treatment of co-occurring alcohol misuse and depression is limited to a handful of studies. The evidence has several methodological limitations, which impact the interpretation of the findings. Therefore, while international guidelines recommend integrated dual-focussed treatment for co-occurring conditions, there is little evidence supporting the superiority of this treatment format for co-occurring alcohol misuse and depression. High-quality research demonstrating improvements in patient outcomes is required to ensure recommendations for clinical practice are based on strong empirical evidence.
|
|
|
2018 |
Baker A, 'Addiction and Change, 2nd edition, How Addictions Develop and Addicted People Recover', DRUG AND ALCOHOL REVIEW, 37 818-818 (2018)
|
|
|
2018 |
McCarter K, Britton B, Baker AL, Halpin SA, Beck AK, Carter G, et al., 'Interventions to improve screening and appropriate referral of patients with cancer for psychosocial distress: Systematic review', BMJ Open, 8 (2018) [C1]
|
|
|
2017 |
Bonevski B, Borland R, Paul CL, Richmond RL, Farrell M, Baker A, et al., 'No smoker left behind: it's time to tackle tobacco in Australian priority populations', MEDICAL JOURNAL OF AUSTRALIA, 207 141-+ (2017)
|
|
|
2017 |
Hitsman B, Baker AL, King A, 'POINT: Are Advanced Practice Professionals More Likely to Achieve Better Tobacco Cessation Results than Physicians? Yes', Chest, 152 466-469 (2017) [C1]
|
|
|
2017 |
Kelly PJ, Robinson LD, Baker AL, Deane FP, McKetin R, Hudson S, Keane C, 'Polysubstance use in treatment seekers who inject amphetamine: Drug use profiles, injecting practices and quality of life', Addictive Behaviors, 71 25-30 (2017) [C1]
© 2017 Elsevier Ltd Background The injection of amphetamine is becoming increasingly common. However, there has been a lack of research examining people who inject amphetamine as ... [more]
© 2017 Elsevier Ltd Background The injection of amphetamine is becoming increasingly common. However, there has been a lack of research examining people who inject amphetamine as the primary drug of use, limiting the potential to ensure services address the unique needs of this group. The current study used latent class analysis to identify classes of polydrug use among people who report injecting amphetamine during the past 12¿months. It also examined differences between classes and drug use patterns, injecting practices, quality of life and psychological distress. Methods Participants who were attending non-government specialist alcohol and other drug treatment across New South Wales, Australia and had identified amphetamine as their principle drug of concern and reported injecting amphetamine in the previous 12¿months were included in the current study (N¿=¿827). Latent class analysis was performed to identify polydrug profiles of participants. Results The large majority of people in the current study (85%) demonstrated low probability of heroin or other opiate use. Three distinct classes of polydrug use were identified: (1) Low-polydrug (n¿=¿491), (2) Opiates-polydrug (n¿=¿123), and (3) Alcohol-polydrug (n¿=¿213). There was a trend for the Low-polydrug class to demonstrate better functioning and safer injecting practices than the Opiates-polydrug and Alcohol-polydrug classes. Conclusion The results suggest that the majority of people accessing treatment who inject amphetamine as their primary drug of choice have a low probability of heroin or other opiate use. It is important that future research consider whether traditional harm minimisation strategies are appropriate for people who primarily inject amphetamine.
|
|
|
2017 |
Beck AK, Britton B, Baker A, Odelli C, Wratten C, Bauer J, et al., 'Preliminary report: training head and neck cancer dietitians in behaviour change counselling', Psycho-Oncology, 26 405-407 (2017) [C1]
|
|
|
2017 |
Bailey KA, Baker AL, McElduff P, Jones MA, Oldmeadow C, Kavanagh DJ, 'Effects of Assault Type on Cognitive Behaviour Therapy for Coexisting Depression and Alcohol Misuse', JOURNAL OF CLINICAL MEDICINE, 6 (2017) [C1]
|
|
|
2017 |
Kay-Lambkin FJ, Baker AL, Palazzi K, Lewin TJ, Kelly BJ, 'Therapeutic Alliance, Client Need for Approval, and Perfectionism as Differential Moderators of Response to eHealth and Traditionally Delivered Treatments for Comorbid Depression and Substance Use Problems', International Journal of Behavioral Medicine, 24 728-739 (2017) [C1]
|
|
|
2017 |
Thornton L, Handley T, Kay-Lambkin F, Baker A, 'Is A Person Thinking About Suicide Likely to Find Help on the Internet? An Evaluation of Google Search Results', Suicide and Life-Threatening Behavior, 47 48-53 (2017) [C1]
© 2016 The American Association of Suicidology It is unclear whether individuals searching the Internet for assistance with thoughts of suicide are likely to encounter predominant... [more]
© 2016 The American Association of Suicidology It is unclear whether individuals searching the Internet for assistance with thoughts of suicide are likely to encounter predominantly helpful or harmful resources. This study investigated websites retrieved by searching Google for information and support for suicidal thoughts. Google searches retrieved a high percentage of irrelevant websites (26%, n¿=¿136). Of the 329 relevant websites retrieved, the majority were suicide preventive (68%); however, a considerable proportion of sites expressed mixed (22%) or neutral (8%) suicide attitudes, and 1% were explicitly pro-suicide. The results highlight a need for suicide prevention organization websites to be made more easily accessible. In the meantime, clinicians should be aware of appropriate websites to recommend to clients.
|
|
|
2017 |
Paul CL, Cox ME, Small HJ, Boyes AW, O'Brien L, Rose SK, et al., 'Techniques for Improving Communication of Emotional Content in Text-Only Web-Based Therapeutic Communications: Systematic Review', JMIR MENTAL HEALTH, 4 (2017)
|
|
|
2017 |
McCrabb S, Baker AL, Attia J, Balogh ZJ, Lott N, Naylor J, et al., 'Smoke-free recovery from trauma surgery: A pilot trial of an online smoking cessation program for orthopaedic trauma patients', International Journal of Environmental Research and Public Health, 14 1-12 (2017) [C1]
|
|
|
2017 |
Britton B, Baker A, Clover K, McElduff P, Wratten C, Carter G, 'Heads Up: a pilot trial of a psychological intervention to improve nutrition in head and neck cancer patients undergoing radiotherapy', EUROPEAN JOURNAL OF CANCER CARE, 26 (2017) [C1]
|
|
|
2017 |
Stuart A, Baker AL, Bowman J, McCarter K, Denham AMJ, Lee N, et al., 'Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes', BMJ OPEN, 7 (2017)
|
|
|
2017 |
McKetin R, Baker AL, Dawe S, Voce A, Lubman DI, 'Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders', Psychiatry Research, 251 349-354 (2017) [C1]
© 2017 We examined the lifetime experience of hallucinations and delusions associated with transient methamphetamine-related psychosis (MAP), persistent MAP and primary psychosis ... [more]
© 2017 We examined the lifetime experience of hallucinations and delusions associated with transient methamphetamine-related psychosis (MAP), persistent MAP and primary psychosis among a cohort of dependent methamphetamine users. Participants were classified as having (a) no current psychotic symptoms, (n=110); (b) psychotic symptoms only when using methamphetamine (transient MAP, n=85); (c) psychotic symptoms both when using methamphetamine and when abstaining from methamphetamine (persistent MAP, n=37), or (d) meeting DSM-IV criteria for lifetime schizophrenia or mania (primary psychosis, n=52). Current psychotic symptoms were classified as a score of 4 or more on any of the Brief Psychiatric Rating Scale items of suspiciousness, hallucinations or unusual thought content in the past month. Lifetime psychotic diagnoses and symptoms were assessed using the Composite International Diagnostic Interview. Transient MAP was associated with persecutory delusions and tactile hallucinations (compared to the no symptom group). Persistent MAP was additionally associated with delusions of reference, thought interference and complex auditory, visual, olfactory and tactile hallucinations, while primary psychosis was also associated with delusions of thought projection, erotomania and passivity. The presence of non-persecutory delusions and hallucinations across various modalities is a marker for persistent MAP or primary psychosis in people who use methamphetamine.
|
|
|
2017 |
Ingram I, Kelly PJ, Deane FP, Baker AL, Lyons G, Blackman R, 'An Exploration of Smoking Among People Attending Residential Substance Abuse Treatment: Prevalence and Outcomes at Three Months Post-Discharge', Journal of Dual Diagnosis, 13 67-72 (2017) [C1]
© 2017 Taylor & Francis Group, LLC. Objectives: Smoking continues to be a major health concern for people with a history of alcohol or other substance use problems. The curr... [more]
© 2017 Taylor & Francis Group, LLC. Objectives: Smoking continues to be a major health concern for people with a history of alcohol or other substance use problems. The current research is aimed to (1) describe the prevalence of smoking in residential addictions treatment services and (2) compare characteristics of people who had or had not quit smoking. Methods: Participants were attending residential substance abuse treatment provided by the Australian Salvation Army. These programs are up to 10¿months in length and offer a range of low-intensity smoking cessation supports. Measures of smoking, substance use, and clinical characteristics were collected from 2008 to 2015 at baseline and three months post-discharge from treatment (N = 702). Results: At baseline, 86% of people were smokers (n = 606). At follow-up, only 48 participants who were smokers at baseline (7%) had quit smoking. Participants who had quit smoking at follow-up also reported higher rates of abstinence from alcohol or other substances at follow-up (72%) than people who had not quit smoking (46%; OR = 2.95, 95% CI [1.52, 5.74]). Conclusions: There is potential for smoking cessation to be better addressed as part of routine care in substance abuse treatment settings. Future research should evaluate the provision of more systematic smoking cessation interventions within these settings.
|
|
|
2017 |
McCrabb S, Baker AL, Attia J, Balogh ZJ, Lott N, Palazzi K, et al., 'Who is More Likely to Use the Internet for Health Behavior Change? A Cross-Sectional Survey of Internet Use Among Smokers and Nonsmokers Who Are Orthopedic Trauma Patients.', JMIR Ment Health, 4 e18 (2017) [C1]
|
|
|
2017 |
McCrabb S, Balogh Z, Baker AL, Harris IA, Attia J, Lott N, et al., 'Development of an online smoking cessation program for use in hospital and following discharge: Smoke-free recovery', BMJ Innovations, 3 115-122 (2017) [C1]
© 2017, BMJ Publishing Group. All rights reserved. Background Tobacco smoking can have negative health outcomes on recovery from surgery. Although it is recommended best practice ... [more]
© 2017, BMJ Publishing Group. All rights reserved. Background Tobacco smoking can have negative health outcomes on recovery from surgery. Although it is recommended best practice to provide patients with advice to quit and follow-up support, provision of postdischarge support is rare. Developing an online smoking cessation program may help address this gap. Objectives This paper describes the development and pretesting of an online smoking cessation program (smoke-free recovery, SFR) tailored to the orthopaedic trauma population for use while in hospital and post-discharge. Methods Drawing on the DoTTI framework for developing an online program, the following steps were followed for program development: (1) design and development; (2) testing early iteration; (3) testing for effectiveness and (4) integration and implementation. This article describes the first two stages of SFR program development. Results SFR is a 10-module online smoking cessation program tailored for patients with orthopaedic trauma. Of the participants who completed testing early iterations, none reported any difficulties orientating themselves to the program or understanding program content. The main themes were that it was ¿helpful¿, provision of ¿help to quit¿ was low and SFR increased thoughts of ¿staying quit post discharge¿. Conclusions This study found that a theory and evidence-based approach as the basis for an online smoking cessation program for patients with orthopaedic trauma was acceptable to users. A randomised controlled trial will be conducted to examine whether the online smoking cessation program is effective in increasing smoking cessation and how it can be integrated and implemented into hospital practice (stages three and four of the DoTTI framework).
|
|
|
2017 |
Hitsman B, Baker AL, King A, 'Rebuttal From Dr Hitsman et al', CHEST, 152 472-473 (2017)
|
|
|
2017 |
Baker A, Blanchard C, 'The effects of female Thin Ideal media on men's appearance schema, cognitive performance, and self-evaluations: A self-determination theory approach', Body Image, 22 103-113 (2017)
© 2017 Elsevier Ltd Research has primarily focused on the consequences of the female thin ideal on women and has largely ignored the effects on men. Two studies were designed to i... [more]
© 2017 Elsevier Ltd Research has primarily focused on the consequences of the female thin ideal on women and has largely ignored the effects on men. Two studies were designed to investigate the effects of a female thin ideal video on cognitive (Study 1: appearance schema, Study 2: visual-spatial processing) and self-evaluative measures in male viewers. Results revealed that the female thin ideal predicted men's increased appearance schema activation and poorer cognitive performance on a visual-spatial task. Constructs from self-determination theory (i.e., global autonomous and controlled motivation) were included to help explain for whom the video effects might be strongest or weakest. Findings demonstrated that a global autonomous motivation orientation played a protective role against the effects of the female thin ideal. Given that autonomous motivation was a significant moderator, SDT is an area worth exploring further to determine whether motivational strategies can benefit men who are susceptible to media body ideals.
|
|
|
2017 |
Baker AL, 'Commentary on Mathew et al. (2017): Improving the effectiveness of interventions to reduce smoking among people living with severe mental ill-health', ADDICTION, 112 413-414 (2017)
|
|
|
2017 |
Nasstasia Y, Baker AL, Halpin SA, Lewin TJ, Hides L, Kelly BJ, Callister R, 'Pilot Study of an Exercise Intervention for Depressive Symptoms and Associated Cognitive-Behavioral Factors in Young Adults with Major Depression', Journal of Nervous and Mental Disease, 205 647-655 (2017) [C1]
© Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved. This study assesses the feasibility of integrating motivational interviewing (MI) with an exercise intervention. ... [more]
© Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved. This study assesses the feasibility of integrating motivational interviewing (MI) with an exercise intervention. It also explores patterns of depressive symptom changes (cognitive, affective, and somatic subscales) and their relationship to cognitive, behavioral, and immunological factors (interleukin 6, IL-6, a marker for inflammation) across the exercise intervention. Twelve young adults (20.8 ± 1.7 years) meeting DSM-IV criteria for major depressive disorder received a brief MI intervention followed by a 12-week exercise intervention. Assessments were conducted preintervention, postintervention, throughout the intervention, and at follow-up. Preliminary results show differential effects of exercise, with the largest standardized mean improvements for the affective subscale (-1.71), followed by cognitive (-1.56) and somatic (-1.39) subscales. A significant relationship was observed between increased behavioral activation and lower levels of IL-6. Despite study limitations, the magnitude of changes suggests that natural remission of depressive symptoms is an unlikely explanation for the findings. A randomized controlled trial has commenced to evaluate effectiveness of the intervention.
|
|
|
2017 |
Kelly PJ, Raftery D, Deane FP, Baker AL, Hunt D, Shakeshaft A, 'From both sides: Participant and facilitator perceptions of SMART Recovery groups', Drug and Alcohol Review, 36 325-332 (2017) [C1]
© 2016 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: The Self-Management and Recovery Training (SMART Recovery) program provides facilitated ... [more]
© 2016 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: The Self-Management and Recovery Training (SMART Recovery) program provides facilitated mutual aid for people with addictions. To date, little research has examined SMART Recovery. This paper examined participant and facilitator perceptions of the helpfulness of cognitive behaviour therapy tools in SMART Recovery groups. SMART Recovery's strengths and areas for improvement were also explored, as well as overall participant satisfaction with SMART Recovery. Design and Methods: This exploratory study was conducted as part of the first national survey of SMART Recovery in Australia. Paper surveys were posted to all registered SMART Recovery groups for participants. SMART Recovery facilitators were emailed a link to an online survey. Results: Overall, satisfaction with SMART Recovery was moderate to strong. Participants and facilitators perceived the cognitive behaviour therapy tools incorporated within SMART Recovery to be helpful. Participants and facilitators nominated the group experience and the SMART Recovery tools and strategies as helpful aspects of SMART Recovery. Participants and facilitators were concerned with improving public knowledge about SMART Recovery groups, updating the structure and content of SMART Recovery groups, and increasing training for facilitators. Discussion and Conclusions: SMART Recovery displays strengths as communicated by those who utilise its services. However, there are opportunities to continue to improve SMART Recovery. Updating the training for facilitators and increasing communication between SMART Recovery Australia's head office and its facilitators may serve to improve service delivery. Future research should focus on examining the efficacy of SMART Recovery groups on participant outcomes.[Kelly PJ, Raftery D, Deane FP, Baker AL, Hunt D, Shakeshaft A. From both sides: Participant and facilitator perceptions of SMART Recovery groups. Drug Alcohol Rev 2017;36:325¿332].
|
|
|
2017 |
McKetin R, Dean OM, Baker AL, Carter G, Turner A, Kelly PJ, Berk M, 'A potential role for N-acetylcysteine in the management of methamphetamine dependence', Drug and Alcohol Review, 36 153-159 (2017) [C1]
© 2016 Australasian Professional Society on Alcohol and other Drugs Methamphetamine dependence is a growing problem in Australia and globally. Currently, there are no approved pha... [more]
© 2016 Australasian Professional Society on Alcohol and other Drugs Methamphetamine dependence is a growing problem in Australia and globally. Currently, there are no approved pharmacotherapy options for the management of methamphetamine dependence. N-acetylcysteine is one potential pharmacotherapy option. It has received growing attention as a therapy for managing addictions because of its capacity to restore homeostasis to brain glutamate systems disrupted in addiction and thereby reduce craving and the risk of relapse. N-acetylcysteine also has antioxidant properties that protect against methamphetamine-induced toxicity and it may therefore assist in the management of the neuropsychiatric and neurocognitive effects of methamphetamine. This commentary overviews the actions of N-acetylcysteine and evidence for its efficacy in treating addiction with a particular focus on its potential utility for methamphetamine dependence. We conclude that the preliminary evidence indicates a need for full-scale trials to definitively establish whether N-acetylcysteine has a therapeutic benefit and the nature of this benefit, for managing methamphetamine dependence. [McKetin R, Dean O, Baker A. L, Carter G, Turner A, Kelly P. J, Berk M. A potential role for N-acetylcysteine in the management of methamphetamine dependence. Drug Alcohol Rev 2017;36:153¿159].
|
|
|
2017 |
McCrabb S, Baker AL, Attia J, Balogh ZJ, Lott N, Palazzi K, et al., 'Smoking, Quitting, and the Provision of Smoking Cessation Support: A Survey of Orthopaedic Trauma Patients', Journal of Orthopaedic Trauma, 31 e255-e262 (2017) [C1]
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved. Objective: This study investigates orthopaedic trauma patients smoking cessation history, intentions to quit, rec... [more]
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved. Objective: This study investigates orthopaedic trauma patients smoking cessation history, intentions to quit, receipt of smoking cessation care during hospital admission, and patient-related factors associated with receipt of smoking cessation care. Methods: An online cross-sectional survey of orthopaedic trauma patients was conducted in 2 public hospitals in New South Wales, Australia. Prevalence of smoking and associated variables were described. Logistic regressions were used to examine whether patient characteristics were associated with receipt of smoking cessation care. Results: Eight hundred nineteen patients (response rate 73%) participated. More than 1 in 5 patients (21.8%) were current smokers (n = 175). Of the current smokers, more than half (55.3%) indicated making a quit attempt in the last 12 months and the majority (77.6%) were interested in quitting. More than a third of smokers (37.4%) were not advised to quit; 44.3% did not receive any form of nicotine replacement therapy; and 24.1% reported that they did not receive any of these 3 forms of smoking cessation care during their admission. Provision of care was not related to patient characteristics. Conclusions: The prevalence of smoking among the sample was high. Respondents were interested in quitting; however, the provision of care during admission was low. Smoking cessation interventions need to be developed to increase the provision of care and to promote quit attempts in this Australian population.
|
|
|
2017 |
Beck AK, Forbes E, Baker AL, Kelly PJ, Deane FP, Shakeshaft A, et al., 'Systematic review of SMART Recovery: Outcomes, process variables, and implications for research.</', Psychology of Addictive Behaviors, 31 1-20 (2017) [C1]
© 2017 American Psychological Association.. Clinical guidelines recommend Self-Management and Recovery Training (SMART Recovery) and 12-step models of mutual aid as important sour... [more]
© 2017 American Psychological Association.. Clinical guidelines recommend Self-Management and Recovery Training (SMART Recovery) and 12-step models of mutual aid as important sources of long-term support for addiction recovery. Methodologically rigorous reviews of the efficacy and potential mechanisms of change are available for the predominant 12-step approach. A similarly rigorous exploration of SMART Recovery has yet to be undertaken. We aim to address this gap by providing a systematic overview of the evidence for SMART Recovery in adults with problematic alcohol, substance, and/or behavioral addiction, including (i) a commentary on outcomes assessed, process variables, feasibility, current understanding of mental health outcomes, and (ii) a critical evaluation of the methodology. We searched six electronic peer-reviewed and four gray literature databases for English-language SMART Recovery literature. Articles were classified, assessed against standardized criteria, and checked by an independent assessor. Twelve studies (including three evaluations of effectiveness) were identified. Alcohol-related outcomes were the primary focus. Standardized assessment of nonalcohol substance use was infrequent. Information about behavioral addiction was restricted to limited prevalence data. Functional outcomes were rarely reported. Feasibility was largely indexed by attendance. Economic analysis has not been undertaken. Little is known about the variables that may influence treatment outcome, but attendance represents a potential candidate. Assessment and reporting of mental health status was poor. Although positive effects were found, the modest sample and diversity of methods prevent us from making conclusive remarks about efficacy. Further research is needed to understand the clinical and public health utility of SMART as a viable recovery support option.
|
|
|
2017 |
Tynan RJ, Considine R, Wiggers J, Lewin TJ, James C, Inder K, et al., 'Alcohol consumption in the Australian coal mining industry', Occupational and Environmental Medicine, 74 259-267 (2017) [C1]
© 2017, BMJ. All rights reserved. Objectives: To investigate patterns of alcohol use within the coal mining industry, and associations with the personal, social, workplace and emp... [more]
© 2017, BMJ. All rights reserved. Objectives: To investigate patterns of alcohol use within the coal mining industry, and associations with the personal, social, workplace and employment characteristics. Design: 8 mine sites across 3 eastern Australian states were surveyed, selected to encompass key geographic characteristics (accessibility and remoteness) and mine type (open cut and underground). Problematic alcohol use was measured using the Alcohol Use Disorders Identification Test (AUDIT) to determine: (1) overall risky or hazardous drinking behaviour; and (2) frequency of single-occasion drinking (6 or more drinks on 1 occasion). Results: A total of 1457 employees completed the survey, of which 45.7% of male and 17.0% of female participants reported levels of alcohol use within the range considered as risky or hazardous, considerably higher than the national average. Hierarchical linear regression revealed a significant contribution of many individual level factors associated with AUDIT scores: younger age, male, current smoking status; illicit substance use; previous alcohol and other drug use (AOD) problems; and higher psychological distress. Workplace factors associated with alcohol use included working in mining primarily for the high remuneration, and the type of mining, with underground miners reporting higher alcohol use than open-cut miners. Conclusions: Our findings provide support for the need to address alcohol use in the coal mining industry over and above routine on-site testing for alcohol use.
|
|
|
2017 |
Clark V, Baker A, Lewin T, Richmond R, Kay-Lambkin F, Filia S, et al., 'Self-Reported Reasons for Smoking: Predicting Abstinence and Implications for Smoking Cessation Treatments Among Those With a Psychotic Disorder', Journal of Dual Diagnosis, 13 6-14 (2017) [C1]
© 2017 Taylor & Francis Group, LLC. Objectives: People living with a psychotic illness have higher rates of cigarette smoking and face unique barriers to quitting compared t... [more]
© 2017 Taylor & Francis Group, LLC. Objectives: People living with a psychotic illness have higher rates of cigarette smoking and face unique barriers to quitting compared to the general population. We examined whether self-reported reasons for smoking are useful predictors of successful quit attempts among people with psychosis. Methods: As part of a randomized controlled trial addressing smoking and cardiovascular disease risk behaviors among people with psychosis, self-reported reasons for smoking were assessed at baseline (n = 235), 15 weeks (n = 151), and 12 months (n = 139). Three factors from the Reasons for Smoking Questionnaire (Coping, Physiological, and Stimulation/Activation) were entered into a model to predict short- and long-term abstinence. The relationship between these factors and mental health symptoms were also assessed. Results: Participants scoring higher on the Stimulation/Activation factor (control of weight, enjoyment, concentration, and ¿peps me up¿) at baseline were just less than half as likely to be abstinent at 15 weeks. Female participants were five times more likely to abstinent at 15 weeks, and those with a higher global functioning at baseline were 5% more likely to be abstinent. There was a positive correlation between changes over time in the Stimulation/Activation factor from baseline to 12-month follow-up and the Brief Psychiatric Rating Scale total score at 12-month follow-up. This indicates that increasingly higher endorsement of the factor was associated with more psychological symptoms. There was also a negative correlation between the change over time in the Stimulation/Activation factor and global functioning at 12 months, indicating that increasingly higher endorsement of the factor led to lower global assessment of functioning. Conclusions: The Stimulation/Activation factor may be particularly important to assess and address among smokers with psychosis. It is recommended that further research use the Reasons for Smoking Questionnaire among smokers with psychosis as a clinical tool to identify specific quit barriers. Further research into why females have higher smoking cessation rates in the short term and relapse prevention interventions seem worthy of further investigation.
|
|
|
2017 |
Bonevski B, Borland R, Paul CL, Richmond RL, Farrell M, Baker A, et al., 'No smoker left behind: It s time to tackle tobacco in Australian priority populations', Medical Journal of Australia, 207 141-142 (2017)
|
|
|
2017 |
McCrabb S, Baker AL, Attia J, Balogh ZJ, Lott N, Palazzi K, et al., 'Hospital smoke-free policy: Compliance, enforcement, and practices. A staff survey in two large public hospitals in Australia', International Journal of Environmental Research and Public Health, 14 (2017) [C1]
|
|
|
2017 |
Segan CJ, Baker AL, Turner A, Williams JM, 'Nicotine Withdrawal, Relapse of Mental Illness, or Medication Side-Effect? Implementing a Monitoring Tool for People With Mental Illness Into Quitline Counseling', Journal of Dual Diagnosis, 13 60-66 (2017) [C1]
© 2017 Taylor & Francis Group, LLC. Background: Smokers with mental illness and their health care providers are often concerned that smoking cessation will worsen mental hea... [more]
© 2017 Taylor & Francis Group, LLC. Background: Smokers with mental illness and their health care providers are often concerned that smoking cessation will worsen mental health. Smokers with mental illness tend to be more nicotine-dependent and experience more severe symptoms of nicotine withdrawal, some of which are difficult to distinguish from psychiatric symptoms. In addition, smoking cessation can increase the blood levels and hence side effects of some psychotropic medications. Improved monitoring of nicotine withdrawal and medication side effects may help distinguish temporary withdrawal symptoms from psychiatric symptoms and facilitate targeted treatment to help smokers with mental illness manage the acute phase of nicotine withdrawal. Objective: The aim of this research was to examine the acceptability and feasibility to quitline counselors of implementing structured assessments of nicotine withdrawal and common medication side effects in people with mental illness who are quitting smoking using a telephone smoking cessation service. Methods: Monitoring involves administering (once pre-cessation and at each contact post-cessation) (1) the Minnesota Nicotine Withdrawal Scale, assessing eight symptoms: anger, anxiety, depression, cravings, difficulty concentrating, increased appetite, insomnia, and restlessness and (2) an adverse side effects checklist of 5 to 10 symptoms, for example, dry mouth and increased thirst. Following a 1-day update training in mental health, quitline counselors were asked to offer these assessments to callers disclosing mental illness in addition to usual counseling. Group interviews with counselors were conducted 2¿months later to examine implementation barriers and benefits. Results: Barriers included awkwardness in integrating a new structured practice into counseling, difficulty in limiting some callers to only the content of new items, and initial anxieties about how to respond to changes in some symptoms. Benefits included the ability to provide objective feedback on changes in symptoms, as this identified early benefits of quitting, provided reassurance for clients, and provided an opportunity for early intervention where symptoms worsened. Conclusions: Structured monitoring of withdrawal symptoms and medication side effects was able to be integrated into the quitline's counseling and was valued by counselors and clients. Given evidence of its benefits in this limited pilot study, we recommend it be considered for larger-scale adoption by quitlines.
|
|
|
2016 |
Tynan RJ, Considine R, Rich JL, Skehan J, Wiggers J, Lewin TJ, et al., 'Help-seeking for mental health problems by employees in the Australian Mining Industry', BMC HEALTH SERVICES RESEARCH, 16 (2016) [C1]
|
|
|
2016 |
McCarter K, Martinez U, Britton B, Baker A, Bonevski B, Carter G, et al., 'Smoking cessation care among patients with head and neck cancer: a systematic review', BMJ OPEN, 6 (2016) [C1]
|
|
|
2016 |
Beck AK, Baker A, Kelly PJ, Deane FP, Shakeshaft A, Hunt D, et al., 'Protocol for a systematic review of evaluation research for adults who have participated in the "SMART recovery' mutual support programme', BMJ OPEN, 6 (2016)
|
|
|
2016 |
Mills KL, Barrett EL, Merz S, Rosenfeld J, Ewer PL, Sannibale C, et al., 'Integrated Exposure-Based Therapy for Co-Occurring Post Traumatic Stress Disorder (PTSD) and Substance Dependence: Predictors of Change in PTSD Symptom Severity.', J Clin Med, 5 (2016) [C1]
|
|
|
2016 |
Kay-Lambkin FJ, Thornton L, Lappin JM, Hanstock T, Sylvia L, Jacka F, et al., 'Study protocol for a systematic review of evidence for lifestyle interventions targeting smoking, sleep, alcohol/other drug use, physical activity, and healthy diet in people with bipolar disorder', SYSTEMATIC REVIEWS, 5 (2016)
|
|
|
2016 |
Handley TE, Kay-Lambkin FJ, Baker AL, Lewin TJ, Kelly BJ, Inder KJ, et al., 'Investigation of a Suicide Ideation Risk Profile in People with Co-occurring Depression and Substance Use Disorder', Journal of Nervous and Mental Disease, 204 820-826 (2016) [C1]
© Wolters Kluwer Health, Inc. All rights reserved. Disengagement from services is common before suicide, hence identifying factors at treatment presentation that predict future su... [more]
© Wolters Kluwer Health, Inc. All rights reserved. Disengagement from services is common before suicide, hence identifying factors at treatment presentation that predict future suicidality is important. This article explores risk profiles for suicidal ideation among treatment seekers with depression and substance misuse. Participants completed assessments at baseline and 6 months. Baseline demographics, psychiatric history, and current symptoms were entered into a decision tree to predict suicidal ideation at follow-up. Sixty-three percent of participants at baseline and 43.5% at follow-up reported suicidal ideation. Baseline ideation most salient when psychiatric illness began before adulthood, increasing the rate of follow-up ideation by 16%. Among those without baseline ideation, dysfunctional attitudes were the most important risk factor, increasing rates of suicidal ideation by 35%. These findings provide evidence of factors beyond initial diagnoses that increase the likelihood of suicidal ideation and are worthy of clinical attention. In particular, providing suicide prevention resources to those with high dysfunctional attitudes may be beneficial.
|
|
|
2016 |
Thornton LK, Harris K, Baker AL, Johnson M, Kay-Lambkin FJ, 'Recruiting for addiction research via Facebook', Drug and Alcohol Review, 35 494-502 (2016) [C1]
© 2015 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: This study aimed to examine the feasibility of recruiting participants to addiction rese... [more]
© 2015 Australasian Professional Society on Alcohol and other Drugs Introduction and Aims: This study aimed to examine the feasibility of recruiting participants to addiction research via Facebook. Design and Methods: Participants were recruited via an advertisement on Facebook, a local research register and university psychology courses. Participants completed a self-report survey regarding substance use, history of mental health issues and current psychological distress. Results: The 524 participants recruited via Facebook cost $1.86 per participant; and 418 participants were recruited via more traditional methods. There were significantly fewer women in the Facebook sample compared with the non-Facebook sample (¿2 = 196.61, P < 0.001), but no differences on age. Significantly more Facebook participants reported current use of tobacco (women: Facebook = 57%, non-Facebook = 21%, ¿2 = 39.71, P < 0.001; men: Facebook = 62%, non-Facebook = 21%, ¿2 = 32.429, P < 0.001) and cannabis (women: Facebook = 26%, non-Facebook = 7%, ¿2 = 14.364, P < 0.001; men: Facebook = 46%, non-Facebook = 24%, ¿2 = 6.765, P < 0.01). They also reported significantly more harmful use of tobacco [women: F degrees of freedom (d.f.) = 6.07, P < 0.05; men: F(d.f.) = 9.03, P < 0.01] and cannabis [women: F(d.f.) = 11.00, P < 0.01; men: F(d.f.) = 6.40, P < 0.05]. The Facebook sample contained a higher percentage of high-severity cannabis users (women: Facebook = 24%, non-Facebook = 4%, ¿2 = 18.12, P < 0.001; men: Facebook = 43%, non-Facebook = 16%, ¿2 = 10.00, P < 0.01) and reported significantly more severe depressive symptoms [women: F(d.f.) = 26.38, P < 0.001; men: F(d.f.) = 7.44, P < 0.05]. Discussion and Conclusions: Through Facebook, we were able to capture a greater proportion of people with high-severity substance use and mental health issues and were able to capture a greater and more severe range of substance use behaviours. This suggests social networking sites are efficient, cost-effective ways to recruit large numbers of participants, with relevant behaviours and conditions, to addiction research. [Thornton LK, Harris K, Baker AL, Johnson M, Kay-Lambkin FJ. Recruiting for addiction research via Facebook. Drug Alcohol Rev 2016;35:494¿502].
|
|
|
2016 |
Paul CL, Boyes AW, O'Brien L, Baker AL, Henskens FA, Roos I, et al., 'Protocol for a Randomized Controlled Trial of Proactive Web-Based Versus Telephone-Based Information and Support: Can Electronic Platforms Deliver Effective Care for Lung Cancer Patients?', JMIR RESEARCH PROTOCOLS, 5 (2016)
|
|
|
2016 |
Bailey KA, Baker AL, McElduff P, Kavanagh DJ, 'The Influence of Parental Emotional Neglect on Assault Victims Seeking Treatment for Depressed Mood and Alcohol Misuse: A Pilot Study', JOURNAL OF CLINICAL MEDICINE, 5 (2016) [C1]
|
|
|
2016 |
McKetin R, Gardner J, Baker AL, Dawe S, Ali R, Voce A, et al., 'Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users', Psychiatry Research, 238 166-171 (2016) [C1]
© 2016 Elsevier Ireland Ltd. This study examined correlates of transient versus persistent psychotic symptoms among people dependent on methamphetamine. A longitudinal prospective... [more]
© 2016 Elsevier Ireland Ltd. This study examined correlates of transient versus persistent psychotic symptoms among people dependent on methamphetamine. A longitudinal prospective cohort study of dependent methamphetamine users who did not meet DSM-IV criteria for lifetime schizophrenia or mania. Four non-contiguous one-month observation periods were used to identify participants who had a) no psychotic symptoms, (n=110); (b) psychotic symptoms only when using methamphetamine (transient psychotic symptoms, n=85); and, (c) psychotic symptoms both when using methamphetamine and when abstaining from methamphetamine (persistent psychotic symptoms, n=37). Psychotic symptoms were defined as a score of 4 or greater on any of the Brief Psychiatric Rating Scale items of suspiciousness, hallucinations or unusual thought content. Relative no psychotic symptoms, both transient and persistent psychotic symptoms were associated with childhood conduct disorder and comorbid anxiety disorders. Earlier onset methamphetamine use and being male were more specifically related to transient psychotic symptoms, while a family history of a primary psychotic disorder and comorbid major depression were specifically related to persistent psychotic symptoms. We conclude that there are overlapping but also distinct clinical correlates of transient versus persistent psychotic symptoms, suggesting potentially heterogeneous etiological pathways underpinning the psychotic phenomena seen amongst people who use methamphetamine.
|
|
|
2016 |
Sankaranarayanan A, Clark V, Baker A, Palazzi K, Lewin TJ, Richmond R, et al., 'Reducing smoking reduces suicidality among individuals with psychosis: Complementary outcomes from a Healthy Lifestyles intervention study', Psychiatry Research, 243 407-412 (2016) [C1]
© 2016 Elsevier Ireland Ltd. This study sought to explore the impact of smoking reduction on suicidality (suicide ideation and behaviour) among people with a psychotic disorder (n... [more]
© 2016 Elsevier Ireland Ltd. This study sought to explore the impact of smoking reduction on suicidality (suicide ideation and behaviour) among people with a psychotic disorder (n=235) who participated in a randomized trial of a healthy lifestyle intervention trial. Suicidality, measured by item -4 of the Brief Psychiatric Rating Scale (BPRS) was the main variable of interest. Measures were collected by research assistants blind to treatment allocation at baseline, at 15 weeks (mid-intervention) and 12 months after baseline. Mediation analysis, adjusted for confounders, was used to determine the relationship between smoking reduction and suicidality and to explore whether this was mediated through depression. At 12 months, smoking reduction was found to be significantly associated with suicidality change; an association was also seen between smoking reduction and depression and depression and suicidality. After adjusting for depression, the association between smoking reduction and suicidality was attenuated but remained statistically significant; the proportion of the total effect that was mediated through depression was 30%. There was no significant association between suicidality and treatment group (vs. controls) over time. Our study suggests that smoking interventions may have benefits over and above those for improved physical health, by reducing suicidal ideation in people with psychosis.
|
|
|
2016 |
Baker A, Sirois-Leclerc H, Tulloch H, 'The Impact of Long-Term Physical Activity Interventions for Overweight/Obese Postmenopausal Women on Adiposity Indicators, Physical Capacity, and Mental Health Outcomes: A Systematic Review', Journal of Obesity, 2016 (2016)
© 2016 Amanda Baker et al. Physical activity interventions have recently become a popular strategy to help postmenopausal women prevent and manage obesity. The current systematic ... [more]
© 2016 Amanda Baker et al. Physical activity interventions have recently become a popular strategy to help postmenopausal women prevent and manage obesity. The current systematic review evaluates the efficacy of physical activity interventions among overweight and obese postmenopausal women and sheds light on the behavioral change techniques that were employed in order to direct future research. Method. Five electronic databases were searched to identify all prospective RCT studies that examine the impact of physical activity on adiposity indicators, physical capacity, and/or mental health outcomes among healthy, sedentary overweight, and obese postmenopausal women in North America. The behavior change technique taxonomy was used to identify the various strategies applied in the programs. Results. Five RCTs met the inclusion criteria. The findings showed that adiposity indicators and physical capacity outcomes significantly improved following long-term interventions; however, mental health outcomes showed nonsignificant changes. Furthermore, 17 behavior change techniques were identified with the taxonomy across all trials. The intrapersonal-level techniques were the most common. Conclusion. Physical activity interventions had a positive effect on adiposity measures and physical capacity. Future research should focus on testing the effectiveness of physical activity interventions on mental health and incorporate strategies at the individual and environmental level to maximize the health impact on the population.
|
|
|
2016 |
Ryan KA, Assari S, Pester BD, Hinrichs K, Angers K, Baker A, et al., 'Similar Trajectory of Executive Functioning Performance over 5 years among individuals with Bipolar Disorder and Unaffected Controls using Latent Growth Modeling', Journal of Affective Disorders, 199 87-94 (2016) [C1]
|
|
|
2016 |
Babic MJ, Smith JJ, Morgan PJ, Lonsdale C, Plotnikoff RC, Eather N, et al., 'Intervention to reduce recreational screen-time in adolescents: Outcomes and mediators from the Switch-Off 4 Healthy Minds (S4HM) cluster randomized controlled trial', Preventive Medicine, 91 50-57 (2016) [C1]
© 2016 Elsevier Inc. Introduction The primary objective was to evaluate the impact of the ¿Switch-off 4 Healthy Minds¿ (S4HM) intervention on recreational screen-time in adolescen... [more]
© 2016 Elsevier Inc. Introduction The primary objective was to evaluate the impact of the ¿Switch-off 4 Healthy Minds¿ (S4HM) intervention on recreational screen-time in adolescents. Methods Cluster randomized controlled trial with study measures at baseline and 6-months (post-intervention). Eligible participants reported exceeding recreational screen-time recommendations (i.e., >¿2¿h/day). In total, 322 adolescents (mean age¿=¿14.4¿±¿0.6¿years) from eight secondary schools in New South Wales, Australia were recruited. The S4HM intervention was guided by Self-Determination Theory and included: an interactive seminar, eHealth messaging, a behavioral contract and parental newsletters. The primary outcome was recreational screen-time. Secondary outcomes included mental health (i.e., well-being, psychological distress, self-perceptions), objectively measured physical activity, and body mass index (BMI). Outcome analyses were conducted using linear mixed models and mediation was examined using a product-of-coefficients test. Results At post-intervention, significant reductions in screen-time were observed in both groups, with a greater reduction observed in the intervention group (-¿50¿min/day versus -¿29¿min, p¿<¿0.05 for both). However, the adjusted difference in change between groups was not statistically significant (mean¿=¿-¿21.3¿min/day, p¿=¿0.255). There were no significant intervention effects for mental health outcomes, physical activity or BMI. Significant mediation effects for autonomous motivation were found. Conclusions Participants in both the S4HM intervention and control groups significantly reduced their screen-time, with no group-by-time effects. Enhancing autonomous motivation might be a useful intervention target for trials aimed at reducing adolescents' recreational screen-time. Trial registration ACTRN12614000163606.
|
|
|
2016 |
McCarter KL, Halpin SA, Baker AL, Kay-Lambkin FJ, Lewin TJ, Thornton LK, et al., 'Associations between personality disorder characteristics and treatment outcomes in people with co-occurring alcohol misuse and depression.', BMC Psychiatry, 16 210 (2016) [C1]
|
|
|
2016 |
Andrews M, Baker AL, Halpin SA, Lewin TJ, Richmond R, Kay-Lambkin FJ, et al., 'Early therapeutic alliance, treatment retention, and 12-month outcomes in a healthy lifestyles intervention for people with psychotic disorders', Journal of Nervous and Mental Disease, 204 894-902 (2016) [C1]
© 2016 Wolters Kluwer Health, Inc. Engaging and retaining individuals with psychotic disorders in psychosocial treatments is difficult. Early therapeutic alliance, treatment reten... [more]
© 2016 Wolters Kluwer Health, Inc. Engaging and retaining individuals with psychotic disorders in psychosocial treatments is difficult. Early therapeutic alliance, treatment retention, and 12-month outcomes were examined in a subsample of smokers with a psychotic disorder (N = 178) participating in a healthy lifestyles study comparing a telephone versus face-to-face delivered intervention. Therapeutic alliance was assessed using the Agnew Relationship Measure; primary outcomes were treatment retention and changes in symptoms and health behaviors. Contrary to expectations, early alliance did not predict treatment retention. However, elements of both client- and therapist-rated alliance predicted some clinical outcomes (e.g., higher confidence in the therapeutic alliance at session 1 predicted improvements in 12-month depression). Some modest interactions between early alliance and intervention condition were also identified (e.g., clients initially with lower self-perceived initiative, or higher therapist-perceived bonding benefited preferentially from the telephone-delivered intervention), highlighting the need to further examine the interplay between therapeutic alliance and treatment modality.
|
|
|
2016 |
Stain HJ, Bucci S, Baker AL, Carr V, Emsley R, Halpin S, et al., 'A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial', Schizophrenia Research, 176 212-219 (2016) [C1]
© 2016 Elsevier B.V. Background Intervention trials for young people at ultra high risk (UHR) for psychosis have shown cognitive behaviour therapy (CBT) to have promising effects ... [more]
© 2016 Elsevier B.V. Background Intervention trials for young people at ultra high risk (UHR) for psychosis have shown cognitive behaviour therapy (CBT) to have promising effects on treating psychotic symptoms but have not focused on functional outcomes. We hypothesized that compared to an active control, CBT would: (i) reduce the likelihood of, and/or delay, transition to psychosis; (ii) reduce symptom severity while improving social functioning and quality of life, whether or not transition occurred. Method This was a single-blind randomised controlled trial for young people at UHR for psychosis comparing CBT to an active control condition, Non Directive Reflective Listening (NDRL), both in addition to standard care, with a 6 month treatment phase and 12 months of follow-up. Statistical analysis is based on intention-to-treat and used random effect models to estimate treatment effects common to all time-points. Results Fifty-seven young people (mean age = 16.5 years) were randomised to CBT (n = 30) or NDRL (n = 27). Rate of transition to psychosis was 5%; the 3 transitions occurred in the CBT condition (baseline, 2 months, 5 months respectively). The NDRL condition resulted in a significantly greater reduction in distress associated with psychotic symptoms compared to CBT (treatment effect = 36.71, standard error = 16.84, p = 0.029). There were no significant treatment effects on frequency and intensity of psychotic symptoms, global, social or role functioning. Conclusion Our sample was higher functioning, younger and experiencing lower levels of psychotic like experiences than other trials. The significantly better treatment effect of NDRL on distress associated with psychotic symptoms supports the recommendations for a stepped-care model of service delivery. This treatment approach would accommodate the younger UHR population and facilitate timely intervention. Trial registration: ANZCTR 12606000101583
|
|
|
2016 |
Keane CA, Kelly PJ, Magee CA, Callister R, Baker A, Deane FP, 'Exploration of Sedentary Behavior in Residential Substance Abuse Populations: Results From an Intervention Study', Substance Use and Misuse, 51 1363-1378 (2016) [C1]
© 2016 Taylor & Francis Group, LLC. ABSTRACT: Background: There is a growing body of research linking sedentary behavior with increased risk of chronic disease and all-cause... [more]
© 2016 Taylor & Francis Group, LLC. ABSTRACT: Background: There is a growing body of research linking sedentary behavior with increased risk of chronic disease and all-cause mortality. It is increasingly recommended that service providers address the multiple behavioral risk factors associated with these chronic diseases as part of routine substance abuse treatment. Objectives: The study objective was to investigate rates of physical activity and sedentary behavior in a residential substance abuse population. In addition, efficacy of a sedentary behavior intervention, ¿Sit Switch,¿ was examined for feasibility in this context. Methods: Participants (n = 54) were residents of The Salvation Army Recovery Service Centres located in Canberra and on the Gold Coast, Australia. Actigraph GT3X+ accelerometers were used to measure rates and patterns of sedentariness and physical activity. A nonrandomized controlled study of a single-session group intervention aimed at decreasing prolonged sitting (¿Sit Switch¿) was conducted. Education, motivational-interviewing, and goal setting components underpinned the ¿Sit Switch¿ intervention. Results: Individuals were highly sedentary, spending 73% of daily activity at sedentary intensity engaged in inadequate levels of moderate physical activity (6.6%/day). The single session educational program did not lead to any significant changes in sedentary behavior. Conclusion/Importance: High levels of sedentariness and low levels of physical activity engagement are evident in residents in substance abuse treatment programs. It is strongly recommended that sedentariness, a modifiable risk behavior with independent consequences for cardiovascular disease and cancer, be addressed within residential programs.
|
|
|
2015 |
Filia SL, Gurvich CT, Horvat A, Shelton CL, Katona LJ, Baker AL, et al., 'Inpatient views and experiences before and after implementing a totally smoke-free policy in the acute psychiatry hospital setting', International Journal of Mental Health Nursing, 24 350-359 (2015) [C1]
© 2015 Australian College of Mental Health Nurses Inc. In the present study, we examined the views and experiences of patients admitted to an acute psychiatry unit before and afte... [more]
© 2015 Australian College of Mental Health Nurses Inc. In the present study, we examined the views and experiences of patients admitted to an acute psychiatry unit before and after the implementation of a totally smoke-free policy. Forty-six inpatients completed a questionnaire assessing their views before the smoking ban. Another 52 inpatients completed a questionnaire assessing their views and experiences after the smoking ban. Before the totally smoke-free policy, 69.6% smoked, with 67.7% smoking more when admitted to the psychiatry ward. Before the smoking ban, 54.4% reported that the totally smoke-free policy would be 'negative' or 'very negative,' and 30.5% said it would be 'positive' or 'very positive.' After the totally smoke-free policy, 57.7% smoked heavily before hospital (mean cigarettes/day = 24.9), with consumption dramatically reducing following admission to a totally smoke-free psychiatric unit (mean cigarettes/day = 8.3). After the totally smoke-free policy, 36.5% reported that it was 'negative' or 'very negative,' and 50% reported that it was 'positive' or 'very positive.' Overall, inpatients reported improved acceptance of the policy following implementation. Inpatients stated that the most difficult thing about the smoking ban was experiencing increased negative emotions, while the most positive aspect was the improved physical environment of the ward. Inpatients who smoke must be appropriately supported using a range of strategies, and in the present study, we suggest relevant clinical implications.
|
|
|
2015 |
Kelly PJ, Baker AL, Deane FP, Callister R, Collins CE, Oldmeadow C, et al., 'Study protocol: A stepped wedge cluster randomised controlled trial of a healthy lifestyle intervention for people attending residential substance abuse treatment Health behavior, health promotion and society', BMC Public Health, 15 (2015) [C3]
© 2015 Kelly et al.; licensee BioMed Central. Background: Cardiovascular disease and cancer are leading causes of mortality for people with a history of alcohol or other substance... [more]
© 2015 Kelly et al.; licensee BioMed Central. Background: Cardiovascular disease and cancer are leading causes of mortality for people with a history of alcohol or other substance use disorders. These chronic diseases share the same four primary behavioural risk factors i.e. excessive alcohol use, smoking, low intake of fruit and vegetables and physical inactivity. In addition to addressing problematic alcohol use, there is the potential for substance abuse treatment services to also address these other behaviours. Healthy Recovery is an 8-session group-based intervention that targets these multiple behavioural health risk factors and was developed specifically for people attending substance abuse treatment. This protocol describes a Cancer Institute NSW funded study that assesses the effectiveness of delivering Healthy Recovery for people who are attending residential alcohol and other substance abuse treatment. Methods/Design: The study uses a stepped wedge randomised controlled design, where randomisation occurs at the service level. Participants will be recruited from residential rehabilitation programs provided by The Australian Salvation Army. All participants who (1) currently smoke tobacco and (2) are expected to be in the residential program for the duration of the 5-week intervention will be asked to participate in the study. Those participants residing at the facilities assigned to the treatment condition will complete Healthy Recovery. The intervention is manual guided and will be delivered over a 5-week period, with participants attending 8 group sessions. All participants will continue to complete The Salvation Army residential program, a predominantly 12-step based, modified therapeutic community. Participants in the control condition will complete treatment as usual. Research staff blind to treatment allocation will complete the primary and secondary outcome assessments at baseline and then at weeks 8, 20 and 32 weeks post intervention. Discussion: This study will provide comprehensive data on the effect of delivering a healthy lifestyle intervention (i.e. Healthy Recovery) within a residential substance abuse setting. If shown to be effective, this intervention can be disseminated within other residential substance abuse programs. Trial registration: Australian and New Zealand Clinical Trials Register (ANZCTR): ACTRN12615000165583. Registered 19th February 2015.
|
|
|
2015 |
Hunt SA, Kay-Lambkin FJ, Baker AL, Michie PT, 'Systematic review of neurocognition in people with co-occurring alcohol misuse and depression', Journal of Affective Disorders, 179 51-64 (2015) [C1]
© 2015 Elsevier B.V. Background Alcohol misuse and depression represent two major social and health problems globally. These conditions commonly co-occur and both are associated w... [more]
© 2015 Elsevier B.V. Background Alcohol misuse and depression represent two major social and health problems globally. These conditions commonly co-occur and both are associated with significant cognitive impairment. Despite this, few studies have examined the impact on cognitive functioning of co-occurring alcohol misuse and depression. This study aims to critically review findings from peer-reviewed published articles examining neuropsychological test performance among samples of people with co-occurring alcohol misuse and depression. Method A comprehensive literature search was conducted, yielding six studies reporting neuropsychological profiles of people with co-occurring alcohol misuse and depression. Results comparing cognitive functioning of people with this comorbidity to those with alcohol misuse alone, depression alone, healthy controls and published norms were examined as well as those describing the correlation between depressive symptoms and cognitive functioning in people with alcohol use disorders. Results In the majority of instances, the comorbid groups did not differ significantly from those with depression only or alcohol misuse only, nor from healthy controls or published norms. In the cases where a difference in neuropsychological test scores between groups was found, it was not consistently identified across studies. However, visual memory was identified in two studies as being impaired in comorbid samples and is worthy of inclusion in future studies. Limitations Due to the small number of included studies and the large variation in inclusion criteria as well as differing assessment tools and methodologies between studies, the review did not include a quantitative synthesis. Conclusions Research into cognitive deficits among people with singly occurring versus co-occurring alcohol misuse and depression is accumulating. Evidence suggests that the neuropsychological performance among samples with this comorbidity is generally not severely impaired and is unlikely to preclude benefit from treatment.
|
|
|
2015 |
Beck AK, Baker A, Turner A, Haddock G, Kelly PJ, Berry K, Bucci S, 'Protocol for a systematic review of telephone delivered psychosocial interventions on relapse prevention, adherence to psychiatric medication and health risk behaviours in adults with a psychotic disorder', BMJ OPEN, 5 (2015) [C3]
|
|
|
2015 |
Stockings EAL, Bowman JA, Bartlem KM, Mcelwaine KM, Baker AL, Terry M, et al., 'Implementation of a smoke-free policy in an inpatient psychiatric facility: Patient-reported adherence, support, and receipt of nicotine-dependence treatment', International Journal of Mental Health Nursing, 24 342-349 (2015) [C1]
© 2015 Australian College of Mental Health Nurses Inc. The implementation of smoke-free policies in inpatient psychiatric facilities, including patient adherence, mental health nu... [more]
© 2015 Australian College of Mental Health Nurses Inc. The implementation of smoke-free policies in inpatient psychiatric facilities, including patient adherence, mental health nursing staff support, and provision of nicotine-dependence treatment to patients, has been reported to be poor. The extent to which the quality of smoke-free policy implementation is associated with patient views of a policy is unknown. We conducted a cross-sectional survey of 181 patients (53.6%, n = 97 smokers; and 46.4%, n = 84 non-smokers) in an Australian inpatient psychiatric facility with a total smoke-free policy. Smokers' adherence to the policy was poor (83.5% smoked). Only half (53.6%) perceived staff to be supportive of the policy. Most smokers used nicotine-replacement therapy (75.3%); although few received optimal nicotine-dependence treatment (19.6%). Overall, 45.9% of patients viewed the smoke-free policy in the unit as positive (29.9% smokers; 64.3% non-smokers). For smokers, adhering to the ban, perceiving staff to be supportive, and reporting that the nicotine-replacement therapy reduced cravings to smoke were associated with a more positive view towards the smoke-free policy. These findings support the importance of patient adherence, mental health nursing staff support, and adequate provision of nicotine-dependence treatment in strengthening smoke-free policy implementation in inpatient psychiatric settings.
|
|
|
2015 |
Jackson M, Baker A, Bucci S, Barkham M, 'Mike Startup (1950-2015) obituary', PSYCHOLOGIST, 28 955-955 (2015) [O1] |
|
|
2015 |
Cohen M, Johnston P, Ehlkes T, Fulham R, Ward P, Thienel R, et al., 'Functional magnetic resonance brain imaging of executive cognitive performance in young first-episode schizophrenia patients and age-matched long-term cannabis users', Neurology Psychiatry and Brain Research, 21 51-63 (2015) [C1]
© 2014 Elsevier GmbH. All rights reserved. Converging evidence from epidemiological, clinical and neuropsychological research suggests a link between cannabis use and increased ri... [more]
© 2014 Elsevier GmbH. All rights reserved. Converging evidence from epidemiological, clinical and neuropsychological research suggests a link between cannabis use and increased risk of psychosis. Long-term cannabis use has also been related to deficit-like "negative" symptoms and cognitive impairment that resemble some of the clinical and cognitive features of schizophrenia. The current functional brain imaging study investigated the impact of a history of heavy cannabis use on impaired executive function in first-episode schizophrenia patients. Whilst performing the Tower of London task in a magnetic resonance imaging scanner, event-related blood oxygenation level-dependent (BOLD) brain activation was compared between four age and gender-matched groups: 12 first-episode schizophrenia patients; 17 long-term cannabis users; seven cannabis using first-episode schizophrenia patients; and 17 healthy control subjects. BOLD activation was assessed as a function of increasing task difficulty within and between groups as well as the main effects of cannabis use and the diagnosis of schizophrenia. Cannabis users and non-drug using first-episode schizophrenia patients exhibited equivalently reduced dorsolateral prefrontal activation in response to task difficulty. A trend towards additional prefrontal and left superior parietal cortical activation deficits was observed in cannabis-using first-episode schizophrenia patients while a history of cannabis use accounted for increased activation in the visual cortex. Cannabis users and schizophrenia patients fail to adequately activate the dorsolateral prefrontal cortex, thus pointing to a common working memory impairment which is particularly evident in cannabis-using first-episode schizophrenia patients. A history of heavy cannabis use, on the other hand, accounted for increased primary visual processing, suggesting compensatory imagery processing of the task.
|
|
|
2015 |
Beck AK, Baker AL, Todd J, 'Smoking in schizophrenia: Cognitive impact of nicotine and relationship to smoking motivators', Schizophrenia Research: Cognition, 2 26-32 (2015) [C1]
© 2015 The Authors. Smoking prevalence in schizophrenia is significantly elevated relative to other clinical and to non-clinical groups. The cognitive self-medication hypothesis a... [more]
© 2015 The Authors. Smoking prevalence in schizophrenia is significantly elevated relative to other clinical and to non-clinical groups. The cognitive self-medication hypothesis attributes this to the beneficial effects of nicotine on illness-related cognitive deficits. Significant effects of nicotine have been observed on visual spatial working memory (VSWM), sustained attention (Continuous Performance Test - Identical Pairs; CPT-IP) and prepulse inhibition (PPI). It remains unclear whether these neurophysiological and neurocognitive effects of nicotine influence self-reported smoking motivation. To explore the relationship between nicotine effects on cognition and self-reported smoking motivation in schizophrenia and non-psychiatric control smokers, the impact of smoking abstinence and reinstatement was examined across three cognitive indices (VSWM, CPT-IP, PPI) and compared to self-reported smoking motivation (Modified Reasons for Smoking Scale revised to include 'cognitive motivators'). Cognitive function was assessed after 'typical' smoking and overnight abstinence. Schizophrenia smokers (but not controls) demonstrated significantly less error on the VSWM task in the smoking relative to abstinent condition. Control (but not schizophrenia) smokers, showed evidence of CPT-IP improvement in the smoking relative to abstinent condition. The overall profile of smoking motivation was comparable between groups. However, significant relationships between subjective and objective indices of smoking related cognitive change were observed for controls. Differential effects of nicotine on cognition have been hypothesised to influence the pattern and persistence of smoking in schizophrenia. These preliminary findings indicate that evidence for such effects is apparent even in small samples - particularly for VSWM. This is the first study to show that neurocognitive effects of smoking may influence self-reported smoking motivation.
|
|
|
2015 |
Hiles SA, Baker AL, de Malmanche T, McEvoy M, Boyle M, Attia J, 'Unhealthy lifestyle may increase later depression via inflammation in older women but not men', Journal of Psychiatric Research, 63 65-74 (2015) [C1]
© 2015 Elsevier Ltd. Depression and inflammatory markers have a reliable cross-sectional association although less is known about the prospective relationship. The current study i... [more]
© 2015 Elsevier Ltd. Depression and inflammatory markers have a reliable cross-sectional association although less is known about the prospective relationship. The current study investigated whether pro-inflammatory markers are prospectively associated with depression, and whether indicators of unhealthy lifestyle, physical health and psychosocial functioning may drive this association. Participants were drawn from the Hunter Community Study, a community-dwelling cohort of individuals aged 55-85 years (N=1410). Participants completed baseline physiological assessment, health-related questionnaires, and blood sampling for the analysis of inflammatory markers, C-reactive protein (CRP) and interleukin (IL)-6. Participants completed the same depressive symptom questionnaire again after 3.5-5.5 years. Depression outcomes at follow-up were analysed dichotomously using established scale cut-off scores and continuously as a "residual score", representing the variation in follow-up depressive symptoms not explained by baseline symptoms and age. Analyses were conducted on males and females separately. At baseline, indicators of unhealthy lifestyle, physical health and psychosocial functioning were associated with depressive symptoms and inflammatory markers. For males, there were no relationships between inflammatory markers and follow-up depression outcomes. In females, IL-6 was significantly associated with depression outcomes in univariate, but not multivariate analyses. However, IL-6 significantly mediated the association between the predictors of waist-to-hip ratio, smoking and psychological coping at baseline, and follow-up depression outcomes. The results support the inflammatory hypothesis of depression, although females may be more vulnerable to effects. The findings raise the possibility that unhealthy lifestyle and psychosocial stress may drive inflammation and subsequent depressive symptoms.
|
|
|
2015 |
Kelly PJ, Deane FP, Baker AL, 'Group cohesion and between session homework activities predict self-reported cognitive-behavioral skill use amongst participants of smart recovery groups', Journal of Substance Abuse Treatment, 51 53-58 (2015) [C1]
© 2015. SMART Recovery groups are cognitive-behaviorally oriented mutual support groups for individuals with addictions. The aim of the study was to assess the extent to which the... [more]
© 2015. SMART Recovery groups are cognitive-behaviorally oriented mutual support groups for individuals with addictions. The aim of the study was to assess the extent to which the quality of group facilitation, group cohesion and the use of between session homework activities contribute to self-rated use of cognitive-behavioral skills amongst group participants. Participants attending SMART Recovery groups in Australia completed a cross sectional survey (N = 124). The survey included measures of cognitive and behavioral skill utilization, group cohesion, quality of group facilitation and a rating of how frequently participants leave group meetings with an achievable between session homework plan. On average, participants had been attending SMART Recovery meetings for 9. months. Participants were most likely to attend SMART Recovery for problematic alcohol use. Regression analyses indicated that group cohesion significantly predicted use of cognitive restructuring, but that only provision of homework at the end of each group session predicted self-reported behavioral activation. Both group cohesion and leaving a group with an achievable homework plan predicted participant use of cognitive behavioral skills. The concrete actions associated with homework activities may facilitate behavioral activation. There is a need for longitudinal research to examine the relationship between the utilization of cognitive and behavioral skills and participant outcomes (e.g. substance use, mental health) for people attending SMART Recovery groups.
|
|
|
2015 |
Baker AL, Richmond R, Kay-Lambkin FJ, Filia SL, Castle D, Williams JM, et al., 'Randomized controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders', Nicotine and Tobacco Research, 17 946-954 (2015) [C1]
© The Author 2015. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. Introduction: People with severe mental... [more]
© The Author 2015. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. Introduction: People with severe mental disorders typically experience a range of health problems; consequently, interventions addressing multiple health behaviors may provide an efficient way to tackle this major public health issue. This two-arm randomized controlled trial among people with psychotic disorders examined the efficacy of nicotine replacement therapy (NRT) plus either a faceto- face or predominantly telephone delivered intervention for smoking cessation and cardiovascular disease (CVD) risk reduction. Methods: Following baseline assessment and completion of a common, individually delivered 90-minute face-to-face intervention, participants (n = 235) were randomized to receive NRT plus: (1) a "Healthy Lifestyles" intervention for smoking cessation and CVD risk behaviors or (2) a predominantly telephone-based intervention (designed to control for NRT provision, session frequency, and other monitoring activities). Research assistants blind to treatment allocation performed assessments at 15 weeks (mid-intervention) and 12 months after baseline. Results: There were no significant differences between intervention conditions in CVD risk or smoking outcomes at 15 weeks or 12 months, with improvements in both conditions (eg, 12 months: 6.4% confirmed point prevalence abstinence rate; 17% experiencing a 50% or greater smoking reduction; mean reduction of 8.6 cigarettes per day; mean improvement in functioning of 9.8 points). Conclusions: The health disparity experienced by people with psychotic disorders is high. Faceto- face Healthy Lifestyle interventions appear to be feasible and somewhat effective. However, given the accessibility of telephone delivered interventions, potentially combined with lower cost, further studies are needed to evaluate telephone delivered smoking cessation and lifestyle interventions for people with psychotic disorders.
|
|
|
2015 |
Adamson SJ, Kay-Lambkin FJ, Baker A, Frampton CMA, Sellman D, Lewin TJ, 'Measuring change in cannabis use', Addiction Research and Theory, 23 43-49 (2015) [C1]
© 2014 Informa UK Ltd. We examined the ability of the Cannabis User Disorders Identification Test - Revised (CUDIT-R) to detect change in a treatment sample, including correlation... [more]
© 2014 Informa UK Ltd. We examined the ability of the Cannabis User Disorders Identification Test - Revised (CUDIT-R) to detect change in a treatment sample, including correlation with changes in other clinically relevant areas of functioning, and to determine reliable and clinically significant change thresholds. 133 cannabis-using patients taking part in a treatment trial for concurrent substance use and mood disorder were administered the 8-item CUDIT-R at baseline, 6 and 12 months, in addition to assessment of current cannabis use disorder, mood, alcohol use, motivation and employment status. Significant reductions in CUDIT-R scores were observed and were correlated with change in cannabis diagnosis, and improvement in mood. Higher motivation at baseline predicted greater reduction in CUDIT-R score. Reliable change was identified as occurring when CUDIT-R score changed by two or more, while clinically significant change, benchmarked against an increase or decrease of one DSM-IV cannabis dependence symptom, was equated to a CUDIT-R score changing by 3 or more points.
|
|
|
2015 |
McCarter KL, Britton B, Baker A, Halpin S, Beck A, Carter G, et al., 'Interventions to improve screening and appropriate referral of patients with cancer for distress: Systematic review protocol', BMJ Open, 5 (2015) [C3]
|
|
|
2015 |
Hiles SA, Baker AL, de Malmanche T, McEvoy M, Boyle M, Attia J, 'The role of inflammatory markers in explaining the association between depression and cardiovascular hospitalisations', Journal of Behavioral Medicine, 38 609-619 (2015) [C1]
© 2015, Springer Science+Business Media New York. This study investigated whether inflammation may explain the relationship between depression and incident cardiovascular hospital... [more]
© 2015, Springer Science+Business Media New York. This study investigated whether inflammation may explain the relationship between depression and incident cardiovascular hospitalisations. Participants (55¿85¿years) completed baseline depression and physical assessment. Those without self-reported cardiovascular events were followed prospectively for hospital admissions for angina, myocardial infarction and cerebral infarction (median 937¿days). Across 5140 person-years of risk (N¿=¿1692), there were 47 incident cardiovascular hospitalisations (2.8¿%). Controlling for age and gender, interleukin (IL)-6, C-reactive protein (CRP), body mass index (BMI) and waist-to-hip ratio were associated with future cardiovascular events. Mediation analysis showed that CRP accounted for 8.1¿% and IL-6 10.9¿% of the effect of depression on cardiovascular events, and including the indirect effect in the model substantially reduced the direct relationship between depression and cardiovascular hospitalisations. BMI and waist-to-hip ratio accounted for indirect effects of 7.7 and 10.4¿%, respectively. Inflammatory markers partly explain the association between depression and cardiovascular events, although other shared factors also likely contribute.
|
|
|
2015 |
Babic MJ, Morgan PJ, Plotnikoff RC, Lonsdale C, Eather N, Skinner G, et al., 'Rationale and study protocol for 'Switch-off 4 Healthy Minds' (S4HM): A cluster randomized controlled trial to reduce recreational screen time in adolescents', Contemporary Clinical Trials, 40 150-158 (2015) [C1]
© 2014 Elsevier Inc. Introduction: Excessive recreational screen time (i.e., screen use for entertainment) is a global public health issue associated with adverse mental and physi... [more]
© 2014 Elsevier Inc. Introduction: Excessive recreational screen time (i.e., screen use for entertainment) is a global public health issue associated with adverse mental and physical health outcomes. Considering the growing popularity of screen-based recreation in adolescents, there is a need to identify effective strategies for reducing screen time among adolescents. The aim of this paper is to report the rationale and study protocol for the 'Switch-off 4 Healthy Minds' (S4HM) study, an intervention designed to reduce recreational screen time among adolescents. Methods: The S4HM intervention will be evaluated using a cluster randomized controlled trial in eight secondary schools (. N=. 322 students) in New South Wales, Australia. The 6-month multi-component intervention will encourage adolescents to manage their recreational screen time using a range of evidence-based strategies. The intervention is grounded in Self-Determination Theory (SDT) and includes the following components: an interactive seminar for students, eHealth messaging, behavioral contract and parental newsletters. All outcomes will be assessed at baseline and at 6-months (i.e., immediate post-test). The primary outcome is recreational screen time measured by the Adolescent Sedentary Activity Questionnaire (ASAQ). Secondary outcomes include: self-reported psychological well-being, psychological distress, global physical self-concept, resilience, pathological video gaming and aggression, and objectively measured physical activity (accelerometry) and body mass index (BMI). Hypothesized mediators of behavior change will also be explored. Discussion: The S4HM study will involve the evaluation of an innovative, theory-driven, multi-component intervention that targets students and their parents and is designed to reduce recreational screen time in adolescents. The intervention has been designed for scalability and dissemination across Australian secondary schools.
|
|
|
2015 |
Britton B, McCarter K, Baker A, Wolfenden L, Wratten C, Bauer J, et al., 'Eating As Treatment (EAT) study protocol: a stepped-wedge, randomised controlled trial of a health behaviour change intervention provided by dietitians to improve nutrition in patients with head and neck cancer undergoing radiotherapy.', BMJ open, 5 e008921 (2015) [C3]
|
|
|
2015 |
Kay-Lambkin FJ, Baker AL, Geddes J, Hunt SA, Woodcock KL, Teesson M, et al., 'The iTreAD project: A study protocol for a randomised controlled clinical trial of online treatment and social networking for binge drinking and depression in young people Health behavior, health promotion and society', BMC Public Health, 15 (2015) [C3]
© 2015 Kay-Lambkin et al. Background: Depression and binge drinking behaviours are common clinical problems, which cause substantial functional, economic and health impacts. These... [more]
© 2015 Kay-Lambkin et al. Background: Depression and binge drinking behaviours are common clinical problems, which cause substantial functional, economic and health impacts. These conditions peak in young adulthood, and commonly co-occur. Comorbid depression and binge drinking are undertreated in young people, who are reluctant to seek help via traditional pathways to care. The iTreAD project (internet Treatment for Alcohol and Depression) aims to provide and evaluate internet-delivered monitoring and treatment programs for young people with depression and binge drinking concerns. Methods: Three hundred sixty nine participants will be recruited to the trial, and will be aged 18-30 years will be eligible for the study if they report current symptoms of depression (score 5 or more on the depression subscale of the Depression Anxiety Stress Scale) and concurrent binge drinking practices (5 or more standard drinks at least twice in the prior month). Following screening and online baseline assessment, participants are randomised to: (a) online monthly self-assessments, (b) online monthly self-assessments¿+¿12-months of access to a 4 week online automated cognitive behaviour therapy program for binge drinking and depression (DEAL); or (c) online monthly assessment¿+¿DEAL¿+¿12-months of access to a social networking site (Breathing Space). Independent, blind follow-up assessments occur at 26, 39, 52 and 64-weeks post-baseline. Discussion: The iTreAD project is the first randomised controlled trial combining online cognitive behaviour therapy, social networking and online monitoring for young people reporting concerns with depression and binge drinking. These treatments represent low-cost, wide-reach youth-appropriate treatment, which will have significantly public health implications for service design, delivery and health policy for this important age group. Trial registration: Australian and New Zealand Clinical Trials Registry ACTRN12614000310662. Date registered 24 March 2014.
|
|
|
2015 |
Beck AK, Baker A, Britton B, Wratten C, Bauer J, Wolfenden L, Carter G, 'Fidelity considerations in translational research: Eating As Treatment - a stepped wedge, randomised controlled trial of a dietitian delivered behaviour change counselling intervention for head and neck cancer patients undergoing radiotherapy', Trials, 16 (2015) [C3]
© 2015 Beck et al. Background: The confidence with which researchers can comment on intervention efficacy relies on evaluation and consideration of intervention fidelity. Accordin... [more]
© 2015 Beck et al. Background: The confidence with which researchers can comment on intervention efficacy relies on evaluation and consideration of intervention fidelity. Accordingly, there have been calls to increase the transparency with which fidelity methodology is reported. Despite this, consideration and/or reporting of fidelity methods remains poor. We seek to address this gap by describing the methodology for promoting and facilitating the evaluation of intervention fidelity in The EAT (Eating As Treatment) project: a multi-site stepped wedge randomised controlled trial of a dietitian delivered behaviour change counselling intervention to improve nutrition (primary outcome) in head and neck cancer patients undergoing radiotherapy. Methods/Design: In accordance with recommendations from the National Institutes of Health Behaviour Change Consortium Treatment Fidelity Workgroup, we sought to maximise fidelity in this stepped wedge randomised controlled trial via strategies implemented from study design through to provider training, intervention delivery and receipt. As the EAT intervention is designed to be incorporated into standard dietetic consultations, we also address unique challenges for translational research. Discussion: We offer a strong model for improving the quality of translational findings via real world application of National Institutes of Health Behaviour Change Consortium recommendations. Greater transparency in the reporting of behaviour change research is an important step in improving the progress and quality of behaviour change research. Trial registration number:ACTRN12613000320752(Date of registration 21 March 2013)
|
|
|
2014 |
Hunt SA, Baker AL, Michie PT, Kay-Lambkin F, 'Change in neurocognition in people with co-occurring alcohol misuse and depression: 12-month follow-up', Journal of Addiction Research & Therapy, S10:004 (2014) [C1]
|
|
|
2014 |
Baker AL, Turner A, Kelly PJ, Spring B, Callister R, Collins CE, et al., ''Better Health Choices' by telephone: A feasibility trial of improving diet and physical activity in people diagnosed with psychotic disorders', Psychiatry Research, (2014) [C1]
The study objective was to evaluate the feasibility of a telephone delivered intervention consisting of motivational interviewing and cognitive behavioural strategies aimed at imp... [more]
The study objective was to evaluate the feasibility of a telephone delivered intervention consisting of motivational interviewing and cognitive behavioural strategies aimed at improving diet and physical activity in people diagnosed with psychotic disorders. Twenty participants diagnosed with a non-acute psychotic disorder were recruited. The intervention consisted of eight telephone delivered sessions targeting fruit and vegetable (F&V) consumption and leisure screen time, as well as smoking and alcohol use (as appropriate). F&V frequency and variety, and overall diet quality (measured by the Australian Recommended Food Score, ARFS), leisure screen time, overall sitting and walking time, smoking, alcohol consumption, mood, quality of life, and global functioning were examined before and 4-weeks post-treatment. Nineteen participants (95%) completed all intervention sessions, and 17 (85%) completed follow-up assessments. Significant increases from baseline to post-treatment were seen in ARFS fruit, vegetable and overall diet quality scores, quality of life and global functioning. Significant reductions in leisure screen time and overall sitting time were also seen. Results indicated that a telephone delivered intervention targeting key cardiovascular disease risk behaviours appears to be feasible and relatively effective in the short-term for people diagnosed with psychosis. A randomized controlled trial is warranted to replicate and extend these findings. © 2014 Elsevier Ireland Ltd. All rights reserved.
|
|
|
2014 |
Stockings EA, Bowman JA, Prochaska JJ, Baker AL, Clancy R, Knight J, et al., 'The impact of a smoke-free psychiatric hospitalization on patient smoking outcomes: A systematic review', Australian and New Zealand Journal of Psychiatry, 48 617-633 (2014) [C1]
Objective: Smoke-free policies have been introduced in inpatient psychiatric facilities in most developed nations. Such a period of supported abstinence during hospitalization may... [more]
Objective: Smoke-free policies have been introduced in inpatient psychiatric facilities in most developed nations. Such a period of supported abstinence during hospitalization may impact smoking behaviours post discharge, yet little quantitative evidence exists. The aim of this review was to provide the first synthesis of the research evidence examining the impact of a smoke-free psychiatric hospitalization on patients smoking-related behaviours, motivation, and beliefs. Methods: We conducted a systematic review of electronic databases PubMed, MEDLINE, PsycINFO, and EMBASE from inception to June 2013. Studies were included if they were conducted in an inpatient psychiatric facility with a smokefree policy and if they examined any change in patients smoking-related behaviours, motivation, or beliefs either during admission, post discharge, or both. Risk of bias was assessed using the Cochrane Collaboration Risk of Bias Tool. Results: Fourteen studies were included in the review. Of the four studies that assessed change in smoking from admission to post discharge, two indicated a significant decline in cigarette consumption up to 3 months post discharge. Positive changes in motivation to quit and beliefs about quitting ability were identified in two studies. One study reported an increase in the rate of quit attempts and one reported a decline in nicotine dependence levels. Conclusions: A smoke-free psychiatric hospitalization may have © The Royal Australian and New Zealand College of Psychiatrists 2014.
|
|
|
2014 |
Filia SL, Baker AL, Gurvich CT, Richmond R, Lewin TJ, Kulkarni J, 'Gender differences in characteristics and outcomes of smokers diagnosed with psychosis participating in a smoking cessation intervention', Psychiatry Research, 215 586-593 (2014) [C1]
While research has identified gender differences in characteristics and outcomes of smokers in the general population, no studies have examined this among smokers with psychosis. ... [more]
While research has identified gender differences in characteristics and outcomes of smokers in the general population, no studies have examined this among smokers with psychosis. This study aimed to explore gender differences among 298 smokers with psychosis (schizophrenia, schizoaffective and bipolar affective disorder) participating in a smoking intervention study. Results revealed a general lack of gender differences on a range of variables for smokers with psychosis including reasons for smoking/quitting, readiness and motivation to quit, use of nicotine replacement therapy, and smoking outcomes including point prevalence or continuous abstinence, and there were no significant predictors of smoking reduction status according to gender at any of the follow-up time-points. The current study did find that female smokers with psychosis were significantly more likely than males to report that they smoked to prevent weight gain. Furthermore, the females reported significantly more reasons for quitting smoking and were more likely to be driven by extrinsic motivators to quit such as immediate reinforcement and social influence, compared to the male smokers with psychosis. Clinical implications include specifically focussing on weight issues and enhancing intrinsic motivation to quit smoking for female smokers with psychosis; and strengthening reasons for quitting among males with psychosis. © 2014 Elsevier Ireland Ltd.
|
|
|
2014 |
Stringer D, Marshall D, Pester B, Baker A, Langenecker SA, Angers K, et al., 'Openness predicts cognitive functioning in bipolar disorder', Journal of Affective Disorders, 168 51-57 (2014) [C1]
Objectives Openness to experience (O) is a well-established personality factor and is associated with cognitive performance. Little is known about the personality-cognitive relati... [more]
Objectives Openness to experience (O) is a well-established personality factor and is associated with cognitive performance. Little is known about the personality-cognitive relationship in bipolar disorder, an illness with significant variability in mood. Cognitive evaluation is essential in psychopathology assessment as it may reflect underlying disease processes and psychosocial functional capacity. Screening using a proxy personality variable may identify those in need of comprehensive cognitive testing. We hypothesized that O and measures of cognition would associate in both the Bipolar Disorder (BD) and healthy control (HC) samples, whereas neuroticism and extraversion would correlate with cognition only in the BD sample. Methods Data from a longitudinal study of BD were used to study the association between personality factors and cognitive measures of attention, executive functioning, memory and fine motor skills. Regression analyses were used to determine the variables that account for the association between personality and cognition. Results Aspects of O explained significant cognitive variance (~5%) in both groups; this persisted when demographic variables (including BD versus HC status) were considered. Neuroticism and extraversion did not consistently correlate with cognitive performance in either group. Limitations There were more females in the HC group who were slightly younger compared to the BD group. We lack direct measures of positive affect, and there is a reliance on a single measure of personality. Conclusions BD Individuals scoring low on self-reported Openness are potential candidates for more comprehensive cognitive assessments (which represent a limited resource). © 2014 Published by Elsevier B.V.
|
|
|
2014 |
Baker AL, Kavanagh DJ, Kay-Lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, McElduff P, 'Randomized controlled trial of MICBT for co-existing alcohol misuse and depression: Outcomes to 36-months', Journal of Substance Abuse Treatment, 46 281-290 (2014) [C1]
Integrated psychological treatment addressing co-existing alcohol misuse and depression has not been compared with single-focused treatment. This trial evaluates changes over 36. ... [more]
Integrated psychological treatment addressing co-existing alcohol misuse and depression has not been compared with single-focused treatment. This trial evaluates changes over 36. months following randomization of 284 outpatients to one of four motivational interviewing and cognitive-behavior therapy (MICBT) based interventions: (1) brief integrated intervention (BI); or BI plus 9 further sessions with (2) an integrated-, (3) alcohol-, or (4) depression-focus. Outcome measures included changes in alcohol consumption, depression (BDI-II: Beck Depression Inventory) and functioning (GAF: Global Assessment of Functioning), with average improvements from baseline of 21.8 drinks per week, 12.6 BDI-II units and 8.2 GAF units. Longer interventions tended to be more effective in reducing depression and improving functioning in the long-term, and in improving alcohol consumption in the short-term. Integrated treatment was at least as good as single-focused MICBT. Alcohol-focused treatment was as effective as depression-focused treatment at reducing depression and more effective in reducing alcohol misuse. The best approach seems to be an initial focus on both conditions followed by additional integrated- or alcohol-focused sessions. © 2014 Elsevier Inc.
|
|
|
2014 |
Kelly PJ, Baker AL, Kay-Lambkin F, 'ADDRESSING MULTIPLE HEALTH RISK BEHAVIOURS IN DISADVANTAGED POPULATIONS: RESEARCH BEING LED BY THE NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL CENTRE OF RESEARCH EXCELLENCE IN MENTAL HEALTH AND SUBSTANCE USE', DRUG AND ALCOHOL REVIEW, 33 37-37 (2014) [E3]
|
|
|
2014 |
Bonevski B, Regan T, Paul C, Baker AL, Bisquera A, 'Associations between alcohol, smoking, socioeconomic status and comorbidities: Evidence from the 45 and Up Study', Drug and Alcohol Review, 33 169-176 (2014) [C1]
Introduction and Aims.: Understanding how tobacco, alcohol and mental health are related is important for developing population-level policies and individual-level treatments that... [more]
Introduction and Aims.: Understanding how tobacco, alcohol and mental health are related is important for developing population-level policies and individual-level treatments that target comorbidities. The current study aimed to examine sociodemographic characteristics and mental health comorbidities associated with the odds of using tobacco and harmful levels of alcohol concurrently. Design and Methods.: Data were drawn from the 45 and Up Study, a large cohort study with 267153 adults aged 45 years and over in New South Wales, Australia. Participants completed a survey assessing alcohol, smoking, psychological distress, treatment for depression and anxiety, and a range of socioeconomic status indicators. Univariate analyses and three multiple-logistic regression models were used to determine associations with (i) tobacco but not alcohol use; (ii) alcohol but not tobacco use; and (iii) concurrent tobacco and risky levels of alcohol use. Results.: Being female, younger, lower individual and area-level socioeconomic status (SES) and depression and psychological distress were associated with tobacco use alone. Factors associated with alcohol use alone were older age, male gender, higher SES, and lower psychological distress and no recent depression treatment. Factors associated with concurrent risky alcohol consumption and tobacco use included being 45-64, being male, less education, earning <$30000, being employed, and living in lower-SES areas, treatment for depression, and high distress on the Kessler-10. Discussion and Conclusions.: Results suggest strong links between SES, treatment for depression, psychological distress, and concurrent tobacco and alcohol use. This has implications for public health policies and clinical treatment for tobacco and alcohol use, suggesting greater emphasis on addressing multiple health and social concerns. © 2013 Australasian Professional Society on Alcohol and other Drugs.
|
|
|
2014 |
Mcketin R, Butterworth P, Lubman DI, Najman JM, Dawe S, Baker AL, 'Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study', Addiction, (2014) [C1]
Aims: To determine whether violent behaviour increases during periods of methamphetamine use and whether this is due to methamphetamine-induced psychotic symptoms. Design: A fixed... [more]
Aims: To determine whether violent behaviour increases during periods of methamphetamine use and whether this is due to methamphetamine-induced psychotic symptoms. Design: A fixed-effects (within-subject) analysis of four non-contiguous 1-month observation periods from a longitudinal prospective cohort study. Setting: Sydney and Brisbane, Australia. Participants: A total of 278 participants aged 16 years or older who met DSM-IV criteria for methamphetamine dependence on entry to the study but who did not meet DSM-IV criteria for life-time schizophrenia or mania. Measurements: Violent behaviour was defined as severe hostility in the past month on the Brief Psychiatric Rating Scale (BPRS) (corresponding to assault/damage to property). Days of methamphetamine and other substance use in the past month were assessed using the Opiate Treatment Index. Positive psychotic symptoms in the past month were identified using the BPRS. Findings: There was a dose-related increase in violent behaviour when an individual was using methamphetamine compared with when they were not after adjusting for other substance use and socio-demographics [cf. no use in the past month: 1-15 days of use odds ratio (OR)=2.8, 95% confidence interval (CI)=1.6-4.9; 16+ days of use OR=9.5, 95% CI=4.8-19.1]. The odds of violent behaviour were further increased by psychotic symptoms (OR=2.0, 95% CI=1.1-3.6), which accounted for 22-30% of violent behaviour related to methamphetamine use. Heavy alcohol consumption also increased the risk of violent behaviour (OR=3.1, 95% CI=1.4-7.0) and accounted for 12-18% of the violence risk related to methamphetamine use. Conclusions: There is a dose-related increase in violent behaviour during periods of methamphetamine use that is largely independent of the violence risk associated with psychotic symptoms. © 2014 Society for the Study of Addiction.
|
|
|
2014 |
Stockings EAL, Bowman JA, Baker AL, Terry M, Clancy R, Wye PM, et al., 'Impact of a postdischarge smoking cessation intervention for smokers admitted to an inpatient psychiatric facility: A randomized controlled trial', Nicotine and Tobacco Research, 16 1417-1428 (2014) [C1]
© The Author 2014. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. Introduction: Persons with a mental dis... [more]
© The Author 2014. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. Introduction: Persons with a mental disorder smoke at higher rates and suffer disproportionate tobacco-related burden compared with the general population. The aim of this study was to determine if a smoking cessation intervention initiated during a psychiatric hospitalization and continued postdischarge was effective in reducing smoking behaviors among persons with a mental disorder. Methods: A randomized controlled trial was conducted at an Australian inpatient psychiatric facility. Participants were 205 patient smokers allocated to a treatment as usual control (n = 101) or a smoking cessation intervention (n = 104) incorporating psychosocial and pharmacological support for 4 months postdischarge. Follow-up assessments were conducted at 1 week, 2, 4, and 6 months postdischarge and included abstinence from cigarettes, quit attempts, daily cigarette consumption, and nicotine dependence. Results: Rates of continuous and 7-day point prevalence abstinence did not differ between treatment conditions at the 6-month follow-up; however, point prevalence abstinence was significantly higher for intervention (11.5%) compared with control (2%) participants at 4 months (OR = 6.46, p = .01). Participants in the intervention condition reported significantly more quit attempts (F[1, 202.5] = 15.23, p = .0001), lower daily cigarette consumption (F[4, 586] = 6.5, p < .001), and lower levels of nicotine dependence (F[3, 406] = 8.5, p < .0001) compared with controls at all follow-up assessments. Conclusions: Postdischarge cessation support was effective in encouraging quit attempts and reducing cigarette consumption up to 6 months postdischarge. Additional support strategies are required to facilitate longer-term cessation benefits for smokers with a mental disorder.
|
|
|
2014 |
Hjorthoj CR, Baker A, Fohlmann A, Nordentoft M, 'Intervention Efficacy in Trials Targeting Cannabis Use Disorders in Patients with Comorbid Psychosis Systematic Review and Meta-analysis', CURRENT PHARMACEUTICAL DESIGN, 20 2205-2211 (2014) [C1]
|
|
|
2014 |
Mask L, Blanchard CM, Baker A, 'Do portrayals of women in action convey another ideal that women with little self-determination feel obligated to live up to? Viewing effects on body image evaluations and eating behaviors', Appetite, 83 277-286 (2014)
© 2014 Elsevier Ltd. Theoretical and empirical research suggests that valuing the body in terms of its functionality and physical competence (rather than its appearance) may impro... [more]
© 2014 Elsevier Ltd. Theoretical and empirical research suggests that valuing the body in terms of its functionality and physical competence (rather than its appearance) may improve women's relationships with their body and food. We tested this proposition by investigating women's responses to contrasting portrayals of the female body as a function of viewers' general motivation (SD: self-determined vs NSD: non self-determined). A sample of undergraduate women (N=91) was randomly assigned to view a "body-as-process" video, a "body-as-object" video, and a neutral video. Afterwards, participants completed measures of appearance and competence self-appraisals and were then offered three varieties of chocolate bars to sample and evaluate. Their actual intake (g) along with motives to exert self-control (identified vs introjected) were assessed. Negative viewing effects were obtained for both the "body-as-process" and the "body-as-object" videos and these effects were exacerbated by participants' motivation. Women with a NSD motivation evaluated their appearance and competence more negatively post-exposure. They also endorsed more guilt-related reasons (introjected motives) to exert control over their consumption of chocolate which predicted diminished intake. These findings suggest that portrayals of female athleticism and physical competence may represent another ideal that women with a NSD motivation feel obligated to live up to.
|
|
|
2014 |
Filia SL, Baker AL, Gurvich CT, Richmond R, Kulkarni J, 'The perceived risks and benefits of quitting in smokers diagnosed with severe mental illness participating in a smoking cessation intervention: Gender differences and comparison to smokers without mental illness', Drug and Alcohol Review, 33 78-85 (2014) [C1]
Introduction and Aims: This study aimed to examine the perceived risks and benefits of quitting in smokers diagnosed with psychosis, including potential gender differences and com... [more]
Introduction and Aims: This study aimed to examine the perceived risks and benefits of quitting in smokers diagnosed with psychosis, including potential gender differences and comparisons to smokers in the general population. Design and Methods: Data were collected from 200 people diagnosed with psychosis participating in a randomised controlled trial testing the effectiveness of a multi-component intervention for smoking cessation and cardiovascular disease risk reduction in people with severe mental illness. Results were compared with both treatment and non-treatment seeking smokers in the general population. Results: Male and female smokers with psychosis generally had similar perceived risks and benefits of quitting. Females rated it significantly more likely that they would experience weight gain and negative affect upon quitting than males diagnosed with psychosis. Compared with smokers in the general population also seeking smoking cessation treatment, this sample of smokers with psychosis demonstrated fewer gender differences and lower ratings of perceived risks and benefits of quitting. The pattern of risk and benefit ratings in smokers diagnosed with psychosis was similar to those of non-treatment seeking smokers in the general population. Discussion and Conclusions: These results increase our understanding of smoking in people with severe mental illness, and can directly inform smoking interventions to maximise successful abstinence for this group of smokers. For female smokers with psychosis, smoking cessation interventions need to address concerns regarding weight gain and negative affect. Intervention strategies aimed at enhancing beliefs about the benefits of quitting smoking for both male and female smokers with psychosis are necessary. © 2013 Australasian Professional Society on Alcohol and other Drugs.
|
|
|
2014 |
Mills KL, Ewer P, Dore G, Teesson M, Baker A, Kay-Lambkin F, Sannibale C, 'The feasibility and acceptability of a brief intervention for clients of substance use services experiencing symptoms of post traumatic stress disorder', Addictive Behaviors, 39 1094-1099 (2014) [C1]
Background: Trauma exposure and post traumatic stress disorder (PTSD) are common among clients of substance use services. Existing treatments for these co-occurring conditions ten... [more]
Background: Trauma exposure and post traumatic stress disorder (PTSD) are common among clients of substance use services. Existing treatments for these co-occurring conditions tend to be lengthy, treatment retention is relatively poor, and they require extensive training and clinical supervision. The aim of the present study was to conduct a preliminary examination of the feasibility and acceptability of a brief intervention for PTSD symptoms among individuals seeking substance use treatment. Methods: An uncontrolled open-label pilot study was conducted among 29 inpatients of a medicated detoxification unit in Sydney, Australia. All participants completed a baseline interview followed by the brief intervention. The intervention consists of a single, one-hour manualised session providing psychoeducation pertaining to common trauma reactions and symptom management. PTSD and substance use outcomes were assessed at 1-week, 1-month and 3-month post-intervention. Results: PTSD symptom severity (assessed using the Clinicians Administered PTSD Scale) decreased significantly from baseline to 1-week follow up (ß - 10.87, 95%CI: - 19.75 to - 1.99) and again between the 1-week and 3-month follow-ups (ß - 15.38, 95%CI: - 23.20 to - 7.57). Despite these reductions, the majority of participants continued to meet criteria for a diagnosis of PTSD and there was no change in participants' negative post-traumatic cognitions. Participants expressed high levels of satisfaction with the intervention. Conclusions: Brief psychoeducation for traumatised clients attending substance use services appears to be feasible, acceptable, and may be of some benefit in reducing PTSD symptoms. However, participants continued to experience symptoms at severe levels; thus, brief intervention may best be conceptualised as a "stepping stone" to further trauma treatment. © 2014 Elsevier Ltd.
|
|
|
2013 |
Stockings E, Bowman J, McElwaine K, Baker A, Terry M, Clancy R, et al., 'Readiness to quit smoking and quit attempts among Australian mental health inpatients.', Nicotine Tob Res, 15 942-949 (2013) [C1]
|
|
|
2013 |
Thornton LK, Baker AL, 'The importance of investigating alcohol use among people with schizophrenia', ACTA PSYCHIATRICA SCANDINAVICA, 128 96-96 (2013) [C3]
|
|
|
2013 |
Turner A, Hambridge J, Baker A, Bowman J, McElduff P, 'Randomised controlled trial of group cognitive behaviour therapy versus brief intervention for depression in cardiac patients', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 47 235-243 (2013) [C1]
|
|
|
2013 |
Hides L, Carroll S, Scott R, Cotton S, Baker A, Lubman DI, 'Quik Fix: A Randomized Controlled Trial of an Enhanced Brief Motivational Interviewing Intervention for Alcohol/Cannabis and Psychological Distress in Young People', PSYCHOTHERAPY AND PSYCHOSOMATICS, 82 122-124 (2013) [C1]
|
|
|
2013 |
Handley TE, Kay-Lambkin FJ, Baker AL, Lewin TJ, Kelly BJ, Inder KJ, et al., 'Incidental treatment effects of CBT on suicidal ideation and hopelessness', JOURNAL OF AFFECTIVE DISORDERS, 151 275-283 (2013) [C1]
|
|
|
2013 |
Connolly JM, Kavanagh DJ, Baker AL, Kay-Lambkin FJ, Lewin TJ, Davis PJ, Quek L-H, 'Craving as a predictor of treatment outcomes in heavy drinkers with comorbid depressed mood', ADDICTIVE BEHAVIORS, 38 1585-1592 (2013) [C1]
|
|
|
2013 |
Thornton LK, Baker AL, Johnson MP, Lewin T, 'Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders', ADDICTIVE BEHAVIORS, 38 2246-2251 (2013) [C1]
|
|
|
2013 |
Baker AL, Kay-Lambkin FJ, Gilligan C, Kavanagh DJ, Baker F, Lewin TJ, 'When does change begin following screening and brief intervention among depressed problem drinkers?', Journal of Substance Abuse Treatment, 44 264-270 (2013) [C1]
Brief interventions are effective for problem drinking and reductions are known to occur in association with screening and assessment. The present study sought to assess, among pa... [more]
Brief interventions are effective for problem drinking and reductions are known to occur in association with screening and assessment. The present study sought to assess, among participants (N= 202) in a clinical trial, how much change occurred between baseline assessment and a one-session brief intervention (S1), and the predictors of early change. The primary focus was on changes in the Beck Depression Inventory Fast Screen scores and alcohol consumption (standard drinks per week) prior to random allocation to nine further sessions addressing either depression, alcohol, or both problems. There were large and clinically significant reductions between baseline and S1, with the strongest predictors being baseline scores in the relevant domain and change in the other domain. Client engagement was also predictive of early depression changes. Monitoring progress in both domains from first contact, and provision of empathic care, followed by brief intervention appear to be useful for this high prevalence comorbidity. © 2013 Elsevier Inc.
|
|
|
2013 |
McKetin R, Dunlop AJ, Holland RM, Sutherland RA, Baker AL, Salmon AM, Hudson SL, 'Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia', DRUG AND ALCOHOL REVIEW, 32 80-87 (2013) [C1]
|
|
|
2013 |
Baker A, Perreault D, Reid A, Blanchard CM, 'Feedback and organizations: Feedback is good, feedback-friendly culture is better', Canadian Psychology, 54 260-268 (2013)
Scholars have noted that an incomplete understanding of various important aspects of feedback still remains prominent (Whitaker & Levy, 2012). The value of organisational feed... [more]
Scholars have noted that an incomplete understanding of various important aspects of feedback still remains prominent (Whitaker & Levy, 2012). The value of organisational feedback culture on feedback outcomes is a recognised gap in the literature. The present article begins with a brief conceptualisation and definition of individual feedback and highlights the element of meaning as a principle intricate to all feedback techniques. The article then builds a case for the added benefits of creating a feedback-friendly culture in order to gain more insight and enhance the meaningfulness of feedback. Three recommendations are offered to support such a culture including the promotion of the learning continuum, the fostering of a trusting climate, and the endorsement of authentic dialogue. Finally, the implications and future research directions are discussed. © 2013 Canadian Psychological Association.
|
|
|
2013 |
Baker A, 'Treating Addiction: A Guide for Professionals by AU - William R. Miller , AU - Alyssa A. Forcehimes & AU - Allen Zweben New York', Drug and Alcohol Review, 32 445-446 (2013) [C3]
|
|
|
2013 |
Allen J, Inder KJ, Lewin TJ, Attia JR, Kay-Lambkin FJ, Baker AL, et al., 'Integrating and extending cohort studies: lessons from the eXtending Treatments, Education and Networks in Depression (xTEND) study', BMC Medical Research Methodology, 13 (2013) [C1]
|
|
|
2013 |
Kay-Lambkin F, Edwards S, Baker A, Kavanagh D, Kelly B, Bowman J, Lewin T, 'The Impact of Tobacco Smoking on Treatment for Comorbid Depression and Alcohol Misuse', International Journal of Mental Health and Addiction, 11 619-633 (2013) [C1]
|
|
|
2013 |
McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL, 'Dose-Related Psychotic Symptoms in Chronic Methamphetamine Users Evidence From a Prospective Longitudinal Study', JAMA PSYCHIATRY, 70 319-324 (2013) [C1]
|
|
|
2012 |
Baker AL, Hiles SA, Thornton LK, Hides L, Lubman DI, 'A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders', Acta Psychiatrica Scandinavica, 126 243-255 (2012) [C1]
|
|
|
2012 |
Thornton LK, Baker AL, Johnson MP, Lewin TJ, 'Attitudes and perceptions towards substances among people with mental disorders: A systematic review', Acta Psychiatrica Scandinavica, 126 87-105 (2012) [C1]
|
|
|
2012 |
Filia SL, Gurvish CT, Baker AL, Kulkarni J, 'Response to Anandarajan et al.: Manic exacerbation induced by nicotine patch', Australian and New Zealand Journal of Psychiatry, 46 484-485 (2012) [C3] |
|
|
2012 |
Hiles SA, Baker AL, De Malmanche T, Attia JR, 'Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: A meta-analysis', Psychological Medicine, 42 2015-2026 (2012) [C1]
|
|
|
2012 |
Mills KL, Teesson M, Back SE, Brady KT, Baker AL, Hopwood S, et al., 'Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: A randomized controlled trial', Jama-Journal of the American Medical Association, 308 690-699 (2012) [C1]
|
|
|
2012 |
Nasstasia Y, Baker AL, Callister R, Halpin SA, 'Born to run, workout or maybe try Zumba: Managing depression with exercise', In Psych, 34 18-19 (2012) [C3]
|
|
|
2012 |
Baker AL, Thornton LK, Hiles SA, Hides L, Lubman DI, 'Psychological interventions for alcohol misuse among people with co-occurring depression or anxiety disorders: A systematic review', Journal of Affective Disorders, 139 217-229 (2012) [C1]
|
|
|
2012 |
Cohen M, Rasser PE, Peck G, Carr VJ, Ward PB, Thompson PM, et al., 'Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults', International Journal of Neuropsychopharmacology, 15 297-307 (2012) [C1]
|
|
|
2012 |
Thornton LK, Baker AL, Lewin TJ, Kay-Lambkin FJ, Kavanagh D, Richmond R, et al., 'Reasons for substance use among people with mental disorders', Addictive Behaviors, 37 427-434 (2012) [C1]
|
|
|
2012 |
Hiles SA, Baker AL, De Malmanche T, Attia JR, 'A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity', Brain, Behavior, and Immunity, 26 1180-1188 (2012) [C1]
|
|
|
2012 |
Thornton LK, Baker AL, Johnson MP, Kay-Lambkin FJ, Lewin TJ, 'Reasons for substance use among people with psychotic disorders: Method triangulation approach', Psychology of Addictive Behaviors, 26 279-288 (2012) [C1]
|
|
|
2012 |
Bonevski B, Baker AL, Twyman LH, Paul CL, Bryant JL, 'Addressing smoking and other health risk behaviours using a novel telephone-delivered intervention for homeless people: A proof-of-concept study', Drug and Alcohol Review, 31 709-713 (2012) [C1]
|
|
|
2012 |
Kelly PJ, Baker AL, Deane FP, Kay-Lambkin FJ, Bonevski B, Tregarthen J, 'Prevalence of smoking and other health risk factors in people attending residential substance abuse treatment', Drug and Alcohol Review, 31 638-644 (2012) [C1]
|
|
|
2012 |
Bonevski B, Baker AL, 'Tobacco smoking as a social justice issue: Advances in research', Drug and Alcohol Review, 31 599-601 (2012) [C3]
|
|
|
2012 |
Bailey KA, Webster RA, Baker AL, Kavanagh DJ, 'Exposure to dysfunctional parenting and trauma events and posttraumatic stress profiles among a treatment sample with coexisting depression and alcohol use problems', Drug and Alcohol Review, 31 529-537 (2012) [C1]
|
|
|
2012 |
Baker AL, Callister R, Kelly PJ, Kypri K, ''Do more, smoke less!' Harm reduction in action for smokers with mental health/substance use problems who cannot or will not quit', Drug and Alcohol Review, 31 714-717 (2012) [C3]
|
|
|
2012 |
McKetin R, Najman JM, Baker AL, Lubman DI, Dawe S, Ali R, et al., 'Evaluating the impact of community-based treatment options on methamphetamine use: Findings from the Methamphetamine Treatment Evaluation Study (MATES)', Addiction, 107 1998-2008 (2012) [C1]
|
|
|
2012 |
Castle D, Baker AL, Richmond R, Filia SL, Harris D, Pirola-Merlo AJ, 'Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders', Annals of Clinical Psychiatry, 24 285-291 (2012) [C1]
|
|
|
2012 |
Baker AL, Thornton LK, Hides L, Dunlop AJ, 'Treatment of cannabis use among people with psychotic disorders: A critical review of randomised controlled trials', Current Pharmaceutical Design, 18 4923-4937 (2012) [C1]
|
|
|
2012 |
Kay-Lambkin FJ, Baker AL, Healey A, Wolfe S, Simpson A, Brooks M, et al., 'Study protocol: A dissemination trial of computerized psychological treatment for depression and alcohol/other drug use comorbidity in an Australian clinical service', BMC Psychiatry, 12 77 (2012) [C3]
|
|
|
2012 |
Kelly PJ, Kay-Lambkin FJ, Baker AL, Deane FP, Brooks AC, Mitchell A, et al., 'Study protocol: A randomized controlled trial of a computer-based depression and substance abuse intervention for people attending residential substance abuse treatment', BMC Public Health, 12 113 (2012) [C3]
|
|
|
2012 |
Kay-Lambkin FJ, Baker AL, Kelly BJ, Lewin TJ, 'It's worth a try: The treatment experiences of rural and urban participants in a randomized controlled trial of computerized psychological treatment for comorbid depression and alcohol/other drug use', Journal of Dual Diagnosis, 8 262-276 (2012) [C1]
|
|
|
2012 |
Filia SL, Baker AL, Kulkarni J, Williams JM, 'Sequential behavioral treatment of smoking and weight control in bipolar disorder', Translational Behavioral Medicine, 2 290-295 (2012) [C3]
|
|
|
2012 |
Deady M, Kay-Lambkin F, Thornton LK, Baker AL, Teesson M, 'Social influence, addictions and the internet: the potential of web 2.0 technologies in enhancing treatment for alcohol/other drug use problems', Journal of Addiction Research & Therapy, S8 1-7 (2012) [C2]
|
|
|
2011 |
Kay-Lambkin FJ, White A, Baker AL, Kavanagh DJ, Klein B, Proudfoot J, et al., 'Assessment of function and clinical utility of alcohol and other drug web sites: An observational, qualitative study', BMC Public Health, 11 277 (2011) [C1]
|
|
|
2011 |
Baker AL, Kay-Lambkin FJ, Richmond R, Filia S, Castle D, Williams J, Lewin TJ, 'Study protocol: A randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders', BMC Public Health, 11 10 (2011) [C3]
|
|
|
2011 |
Stockings EA, Bowman JA, Wiggers JH, Baker AL, Terry M, Clancy R, et al., 'A randomised controlled trial linking mental health inpatients to community smoking cessation supports: A study protocol', BMC Public Health, 11 570 (2011) [C3]
|
|
|
2011 |
Farrugia PL, Mills KL, Barrett E, Back SE, Teesson M, Baker AL, et al., 'Childhood trauma among individuals with co-morbid substance use and post-traumatic stress disorder', Mental Health and Substance Use, 4 314-326 (2011) [C1]
|
|
|
2011 |
Thornton LK, Baker AL, Johnson MP, Kay-Lambkin FJ, 'Perceptions of anti-smoking public health campaigns among people with psychotic disorders', Mental Health and Substance Use: Dual Diagnosis, 4 110-115 (2011) [C1]
|
|
|
2011 |
Filia SL, Baker AL, Richmond R, Castle DJ, Kay-Lambkin FJ, Sakrouge RE, et al., 'Health behaviour risk factors for coronary heart disease (CHD) in smokers with a psychotic disorder: Baseline results', Mental Health and Substance Use: Dual Diagnosis, 4 158-171 (2011) [C1]
|
|
|
2011 |
Baker AL, Kay-Lambkin FJ, Richmond R, Filia S, Castle D, Williams J, Thornton LK, 'Healthy lifestyle intervention for people with severe mental disorders', Mental Health and Substance Use: Dual Diagnosis, 4 144-157 (2011) [C1]
|
|
|
2011 |
Baker AL, McNeill A, 'Beyond the smokescreen: Reducing smoking among people with mental health problems', Mental Health and Substance Use: Dual Diagnosis, 4 93-95 (2011) [C3]
|
|
|
2011 |
Kay-Lambkin FJ, Baker AL, Kelly BJ, Lewin TJ, 'Clinician-assisted computerised versus therapist-delivered treatment for depressive and addictive disorders: A randomised controlled trial', Medical Journal of Australia, 195 S44-S50 (2011) [C1]
|
|
|
2011 |
Kay-Lambkin FJ, Baker AL, Lee NM, Jenner L, Lewin TJ, 'The influence of depression on treatment for methamphetamine use', Medical Journal of Australia, 195 S38-S43 (2011) [C1]
|
|
|
2011 |
De Ville M, Baker AL, Lewin TJ, Bucci S, Loughland CM, 'Associations between substance use, neuropsychological functioning and treatment response in psychosis', Psychiatry Research, 186 190-196 (2011) [C1]
|
|
|
2011 |
Lee N, Jenner L, Baker AL, Ritter A, Hides L, Norman J, et al., 'Screening and intervention for mental health problems in alcohol and other drug settings: Can training change practitioner behaviour?', Drugs: Education, Prevention and Policy, 18 157-160 (2011) [C1]
|
|
|
2011 |
Barrowclough C, Baker AL, Lewin TJ, 'Psychosis and comorbid substance misuse: Integrated motivational interviewing and cognitive behavioural therapy reduces alcohol intake', Evidence-Based Mental Health, 14 51 (2011) [C3]
|
|
|
2011 |
Kay-Lambkin F, Baker AL, Lewin TJ, Carr V, 'Acceptability of a clinician-assisted computerized psychological intervention for comorbid mental health and substance use problems: Treatment adherence data from a randomized controlled trial', Journal of Medical Internet Research, 13 254-264 (2011) [C1]
|
|
|
2011 |
Hides L, Baker AL, Kavanagh D, Proctor D, 'Psychological interventions for co-occurring depression and substance misuse', Cochrane Database of Systematic Reviews, 12 (2011) [C1]
|
|
|
2010 |
Conrad A, Lewin TJ, Carr VJ, Baker AL, Terry MA, Taylor A, 'Pathways to care and community-based service contact patterns among clients with a dual diagnosis', Mental Health and Substance Use: Dual Diagnosis, 3 10-24 (2010) [C1]
|
|
|
2010 |
Bucci S, Baker AL, Halpin SA, Hides L, Lewin TJ, Carr VJ, Startup MJ, 'Intervention for cannabis use in young people at ultra high risk for psychosis and in early psychosis', Mental Health and Substance Use: Dual Diagnosis, 3 66-73 (2010) [C1]
|
|
|
2010 |
Staiger PK, Long C, Baker AL, 'Health service systems and comorbidity: Stepping up to the mark', Mental Health and Substance Use: Dual Diagnosis, 3 148-161 (2010) [C1]
|
|
|
2010 |
Baker AL, Richmond R, Lewin TJ, Kay-Lambkin FJ, 'Cigarette smoking and psychosis: Naturalistic follow up 4 years after an intervention trial', Australian and New Zealand Journal of Psychiatry, 44 342-350 (2010) [C1]
|
|
|
2010 |
Turner A, Phillips L, Hambridge JA, Baker AL, Bowman JA, Colyvas KJ, 'Clinical outcomes associated with depression, anxiety and social support among cardiac rehabilitation attendees', Australian and New Zealand Journal of Psychiatry, 44 658-666 (2010) [C1]
|
|
|
2010 |
Baker AL, Hides L, Lubman DI, 'Treatment of cannabis use among people with psychotic or depressive disorders: A systematic review', Journal of Clinical Psychiatry, 71 247-254 (2010) [C1]
|
|
|
2010 |
Hides L, Carroll S, Catania L, Cotton SM, Baker AL, Scaffidi A, Lubman DI, 'Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people', Journal of Affective Disorders, 121 169-174 (2010) [C1]
|
|
|
2010 |
Lubman DI, Baker AL, 'Cannabis and mental health: Management in primary care', Australian Family Physician, 39 554-557 (2010) [C1]
|
|
|
2010 |
Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton LK, Kelly BJ, Sellman JD, 'An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R)', Drug and Alcohol Dependence, 110 137-143 (2010) [C1]
|
|
|
2010 |
Lee NK, Pohlman S, Baker AL, Femis J, Kay-Lambkin FJ, 'It's the thought that counts: Craving metacognitions and their role in abstinence from methamphetamine use', Journal of Substance Abuse Treatment, 38 245-250 (2010) [C1]
|
|
|
2010 |
Bailey K, Webster R, Baker A, Kavanagh D, 'TRAUMA EVENTS AND PSYCHOLOGICAL SEQUALAE', DRUG AND ALCOHOL REVIEW, 29 3-3 (2010) [E3]
|
|
|
2010 |
Hides L, Carroll S, Scaffidi A, Scott R, Baker A, Lubman DI, 'STEPPED CARE FOR YOUNG PEOPLE WITH CO-EXISTING DEPRESSION AND SUBSTANCE USE', DRUG AND ALCOHOL REVIEW, 29 5-5 (2010) |
|
|
2010 |
Mills KL, Teesson M, Barrett EL, Merz S, Rosenfeld J, Farrugia P, et al., 'FEASIBILITY OF STEPPED CARE FOR POSTTRAUMATIC STRESS DISORDER AND SUBSTANCE USE DISORDER', DRUG AND ALCOHOL REVIEW, 29 5-5 (2010) |
|
|
2010 |
White A, Kavanagh DJ, Stallman HM, Klein B, Kay-Lambkin F, Proudfoot J, et al., 'ONLINE ALCOHOL INTERVENTIONS: A SYSTEMATIC REVIEW', DRUG AND ALCOHOL REVIEW, 29 13-13 (2010)
|
|
|
2010 |
Kay-Lambkin F, White A, Baker A, Kavanagh DJ, Klein B, Proudfoot J, et al., 'ASSESSMENT OF FUNCTION AND CLINICAL UTILITY OF ALCOHOL AND OTHER DRUG WEB SITES: AN OBSERVATIONAL, QUALITATIVE STUDY', DRUG AND ALCOHOL REVIEW, 29 13-14 (2010)
|
|
|
2010 |
Thornton L, Baker A, Johnson M, 'PERCEPTIONS OF PUBLIC HEALTH CAMPAIGNS AND KNOWLEDGE REGARDING TOBACCO, ALCOHOL AND CANNABIS AMONG PEOPLE WITH PSYCHOTIC DISORDERS: A MIXED METHOD EXPLORATION', DRUG AND ALCOHOL REVIEW, 29 77-77 (2010)
|
|
|
2010 |
Baker AL, 'New methodological directions for psychological intervention research among substance users', Drug and Alcohol Review, 29 467-468 (2010) [C3]
|
|
|
2010 |
Kay-Lambkin FJ, Baker AL, McKetin R, Lee N, 'Stepping through treatment: Reflections on an adaptive treatment strategy among methamphetamine users with depression', Drug and Alcohol Review, 29 475-482 (2010) [C1]
|
|
|
2010 |
Baker AL, Kavanagh DJ, Kay-Lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, Connolly J, 'Randomized controlled trial of cognitive-behavioural therapy for coexisting depression and alcohol problems: Short-term outcome', Addiction, 105 87-99 (2010) [C1]
|
|
|
2010 |
Baker AL, Lubman DI, Hides L, 'Smoking and schizophrenia: Treatment approaches within primary care', Primary Psychiatry, 17 49-54 (2010) [C1]
|
|
|
2010 |
Wye PM, Bowman JA, Wiggers JH, Baker AL, Carr VJ, Terry MA, et al., 'An audit of the prevalence of recorded nicotine dependence treatment in an Australian psychiatric hospital', Australian and New Zealand Journal of Public Health, 34 298-303 (2010) [C1]
|
|
|
2010 |
Wye P, Bowman JA, Wiggers J, Baker AL, Carr V, Terry M, et al., 'Providing nicotine dependence treatment to psychiatric inpatients: the views of Australian nurse managers', Journal of Psychiatric and Mental Health Nursing, 17 319-327 (2010) [C1]
|
|
|
2010 |
Klein B, White A, Kavanagh D, Shandley K, Kay-Lambkin FJ, Proudfoot J, et al., 'Content and functionality of alcohol and other drug websites: Results of an online survey', Journal of Medical Internet Research, 12 e51 (2010) [C1]
|
|
|
2010 |
White A, Kavanagh D, Stallman H, Klein B, Kay-Lambkin FJ, Proudfoot J, et al., 'Online alcohol Interventions: A systematic review', Journal of Medical Internet Research, 12 1-9 (2010) [C1]
|
|
|
2010 |
Wye PM, Bowman JA, Wiggers JH, Baker AL, Knight JJ, Carr V, et al., 'Total smoking bans in psychiatric inpatient services: a survey of perceived benefits, barriers and support among staff', BMC Public Health, 10 372-383 (2010) [C1]
|
|
|
2009 |
Johns K, Baker AL, Webster RA, Lewin TJ, 'Factors associated with retention in a long-term residential rehabilitation programme for women with substance use problems', Mental Health and Substance Use: Dual Diagnosis, 2 40-51 (2009) [C1]
|
|
|
2009 |
Baker AL, Kay-Lambkin FJ, Lee N, 'When less is more: Addressing symptoms of mental health problems in drug and alcohol treatment settings', Mental Health and Substance Use: Dual Diagnosis, 2 130-139 (2009) [C1]
|
|
|
2009 |
Baker AL, Velleman R, 'Helping non-specialist professionals to detect and assist with co-existing mental health and drug and alcohol problems', Mental Health and Substance Use: Dual Diagnosis, 2 173-181 (2009) [C1]
|
|
|
2009 |
Baker AL, Richmond R, Castle D, Kulkarni J, Kay-Lambkin FJ, Sakrouge RE, et al., 'Coronary heart disease risk reduction intervention among overweight smokers with a psychotic disorder: Pilot trial', Australian and New Zealand Journal of Psychiatry, 43 129-135 (2009) [C1]
|
|
|
2009 |
Hambridge JA, Turner A, Baker AL, 'BraveHeart begins: Pilot results of group cognitive behaviour therapy for depression and anxiety in cardiac patients', Australian and New Zealand Journal of Psychiatry, 43 1171-1177 (2009) [C1]
|
|
|
2009 |
Hunt SA, Baker AL, Michie PT, Kavanagh DJ, 'Neurocognitive profiles of people with comorbid depression and alcohol use: Implications for psychological interventions', Addictive Behaviors, 34 878-886 (2009) [C1]
|
|
|
2009 |
Baker AL, Turner A, Kay-Lambkin FJ, Lewin TJ, 'The long and the short of treatments for alcohol or cannabis misuse among people with severe mental disorders', Addictive Behaviors, 34 852-858 (2009) [C1]
|
|
|
2009 |
Baker AL, 'New directions for research on psychological interventions for drug and alcohol problems', Drug and Alcohol Review, 28 219-221 (2009) [C3]
|
|
|
2009 |
Baker AL, 'Motivational interviewing in the treatment of psychological problems', Drug and Alcohol Review, 28 696 (2009) [C3] |
|
|
2009 |
Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ, 'Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: A randomized controlled trial of clinical efficacy', Addiction, 104 378-388 (2009) [C1]
|
|
|
2009 |
Wye PM, Bowman JA, Wiggers JH, Baker AL, Knight JJ, Carr VJ, et al., 'Smoking restrictions and treatment for smoking: Policies and procedures in psychiatric inpatient units in Australia', Psychiatric Services, 60 100-107 (2009) [C1]
|
|
|
2008 |
Degenhardt L, Baker AL, Maher L, 'Methamphetamine: Geographic areas and populations at risk, and emerging evidence for effective interventions', Drug and Alcohol Review, 27 217-219 (2008) [C3]
|
|
|
2008 |
Spain D, Crilly J, Whyte IM, Jenner L, Carr VJ, Baker AL, 'Safety and effectiveness of high-dose midazolam for severe behavioural disturbance in an emergency department with suspected psychostimulant-affected patients', Emergency Medicine Australasia: EMA, 20 112-120 (2008) [C1]
|
|
|
2008 |
Velleman R, Baker AL, 'Moving away from medicalised and partisan terminology: A contribution to the debate', Mental Health and Substance Use, 1 2-9 (2008) [C1]
|
|
|
2008 |
Bucci SR, Startup MJ, Wynn PL, Heathcote AJ, Baker AL, Lewin TJ, 'Referential delusions of communication and reality discrimination deficits in psychosis', British Journal of Clinical Psychology, 47 323-334 (2008) [C1]
|
|
|
2008 |
Bucci SR, Startup MJ, Wynn PL, Baker AL, Lewin TJ, 'Referential delusions of communication and interpretations of gestures', Psychiatry Research, 158 27-34 (2008) [C1]
|
|
|
2008 |
McKetin R, Ross J, Kelly E, Baker AL, Lee N, Lubman DI, Mattick R, 'Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants', Drug and Alcohol Review, 27 277-285 (2008) [C1]
|
|
|
2007 |
Baker AL, 'Medication treatments for nicotine dependence', Drug and Alcohol Review, 26 455-456 (2007) [C3]
|
|
|
2007 |
Baker A, Lewin TJ, 'Drs. Baker and Lewin reply [4]', American Journal of Psychiatry, 164 828 (2007)
|
|
|
2007 |
Baker AL, Lewin TJ, 'Readiness to quit and smoking reduction outcomes - Drs Baker and Lewin reply', American Journal of Psychiatry, 164 828 (2007) [C3] |
|
|
2007 |
Bradley AC, Baker AL, Lewin TJ, 'Group intervention for coexisting psychosis and substance use disorders in rural Australia: Outcomes over 3 years', Australian and New Zealand Journal of Psychiatry, 41 501-508 (2007) [C1]
|
|
|
2007 |
Baker AL, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, et al., 'Characteristics of smokers with a psychotic disorder and implications for smoking interventions', Psychiatry Research, 150 141-152 (2007) [C1]
|
|
|
2006 |
Turner A, Hambridge J, Baker A, Grace C, Kay-Lambkin F, Bowman J, 'BraveHeart: a new development in cognitive behaviour therapy for co-existing depression and coronary heart disease', JOURNAL OF AFFECTIVE DISORDERS, 91 S27-S27 (2006)
|
|
|
2006 |
Baker A, 'Talking with college students about alcohol', DRUG AND ALCOHOL REVIEW, 25 651-651 (2006)
|
|
|
2006 |
Baker AL, Ivers RG, Bowman JA, Butler T, Kay-Lambkin FJ, Wye PM, et al., 'Where there's smoke, there's fire: high prevalence of smoking among some sub-populations and recommendations for intervention', Drug and Alcohol Review, 25 85-96 (2006) [C1]
|
|
|
2006 |
Greig RL, Baker AL, Lewin TJ, Webster RA, Carr VJ, 'Long-term follow-up of people with co-existing psychiatric and substance use disorders: patterns of use and outcomes', Drug and Alcohol Review, 25 249-258 (2006) [C1]
|
|
|
2006 |
Baker AL, 'Talking with college students about alcohol (Book review)', Drug and Alcohol Review, 25 651 (2006) [C3] |
|
|
2006 |
Bucci S, Baker A, Kay-Lambkin F, Lewin T, Carr V, 'A randomized controlled trial of cognitive-behaviour therapy among people with a psychotic illness and coexisting alcohol and other drug problems', ACTA PSYCHIATRICA SCANDINAVICA, 114 57-57 (2006)
|
|
|
2006 |
Baker AL, Richmond R, Haile MJ, Lewin TJ, Carr VJ, Taylor RL, et al., 'A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder', American Journal of Psychiatry, 163 1934-1942 (2006) [C1]
|
|
|
2006 |
Baker AL, Bucci SR, Lewin TJ, Kay-Lambkin FJ, Constable PM, Carr VJ, 'Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders - Randomised controlled trial', British Journal of Psychiatry, 188 439-448 (2006) [C1]
|
|
|
2006 |
Startup M, Carr V, Baker A, Stain H, Halpin S, Bucci S, '01-07 Cannabis use as a complication in psychological treatments for people at ultrahigh risk of psychosis: early findings from the DEPTh trial.', Acta Neuropsychiatr, 18 316 (2006)
|
|
|
2005 |
Kelly B, Underwood L, Baker A, 'Computerised cognitive behavioural therapy for coexisting depression and alcohol/other drug use problems: A rural and remote perspective', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 39 A99-A100 (2005)
|
|
|
2005 |
Underwood L, Kelly B, Baker A, 'Treating co-morbid diabetes type II and depression: The development of a computer assisted cognitive behavioural intervention "made it"', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 39 A100-A100 (2005)
|
|
|
2005 |
Baker AL, Dawe S, 'Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment', Australian Psychologist, 40 88-95 (2005) [C1]
|
|
|
2005 |
Baker AL, Bucci SR, Lewin TJ, Richmond R, Carr VJ, 'Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies', Psychiatry Research, 134 241-250 (2005) [C1]
|
|
|
2005 |
Baker AL, Lee NK, Claire MR, Lewin TJ, Grant T, Pohlman S, et al., 'Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction', Addiction, 100 367-378 (2005) [C1]
|
|
|
2005 |
Baker AL, 'Cognitive-behavioural integrated treatment (C-BIT): A treatment manual for substance misuse in people with severe mental health problems (book review)', Drug and Alcohol Review, 24 200-201 (2005) [C3] |
|
|
2004 |
Kavanagh DJ, Baker A, Teesson M, 'Co-morbidity of mental disorders and substance misuse--introduction.', Drug and alcohol review, 23 405-406 (2004)
|
|
|
2004 |
Baker A, 'Treating alcohol dependence, 2nd edition', DRUG AND ALCOHOL REVIEW, 23 127-128 (2004)
|
|
|
2004 |
Baker A, 'Motivational interviewing: Preparing people for change, 2nd edition', DRUG AND ALCOHOL REVIEW, 23 127-128 (2004)
|
|
|
2004 |
Bailey KA, Baker AL, Webster RA, Lewin TJ, 'Pilot randomized controlled trial of a brief alcohol intervention group for adolescents', Drug and Alcohol Review, 23 157-166 (2004) [C1]
|
|
|
2004 |
Kay-Lambkin FJ, Baker AL, Lewin TJ, 'The 'co-morbidity roundabout': a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems', Drug and Alcohol Review, 23 407-423 (2004) [C1]
|
|
|
2004 |
Kavanagh DJ, Baker AL, Teesson M, 'Special Section- Co-morbidity of mental disorders and substance misuse. Introduction', Drug and Alcohol Review, 23 405-406 (2004) [C3]
|
|
|
2004 |
Baker AL, Lee NK, Claire MR, Lewin TJ, Grant T, Pohlman S, et al., 'Drug use patterns and mental health of regular ampthetamine users during a reported 'heroin drought'', Addiction, 99 875-884 (2004) [C1]
|
|
|
2003 |
Baker AL, Lee NK, 'A review of psychosocial interventions for amphetamine use', Drug and Alcohol Review, 22 323-335 (2003) [C1]
|
|
|
2003 |
Claire M, Baker A, Lee N, Pohlman S, Saunders J, Lewin T, et al., 'Nonpharmacological interventions for psychostimulant use', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55 101-101 (2003)
|
|
|
2003 |
Claire M, Baker A, Lewin T, Lee N, Grant T, Pohlman S, 'Cognitive behaviour therapy, aggression and psychostimulant use', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55 101-101 (2003)
|
|
|
2003 |
Haile M, Baker A, Richmond R, Carr V, Lewin T, Wilhelm K, et al., 'A randomised controlled trial of an intervention for tobacco dependence among people with a psychotic illness', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55 102-103 (2003)
|
|
|
2003 |
Kay-Lambkin F, Baker A, Bucci S, Lewin T, Rajkumar S, Carr V, 'Computer-based therapy for depression and alcohol/other drug (AOD) problems', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55 104-104 (2003)
|
|
|
2003 |
Bucci SR, Baker AL, Kay-Lambkin FJ, Lewin (Ext) T, Carr VJ, Constable PM, 'Randomised controlled trial of cognitive behavioural therapy for comorbid psychotic illness and alcohol and other drug problems', Australian Journal of Psychology, 55 100 (2003) [C3]
|
|
|
2003 |
Baker A, 'Drug use and drug-related harm: A delicate balance', DRUG AND ALCOHOL REVIEW, 22 238-239 (2003)
|
|
|
2003 |
Baker A, 'Addictions', DRUG AND ALCOHOL REVIEW, 22 376-376 (2003)
|
|
|
2003 |
Baker A, 'International handbook of alcohol dependence and problems', DRUG AND ALCOHOL REVIEW, 22 477-477 (2003)
|
|
|
2002 |
Baker A, Hambridge J, 'Motivational interviewing: Enhancing engagement in treatment for mental health problems', BEHAVIOUR CHANGE, 19 138-145 (2002)
|
|
|
2002 |
Baker AL, Roche A, 'From training to work-force development: a large and important conceptual leap', Drug and Alcohol Review, 21 205-207 (2002) [C3]
|
|
|
2002 |
Baker AL, Lewin TJ, Reichler HM, Clancy R, Carr VJ, Garrett R, et al., 'Evaluation of a motivational interview for substance use within psychiatric in-patient services', Addiction, 97(10) 1329-1337 (2002) [C1]
|
|
|
2002 |
Baker AL, Lewin TJ, Reichler HM, Clancy R, Carr VJ, Garrett R, et al., 'Motivational interviewing among psychiatric in-patients with substance use disorders', ACTA Psychiatrica Scandinavica, 106 233-240 (2002) [C1]
|
|
|
2001 |
Baker A, 'Counselling for alcohol problems', DRUG AND ALCOHOL REVIEW, 20 462-463 (2001) |
|
|
2001 |
Reichler HM, Baker AL, Lewin T, Carr VJ, 'Smoking among in-patients with drug-related problems in an Australian psychiatric hospital', Drug and Alcohol Review, 20 231-237 (2001) [C1]
|
|
|
2001 |
Baker AL, Boggs TG, Lewin TJ, 'Characteristics of regular amphetamine users and implications for treatment', Drug and Alcohol Review, 20 49-56 (2001) [C1]
|
|
|
2001 |
Baker AL, Heather N, Wodak A, Lewin TJ, 'Heroin use and HIV risk-taking behaviour among women injecting drug users', Drug and Alcohol Review, 20 205-211 (2001) [C1]
|
|
|
2001 |
Baker AL, Boggs TG, Lewin TJ, 'Randomized controlled trial of brief cognitive-behavioural interventions among regular users of amphetamine', Addiction, 96 1279-1287 (2001) [C1]
|
|
|
2001 |
Hambridge J, Baker AL, 'Medical Psychology in Australia', Jourjnal of Clinical Psychology in Medical Settings, 8 3-7 (2001) [C1]
|
|
|
1996 |
O'Neill K, Baker A, Cooke M, Collins E, Heather N, Wodak A, 'Evaluation of a cognitive-behavioural intervention for pregnant injecting drug users at risk of HIV infection', Addiction, 91 1115-1126 (1996)
Pregnant injecting drug users were randomly assigned to: (i) individually receive a six-session cognitive-behavioural intervention in addition to their usual methadone maintenance... [more]
Pregnant injecting drug users were randomly assigned to: (i) individually receive a six-session cognitive-behavioural intervention in addition to their usual methadone maintenance treatment (intervention condition (I) (n = 40)); or (ii) their usual methadone maintenance treatment only (control condition (C) (n = 40)). There was no change in drug use per se in either group after the intervention. However, at 9-month follow-up the I group had significantly reduced some HIV risk-taking behaviours (in particular injecting risk behaviours). The I group reduced the needle risk associated both with 'typical' use (drug use in the month before interview) and 'binge' use (drug use in the month nominated as the heaviest month of drug use in the previous 6 months). The intervention had no effect on sexual risk behaviours. The finding of reduced injecting risk behaviour following the six-session intervention suggests that such an intervention may be of benefit for individuals persisting with injecting risk behaviours despite methadone maintenance treatment and the availability of sterile injection equipment.
|
|
|
1994 |
Baker A, Kochan N, Dixon J, Wodak A, Heather N, 'Drug use and HIV risk-taking behaviour among injecting drug users not currently in treatment in Sydney, Australia', Drug and Alcohol Dependence, 34 155-160 (1994)
This study investigated the drug use patterns and HIV risk-taking behaviour of 200 injecting drug users (IDU) not currently in treatment in Sydney, Australia. Although there was l... [more]
This study investigated the drug use patterns and HIV risk-taking behaviour of 200 injecting drug users (IDU) not currently in treatment in Sydney, Australia. Although there was low HIV seroprevalence, unsafe injecting and sexual practices were common. Variables that were predictive of injecting risk-taking were higher level of heroin use, sexual relationship with an IDU and greater polydrug use. Two variables were predictive of sexual risk-taking: higher level of hallucinogen use and sexual relationship with an IDU. Female subjects were significantly more likely to have an IDU sexual partner. A higher level of cannabis use was associated with greater polydrug use and a higher level of amphetamine use was associated with greater use of opiates other than heroin. The findings are discussed in terms of the need for interventions aimed towards reducing sexual risk-taking among users of hallucinogens and towards reducing injecting and sexual risk-taking among IDU and their sexual partners. The potential difficulty in producing behaviour change among polydrug users is highlighted. © 1994.
|
|
|
1993 |
Tarrier N, Beckett R, Harwood S, Baker A, Yusupoff L, Ugarteburu I, 'A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome', British Journal of Psychiatry, 162 524-532 (1993)
Despite neuroleptic medication, many schizophrenic patients continue to experience residual positive psychotic symptoms. These residual symptoms cause distress and disability. We ... [more]
Despite neuroleptic medication, many schizophrenic patients continue to experience residual positive psychotic symptoms. These residual symptoms cause distress and disability. We report a controlled trial of two cognitive-behavioural treatments to alleviate residual hallucinations and delusions. Forty-nine patients were recruited into the trial, of whom 27 entered the trial and completed post-treatment assessment, and 23 were assessed at six-month follow-up. Patients were randomly allocated to either coping strategy enhancement (CSE) or problem solving (PS). Half the patients were allocated to a high-expectancy positive demand condition and half to a counter-demand condition to evaluate expectations of improvement. Patients receiving either cognitive-behavioural treatment showed significant reductions in psychotic symptoms compared with those in the waiting period, who showed no improvement. There was some evidence, although equivocal, that patients receiving CSE improved more than those receiving PS. There was no evidence that improvements generalised to negative symptoms or social functioning, nor was there evidence that expectancy of treatment benefit contributed to the treatment effect.
|
|
|
1993 |
Baker A, Heather N, Wodak A, Dixon J, Holt P, 'Evaluation of a cognitive-behavioural intervention for HIV prevention among injecting drug users', AIDS, 7 247-256 (1993)
Objective: To evaluate the effectiveness of relapse prevention (RP) and brief intervention (BI) in reducing HIV risk-taking behaviours among injecting drug users (IDU) enrolled in... [more]
Objective: To evaluate the effectiveness of relapse prevention (RP) and brief intervention (BI) in reducing HIV risk-taking behaviours among injecting drug users (IDU) enrolled in methadone programmes. The hypotheses tested were: (1) that a six-session RP programme would be more effective in reducing HIV risk-taking behaviours than a one-session BI and a non-intervention control condition (C); and (2) that BI would be more effective in reducing HIV risk-taking behaviours than C. Design: Clients of methadone programmes were randomly assigned to either RP, BI, or C. Follow-up occurred 6 months after pre-intervention assessment and was conducted by independent research assistants who were not aware of subjects' group allocations. Setting: Confidential assessment interviews and interventions generally took place at the methadone unit treating the subject. Participants: Ninety-five IDU enrolled in methadone programmes. Study entry criteria were: injection of any drug in the 6 months before the day of pre-intervention assessment; literacy in English; agreement to HIV-antibody testing for research purposes; and no known diagnosis of a serious mental illness. Eighty subjects were contacted successfully for a 6-month follow-up. Interventions: The RP intervention was a six-session programme. Each 60-90-min session was conducted individually. The BI was a one-session motivational interview lasting 60-90min, accompanied by a self-help booklet. Main outcome measures: All subjects were administered the Drug Use Scale and HIV Risk-Taking Behaviour Scale of the Opiate Treatment Index and consented to the collection of a capillary blood sample for HIV-antibody testing at pre-intervention assessment and follow-up. At follow-up, the Highest HIV Risk-Taking Behaviour Scale, collateral reports from subjects' sexual partners pertaining to the previous month and urinalysis results for the month before follow-up were collected. Results: Compliance with interventions was good. Correspondence of self-reports with urinalysis and collateral reports was satisfactory. There were no significant differences between groups in risk-taking behaviours during the month before follow-up. However, there was evidence of a lower rate of needle-risk behaviour (sharing and cleaning) during the heaviest risk-taking month since pre-intervention assessment in the group given RP. There were no indications that BI was of greater benefit than the usual methadone treatment and neither intervention appeared to reduce sexual risk behaviour. Conclusions: The results are cautiously interpreted as showing that individual RP programmes decrease the level of needle-risk behaviour during relapse episodes, but further research is required to replicate this finding.
|
|
|
1993 |
Tarrier N, Sharpe L, Beckett R, Harwood S, Baker A, Yusopoff L, 'A trial of two cognitive behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients - II. Treatment-specific changes in coping and problem-solving skills', Social Psychiatry and Psychiatric Epidemiology, 28 5-10 (1993)
Changes in coping skills and problem-solving skills were examined in two groups of schizophrenic patients. The groups received either coping skills enhancement or problem-solving ... [more]
Changes in coping skills and problem-solving skills were examined in two groups of schizophrenic patients. The groups received either coping skills enhancement or problem-solving treatments to reduce their drugresistant residual psychotic symptoms. The coping skills group showed significant increases both in the number of positive coping strategies used and in their efficacy, whereas the problem-solving group showed a decrease in these measures during treatment. Both groups showed significant improvements in problem-solving skills. Changes in coping but not problem solving were significantly related to decreases in psychotic symptoms during treatment. It was concluded that treatment involving the teaching of coping skills had a specific treatment effect. © 1993 Springer-Verlag.
|
|
|
1992 |
Darke S, Baker A, Dixon J, Wodak A, Heather N, 'Drug use and HIV risk-taking behaviour among clients in methadone maintenance treatment', Drug and Alcohol Dependence, 29 263-268 (1992)
Current drug use and HIV risk-taking behaviour of a sample of 95 methadone maintenance clients was investigated. Subjects had been on their current programme for an average of 70.... [more]
Current drug use and HIV risk-taking behaviour of a sample of 95 methadone maintenance clients was investigated. Subjects had been on their current programme for an average of 70.9 weeks with a mean daily dose of methadone of 65.6 mg. Two-thirds had injected heroin, and 82% had injected a street drug in the month prior to interview. Over 20% of subjects had shared a needle in the month before interview, all with only one other person. Subjects who had injected cocaine in the month before interview had significantly higher levels of injecting risk-taking behaviour than those subjects who had injected but not used cocaine. Condom use among subjects was low, particularly in regular relationships. While knowledge concerning HIV was high among subjects, there was no relation between level of knowledge and actual behaviour. It is concluded that knowledge alone is not sufficient to ensure behaviour change. © 1992.
|
|
|
1990 |
Tarrier N, Harwood S, Yusopoff L, Beckett R, Baker A, 'Coping Strategy Enhancement (CSE): A Method of Treating Residual Schizophrenic Symptoms', Behavioural Psychotherapy, 18 283-293 (1990)
A method of teaching coping skills to patients with schizophrenia who experience unremitting psychotic symptoms is described. This method (Coping Strategy Enhancement CSE) is base... [more]
A method of teaching coping skills to patients with schizophrenia who experience unremitting psychotic symptoms is described. This method (Coping Strategy Enhancement CSE) is based on a thorough behaviour analysis of each symptom and the assessment of any coping strategy the subject may already employ. The subject is then systematically trained in the use of appropriate coping strategies in response to the occurrence of their psychotic symptoms. Two case studies are described in which CSE was used. Both patients showed considerable improvements over treatment. In one patient improvement continued at 6 month follow-up, in the other there was some deterioration at follow-up. Possible reasons for these results were discussed. © 1990, British Association for Behavioural and Cognitive Psychotherapies. All rights reserved.
|
|
|
|
Denham AMJ, Baker AL, Spratt NJ, Wynne O, Hunt S, Sharma-Kumar R, Bonevski B, 'The unmet needs of caregivers of stroke survivors: A review of the content of YouTube videos (Preprint)', JMIR Rehabilitation and Assistive Technologies,
|
|
|
|
Thornton L, Kay-Lambkin F, Tebbutt B, Hanstock TL, Baker AL, 'MyHealthPA: Development and Pilot Testing of a Mobile-Based Monitoring Tool to Reduce Cardio-Vascular Disease Risk in People with Mental Health Problems (Preprint)
|
|
|
|
Denham AMJ, Baker AL, Spratt NJ, Wynne O, Hunt S, Sharma-Kumar R, Bonevski B, 'The unmet needs of caregivers of stroke survivors: A review of the content of YouTube videos (Preprint)
|
|
|